MVLS Research Outputs
Discover and explore the research currently being undertaken across our seven schools in response to the Covid19 pandemic.
School of Biodiversity, One Health & Veterinary Medicine
Covid19 Publications
Naserrudin, N. A. et al. (2023) The public health response to a Plasmodium malariae outbreak in Penampang district, Sabah during a COVID-19 movement control order. Malaria Journal, 22, 292. (doi: 10.1186/s12936-023-04693-1) (PMID:37789320) (PMCID:PMC10546630)
Vöhringer, H. S. et al. (2021) Genomic reconstruction of the SARS-CoV-2 epidemic in England. Nature, 600(7889), pp. 506-511. (doi: 10.1038/s41586-021-04069-y) (PMID:34649268) (PMCID:PMC8674138)
Nickbakhsh, S. et al. (2022) Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning. Scientific Reports, 12, 11735. (doi: 10.1038/s41598-022-15661-1) (PMID:35853960) (PMCID:PMC9296497)
Cannata, A. et al. (2024) A nationwide, population-based study on specialized care for acute heart failure throughout the COVID-19 pandemic. European Journal of Heart Failure, 26(7), pp. 1574-1584. (doi: 10.1002/ejhf.3306) (PMID:38837310)
Nadal, D. , Abela-Ridder, B., Beeching, S., Cleaveland, S. , Cronin, K., Steenson, R. and Hampson, K. (2022) The impact of the first year of the COVID-19 pandemic on canine rabies control efforts: a mixed-methods study of observations about the present and lessons for the future. Frontiers in Tropical Diseases, 3, 866811. (doi: 10.3389/fitd.2022.866811)
Borremans, B., Gamble, A. , Prager, K.C., Helman, S. K., McClain, A. M., Cox, C., Savage, V. and Lloyd-Smith, J. O. (2020) Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset. eLife, 9, e60122. (doi: 10.7554/eLife.60122) (PMID:32894217) (PMCID:PMC7508557)
Tyson, G. B. et al. (2023) Increase in SARS-CoV-2 seroprevalence in UK domestic felids despite weak immunogenicity of post-Omicron variants. Viruses, 15(8), 1661. (doi: 10.3390/v15081661) (PMID:37632004) (PMCID:PMC10458763)
Olival, K. J. et al. (2020) Possibility for reverse zoonotic transmission of SARS-CoV-2 to free-ranging wildlife: a case study of bats. PLoS Pathogens, 16(9), e1008758. (doi: 10.1371/journal.ppat.1008758) (PMID:32881980) (PMCID:PMC7470399)
Atsawawaranunt, K. et al. (2021) COVID-19 transmission among healthcare workers at a quarantine facility in Thailand: genomic and outbreak investigations. American Journal of Tropical Medicine and Hygiene, 105(2), pp. 421-424. (doi: 10.4269/ajtmh.21-0344) (PMID:34170846) (PMCID:PMC8437180)
Vollmer, M.A.C. et al. (2021) The impact of the COVID-19 pandemic on patterns of attendance at emergency departments in two large London hospitals: an observational study. BMC Health Services Research, 21(1), 1008. (doi: 10.1186/s12913-021-07008-9) (PMID:34556119) (PMCID:PMC8460185)
Meng, B. et al. (2021) Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the variant of concern lineage B.1.1.7. Cell Reports, 35(13), 109292. (doi: 10.1016/j.celrep.2021.109292) (PMID:34166617) (PMCID:PMC8185188)
Ferguson, E. A. et al. (2022) Modelling how face masks and symptoms-based quarantine synergistically and cost-effectively reduce SARS-CoV-2 transmission in Bangladesh. Epidemics, 40, 100592. (doi: 10.1016/j.epidem.2022.100592) (PMID:35738153) (PMCID:PMC9192122)
van Doremalen, N. et al. (2020) Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, 382(16), pp. 1564-1567. (doi: 10.1056/NEJMc2004973) (PMID:32182409) (PMCID:PMC7121658)
Morris, D. H. et al. (2021) Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses. eLife, 10, e65902. (doi: 10.7554/eLife.65902) (PMID:33904403) (PMCID:PMC8277363)
Addie, D., Houe, L., Maitland, K. , Passantino, G. and Decaro, N. (2020) Effect of cat litters on feline coronavirus infection of cell culture and cats. Journal of Feline Medicine and Surgery, 22(4), pp. 350-357. (doi: 10.1177/1098612x19848167) (PMID:31094626)
Ceron, J. J., Lamy, E., Martinez-Subiela, S., Lopez-Jornet, P., Capela e Silva, F., Eckersall, P. D. and Tvarijonaviciute, A. (2020) Use of saliva for diagnosis and monitoring the SARS-CoV-2: a general perspective. Journal of Clinical Medicine, 9(5), e1491. (doi: 10.3390/jcm9051491) (PMID:32429101) (PMCID:PMC7290439)
Mena, J. et al. (2023) Molecular surveillance of potential SARS-CoV-2 reservoir hosts in wildlife rehabilitation centers. Veterinary Quarterly, 43(1), pp. 1-10. (doi: 10.1080/01652176.2023.2164909) (PMID:36594266) (PMCID:PMC9858396)
Rowland, H., Holding, E., Falces, P. M., Wissink-Argilaga, N., Stidworthy, M. F., Denk, D., Weir, W. , Krumrie, S. , Dunbar, D. and Hopper, J. S. (2021) Canine coronavirus subtype 2a associated with outbreaks of fatal diarrhoea in bush dog (Speothos venaticus) groups. Schweizer Archiv fur Tierheilkunde, 164(10), pp. 661-671. (doi: 10.17236/sat00320) (PMID:34758958)
Hughes, E. C. et al. (2021) Severe Acute Respiratory Syndrome Coronavirus 2 serosurveillance in a patient population reveals differences in virus exposure and antibody-mediated immunity according to host demography and healthcare setting. Journal of Infectious Diseases, 223(6), pp. 971-980. (doi: 10.1093/infdis/jiaa788) (PMID:33367847) (PMCID:PMC7798933)
Quezada-Acuña, L. et al. (2024) Stress factors and food purchase prioritization during the pandemic of coronavirus disease 2019. Clinical Nutrition ESPEN, 61, pp. 145-150. (doi: 10.1016/j.clnesp.2024.03.001) (PMID:38777426)
Adamson, W. (2021) AFRIDATA: a COVID-19 dashboard for Africa. [Website]
Fischer, R. J. et al. (2020) Effectiveness of N95 respirator decontamination and reuse against SARS-CoV-2 virus. Emerging Infectious Diseases, 26(9), pp. 2253-2255. (doi: 10.3201/eid2609.201524) (PMID:32491983) (PMCID:PMC7454118)
Collier, D. A. et al. (2021) Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature, 593(7857), pp. 136-141. (doi: 10.1038/s41586-021-03412-7) (PMID:33706364)
Hanlon, P. et al. (2021) COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study. Wellcome Open Research, 5, 75. (doi: 10.12688/wellcomeopenres.15849.3) (PMID:33709037) (PMCID:PMC7927210)
Da Silva Filipe, A. et al. (2021) Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland. Nature Microbiology, 6(1), pp. 112-122. (doi: 10.1038/s41564-020-00838-z) (PMID:33349681)
Snedden, C. E. et al. (2021) SARS-CoV-2: cross-scale insights from ecology and evolution. Trends in Microbiology, 29(7), pp. 593-605. (doi: 10.1016/j.tim.2021.03.013) (PMID:33893024) (PMCID:PMC7997387)
Rihn, S. J. et al. (2021) A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLoS Biology, 19(2), e3001091. (doi: 10.1371/journal.pbio.3001091) (PMID:33630831) (PMCID:PMC7906417)
Hosie, M. J. et al. (2021) Detection of SARS-CoV-2 in respiratory samples from cats in the UK associated with human-to-cat transmission. Veterinary Record, 188(8), e247. (doi: 10.1002/vetr.247) (PMID:33890314) (PMCID:PMC8251078)
Li, K. K. et al. (2021) Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface. Journal of Infection, 83(1), pp. 96-103. (doi: 10.1016/j.jinf.2021.04.020) (PMID:33895226) (PMCID:PMC8061788)
Kuhlmeier, E. et al. (2023) Risk factor analysis of SARS-CoV-2 infection in animals in COVID-19-affected households. Viruses, 15(3), 731. (doi: 10.3390/v15030731) (PMID:36992440) (PMCID:PMC10051903)
Mollentze, N. , Keen, D., Munkhbayar, U., Biek, R. and Streicker, D. G. (2022) Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction. eLife, 11, e80329. (doi: 10.7554/eLife.80329) (PMID:36416537) (PMCID:PMC9683784)
Lampo, M., Hernández-Villena, J. V., Cascante, J., Vincenti-González, M. F., Forero-Peña, D. A., Segovia, M. J., Hampson, K. , Castro, J. and Grillet, M. E. (2021) Signatures of the Venezuelan humanitarian crisis in the first wave of COVID-19: fuel shortages and border migration. Vaccines, 9(7), 719. (doi: 10.3390/vaccines9070719) (PMID:34358135) (PMCID:PMC8310363)
Kuhlmeier, E. et al. (2023) Detection and molecular characterization of the SARS-CoV-2 Delta variant and the specific immune response in companion animals in Switzerland. Viruses, 15(1), 245. (doi: 10.3390/v15010245) (PMID:36680285) (PMCID:PMC9864232)
Metcalf, C. J. E., Paireau, J., O'Driscoll, M., Pivette, M., Hubert, B., Pontais, I., Nickbakhsh, S. , Cummings, D. A.T., Cauchemez, S. and Salje, H. (2022) Comparing the age and sex trajectories of SARS-CoV-2 morbidity and mortality with other respiratory pathogens. Royal Society Open Science, 9(6), 211498. (doi: 10.1098/rsos.211498) (PMID:35719888) (PMCID:PMC9198511)
Murcia, P. , Streiker, D. , Da Silva Filipe, A. , Robertson, D. , Jarrett, R. , Willett, B. , Hosie, M. , Biek, R. , Allan, K. and Weir, W. (2020) Send cat and dog samples to test for SARS-CoV-2. Veterinary Record, 186(17), p. 571. (doi: 10.1136/vr.m2019) (PMID:32451348)
Kronfeld-Schor, N., Stevenson, T., Nickbakhsh, S. , Schernhammer, E., Dopico, X., Dayan, T., Martinez, M. and Helm, B. (2021) Drivers of infectious disease seasonality: potential implications for COVID-19. Journal of Biological Rhythms, 36(1), pp. 35-54. (doi: 10.1177/0748730420987322) (PMID:33491541) (PMCID:PMC7924107)
Petrovan, S. O. et al. (2021) Post COVID‐19: a solution scan of options for preventing future zoonotic epidemics. Biological Reviews, 96(6), pp. 2694-2715. (doi: 10.1111/brv.12774) (PMID:34231315) (PMCID:PMC8444924)
Sania, A. et al. (2022) Rapid antigen testing by community health workers for detection of SARS-CoV-2 in Dhaka, Bangladesh: a cross-sectional study. BMJ Open, 12(6), e060832. (doi: 10.1136/bmjopen-2022-060832) (PMID:35649599) (PMCID:PMC9160589)
Mungaomklang, A. et al. (2021) Pitfalls of exceptions for COVID-19 travel quarantine: lessons from a dignitary visit to Thailand. Journal of Travel Medicine, 28(2), taab010. (doi: 10.1093/jtm/taab010) (PMID:33506268) (PMCID:PMC7901055)
Kamau, E., Luka, M. M., de Laurent, Z. R., Adema, I., Agoti, C. N. and Nokes, D. J. (2019) Genome sequences of human coronavirus OC43 and NL63, associated with respiratory infections in Kilifi, Kenya. Microbiology Resource Announcements, 8, e00730-19. (doi: 10.1128/mra.00730-19) (PMID:31727697) (PMCID:PMC6856263)
Faust, C. L. , Lambert, B., Kochenour, C., Robinson, A. C. and Bharti, N. (2021) Passive surveillance assesses compliance with COVID-19 behavioural restrictions in a rural US county. Epidemiology and Infection, 149(e211), (doi: 10.1017/S0950268821002107) (PMCID:PMC848503)
Vink, E. et al. (2024) Prevalence of endemic respiratory viruses during the COVID-19 pandemic in urban and rural Malawi. Open Forum Infectious Diseases, 11(2), ofad643. (doi: 10.1093/ofid/ofad643) (PMID:38312213) (PMCID:PMC10836885)
Li, Y.-T. et al. (2022) Lineage BA.2 dominated the Omicron SARS-CoV-2 epidemic wave in the Philippines. Virus Evolution, 8(2), veac078. (doi: 10.1093/ve/veac078) (PMID:36090771) (PMCID:PMC9452094)
Gorecka, M. et al. (2021) Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART—a UK, multicentre, observational study. Journal of Cardiovascular Magnetic Resonance, 23, 77. (doi: 10.1186/s12968-021-00752-1) (PMID:34112195) (PMCID:PMC8190746)
Pascall, D. J. et al. (2023) The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: a genomics-based retrospective cohort analysis. PLoS ONE, 18(4), e0284187. (doi: 10.1371/journal.pone.0284187) (PMID:37053201) (PMCID:PMC10101505)
Hynes, S., Armstrong, C. W., Xuan, B. B., Ankamah-Yeboah, I., Simpson, K. , Tinch, R. and Ressurreição, A. (2021) Have environmental preferences and willingness to pay remained stable before and during the global Covid-19 shock? Ecological Economics, 189, 107142. (doi: 10.1016/j.ecolecon.2021.107142)
Chechet, G. D., Kwaga, J. K.P., Yahaya, J., Noyes, H., MacLeod, A. and Adamson, W. E. (2022) SARS-CoV-2 seroprevalence at urban and rural sites in Kaduna State, Nigeria, during October/November 2021, immediately prior to detection of the Omicron variant. International Journal of Epidemiology, 51(5), pp. 1361-1370. (doi: 10.1093/ije/dyac141) (PMID:35771662) (PMCID:PMC9278217)
Khan, N. M. , Adil, M., Nasir, A. and Sikandar, A. (2021) Chest CT scan: an ideal diagnostic tool for COVID-19. In: Niaz, K. and Nisar, M. F. (eds.) COVID-19: Epidemiology, Biochemistry, and Diagnostics. Bentham Science Publishers, pp. 372-404. ISBN 9789814998949 (doi: 10.2174/9789814998932121010017)
Rees, E. M. , Nightingale, E. S., Jafari, Y., Waterlow, N. R., Clifford, S., Pearson, C. A.B., CMMID Working Group, ., Jombart, T., Procter, S. R. and Knight, G. M. (2020) COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Medicine, 18, 270. (doi: 10.1186/s12916-020-01726-3) (PMID:32878619) (PMCID:PMC7467845)
Harvey, W. T. et al. (2021) SARS-CoV-2 variants, spike mutations and immune escape. Nature Reviews Microbiology, 19(7), pp. 409-424. (doi: 10.1038/s41579-021-00573-0) (PMID:34075212) (PMCID:PMC8167834)
Gamble, A. , Fischer, R. J., Morris, D. H., Yinda, C. K., Munster, V. J., Lloyd-Smith, J. O. and Elkins, C. A. (2021) Heat-treated virus inactivation rate depends strongly on treatment procedure: illustration with SARS-CoV-2. Applied and Environmental Microbiology, 87(19), e00314-21. (doi: 10.1128/AEM.00314-21) (PMID:34288702) (PMCID:PMC8432576)
Tucker, M. A. et al. (2023) Behavioral responses of terrestrial mammals to COVID-19 lockdowns. Science, 380(6649), pp. 1059-1064. (doi: 10.1126/science.abo6499) (PMID:37289888)
Jones, S. et al. (2023) SARS-CoV-2 in domestic UK cats from Alpha to Omicron: Swab surveillance and case reports. Viruses, 15(8), 1769. (doi: 10.3390/v15081769) (PMID:37632111) (PMCID:PMC10459977)
Barbosa, A. et al. (2021) Risk assessment of SARS-CoV-2 in Antarctic wildlife. Science of the Total Environment, 755, 143352. (doi: 10.1016/j.scitotenv.2020.143352) (PMID:33162142) (PMCID:PMC7598351)
Jackson, M. R. et al. (2022) Low-dose lung radiotherapy for COVID-19 lung disease: a preclinical efficacy study in a bleomycin model of pneumonitis. International Journal of Radiation Oncology, Biology, Physics, 112(1), pp. 197-211. (doi: 10.1016/j.ijrobp.2021.08.029) (PMID:34478832) (PMCID:PMC8406661)
Chadwick, F. J. et al. (2022) Combining rapid antigen testing and syndromic surveillance improves community-based COVID-19 detection in a low-income country. Nature Communications, 13, 2877. (doi: 10.1038/s41467-022-30640-w) (PMID:35618714) (PMCID:PMC9135686)
De Clippele, L. H. and Risch, D. (2021) Measuring sound at a cold-water coral reef to assess the impact of COVID-19 on noise pollution. Frontiers in Marine Science, 8, 674702. (doi: 10.3389/fmars.2021.674702)
van Dorp, L., Shey, M. S., Ghedin, E., Michor, F., Koonin, E. V. and Hampson, K. (2021) How does large-scale genomic analysis shape our understanding of COVID variants in real time? Cell Systems, 12(2), pp. 109-111. (doi: 10.1016/j.cels.2021.01.004) (PMID:33539725) (PMCID:PMC7846266)
Banks, C. J. et al. (2022) SCoVMod – a spatially explicit mobility and deprivation adjusted model of first wave COVID-19 transmission dynamics. Wellcome Open Research, 7, 161. (doi: 10.12688/wellcomeopenres.17716.1) (PMID:35865220) (PMCID:PMC9274017)
Kite, T. A. et al. (2024) Complex percutaneous coronary intervention in patients unable to undergo coronary artery bypass grafting during the COVID-19 pandemic: insights from the UK-ReVasc Registry. Journal of Invasive Cardiology, (doi: 10.25270/jic/24.00030) (PMID:38471155) (Early Online Publication)
School of Cancer Sciences
Covid19 Publications
Spiliopoulou, P. et al. (2023) Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy. Cell Death and Disease, 14(1), 49. (doi: 10.1038/s41419-022-05548-4) (PMID:36670100) (PMCID:PMC9853486)
Pouwels, K. B. et al. (2021) Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. Nature Medicine, 27(12), pp. 2127-2135. (doi: 10.1038/s41591-021-01548-7) (PMID:34650248) (PMCID:PMC8674129)
Lee, L. Y. W. et al. (2020) COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncology, 21(10), pp. 1309-1316. (doi: 10.1016/s1470-2045(20)30442-3) (PMID:32853557) (PMCID:PMC7444972)
Turco, F. et al. (2022) What experts think about prostate cancer management during the COVID-19 pandemic: report from the Advanced Prostate Cancer Consensus Conference 2021. European Urology, 82(1), pp. 6-11. (doi: 10.1016/j.eururo.2022.02.010) (PMID:35393158) (PMCID:PMC8849852)
Choe, K., Park, H. Y., Ikram, M., Lee, H. J., Park, T. J., Ullah, R. and Kim, M. O. (2022) Systematic review of the common pathophysiological mechanisms in COVID-19 and neurodegeneration: the role of bioactive compounds and natural antioxidants. Cells, 11(8), 1298. (doi: 10.3390/cells11081298) (PMID:35455977) (PMCID:PMC9031507)
Jensen, M. P., Le Quesne, J., Officer‐Jones, L., Teodòsio, A., Thaventhiran, J., Ficken, C., Goddard, M., Smith, C., Menon, D. and Allinson, K. S. J. (2021) Neuropathological findings in two patients with fatal COVID‐19. Neuropathology and Applied Neurobiology, 47(1), pp. 17-25. (doi: 10.1111/nan.12662) (PMID:32895961)
Keith, N. , Plummer, R., Coyle, V., Cameron, D., Evans, J. , Twelves, C., Palmer, D., Danson, S., Graham, D. and Welisch, G. (2021) Early Phase Cancer Research in the COVID-19 Pandemic: an ECMC North Initiative. Project Report. OSF. (doi: 10.17605/OSF.IO/6WTN2).
Pouwels, K. B. et al. (2021) Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey. Lancet Public Health, 6(1), e30-e38. (doi: 10.1016/s2468-2667(20)30282-6) (PMID:33308423) (PMCID:PMC7786000)
Stock, S. J. et al. (2022) Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study. Lancet Respiratory Medicine, 10(12), pp. 1129-1136. (doi: 10.1016/S2213-2600(22)00360-5) (PMID:36216011) (PMCID:PMC9708088)
Duffy, C. et al. (2020) Chest drain aerosol generation in COVID-19 and emission reduction using a simple anti-viral filter. BMJ Open, 7, e000710. (doi: 10.1136/bmjresp-2020-000710) (PMID:33148778) (PMCID:PMC7643431)
McPeake, J. et al. (2021) Long-term outcomes following severe COVID-19 infection: a propensity matched cohort study. BMJ Open Respiratory Research, 8, e001080. (doi: 10.1136/bmjresp-2021-001080)
Khan, K. S. , El-Zanati, H. and Mahmud, S. (2020) Can age adjusted Charlson comorbidity index predict prognosis in hospitalised COVID-19 patients? Annals of Public Health Reports, 4(1), pp. 115-121. (doi: 10.36959/856/506)
Wei, J. et al. (2024) Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population. Nature Communications, 15, 1008. (doi: 10.1038/s41467-024-44973-1) (PMID:38307854) (PMCID:PMC10837445)
CHOLECOVID Collaborative, (2022) Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study). BJS Open, 6(3), zrac052. (doi: 10.1093/bjsopen/zrac052) (PMID:35511954) (PMCID:PMC9071082)
Niemi, M. E. K. et al. (2021) Mapping the human genetic architecture of COVID-19. Nature, 600(7889), pp. 472-477. (doi: 10.1038/s41586-021-03767-x) (PMID:34237774) (PMCID:PMC8674144)
McKay, S. C. et al. (2021) Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. HPB, 23(11), pp. 1656-1665. (doi: 10.1016/j.hpb.2021.03.003) (PMID:34544628) (PMCID:PMC7973054)
Hadjiyiannakis, D., Dimitroyannis, D., Eastlake, L., Peedell, C., Tripathi, L., Simcock, R., Vyas, A., Deutsch, E. and Chalmers, A.J. (2021) Personal view: low-dose lung radiotherapy should be evaluated as a treatment for severe COVID-19 lung disease. Clinical Oncology, 33(1), e64-e68. (doi: 10.1016/j.clon.2020.08.003) (PMID:32829986) (PMCID:PMC7427522)
Shukla, P. et al. (2022) Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage. Briefings in Bioinformatics, 23(1), bbab496. (doi: 10.1093/bib/bbab496) (PMID:34962259) (PMCID:PMC8769887)
Sykes, R. A. et al. (2023) Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy. European Heart Journal: Cardiovascular Pharmacotherapy, 9(4), pp. 371-386. (doi: 10.1093/ehjcvp/pvad025) (PMID:37019821) (PMCID:PMC10236521)
Clements, K., Cowell, A., White, G., Flynn, W., Conway, D. I. , Douglas, C. M. and Paterson, C. (2023) The COVID-19 pandemic has not changed stage at presentation nor treatment patterns of head and neck cancer: a retrospective cohort study. Clinical Otolaryngology, 48(4), pp. 587-594. (doi: 10.1111/coa.14048) (PMID:36929626)
Ferguson, K., Quail, N., Kewin, P. and Blyth, K. G. (2020) COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis. BMJ Case Reports, 13(8), e237460. (doi: 10.1136/bcr-2020-237460) (PMID:32747597) (PMCID:PMC7401579)
Creaney, G. , McMahon, A. D. , Ross, A. J. , Bhatti, L. A., Paterson, C. and Conway, D. I. (2022) Head and neck cancer in the UK: what was the stage before COVID-19? UK cancer registries analysis (2011-2018). British Dental Journal, 233(9), pp. 787-793. (doi: 10.1038/s41415-022-5151-4) (PMID:36369569) (PMCID:PMC9650177)
Faivre-Finn, C. et al. (2020) Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the COVID-19 pandemic. Clinical Oncology, 32(8), pp. 481-489. (doi: 10.1016/j.clon.2020.05.001) (PMID:32405158) (PMCID:PMC7218369)
Hanna, C. R. et al. (2020) Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(935), (doi: 10.1186/s13063-020-04891-1) (PMID:33213530) (PMCID:PMC7675389)
Muñoz‐Martínez, S. et al. (2022) Outcome of liver cancer patients with SARS‐CoV‐2 infection: an international, multicentre, cohort study. Liver International, 42(8), pp. 1891-1901. (doi: 10.1111/liv.15320) (PMID:35608939)
McPeake, J. et al. (2021) Long-term outcomes following severe COVID-19 infection: a multicentre cohort study of family member outcomes. Annals of the American Thoracic Society, 18(12), pp. 2098-2101. (doi: 10.1513/AnnalsATS.202104-481RL) (PMID:34192506) (PMCID:PMC8641813)
Quinn, T. M. et al. (2022) Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics. EBioMedicine, 76, 103856. (doi: 10.1016/j.ebiom.2022.103856) (PMID:35152152) (PMCID:PMC8831100)
O'Cathail, S.M. , Gilbert, D.C., Sebag-Montefiore, D. and Muirhead, R. (2020) Challenges and consequences of COVID-19 in the management of anorectal cancer: coming together through social distancing. Clinical Oncology, 32(7), pp. 413-416. (doi: 10.1016/j.clon.2020.04.009) (PMID:32359847) (PMCID:PMC7184022)
Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, 116(14), pp. 2185-2196. (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (PMCID:PMC7454350)
Conway, D.I. et al. (2021) SARS-CoV-2 positivity in asymptomatic-screened dental patients. Journal of Dental Research, 100(6), pp. 583-590. (doi: 10.1177/00220345211004849) (PMID:33779355) (PMCID:PMC8138329)
Khan, K. S. , Torpiano, G., McLellan, M. and Mahmud, S. (2021) The impact of socioeconomic status on 30‐day mortality in hospitalized patients with COVID‐19 infection. Journal of Medical Virology, 93(2), pp. 995-1001. (doi: 10.1002/jmv.26371) (PMID:32729937)
Boyle, J. G., Walters, M. R. , Jamieson, S. and Durning, S. J. (2020) Clinical reasoning in the wild: premature closure during the COVID-19 pandemic. Diagnosis, 7(3), pp. 177-179. (doi: 10.1515/dx-2020-0061) (PMID:32710716)
Bedawi, E. O. et al. (2022) The impact of the COVID-19 pandemic on pleural infection incidence: a UK multicentre retrospective analysis. ERJ Open Research, 8(3), 00206-2022. (doi: 10.1183/23120541.00206-2022) (PMID:35919861) (PMCID:PMC9235054)
McLaren, A. S. et al. (2023) Impact of the COVID-19 pandemic on patients with hepatocellular carcinoma in the west of Scotland: a cohort study. BMJ Open Gastroenterology, 10(1), e001231. (doi: 10.1136/bmjgast-2023-001231) (PMID:37989352) (PMCID:PMC10660158)
Baxter, M. A. et al. (2023) Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study. British Journal of Surgery, 110(4), pp. 456-461. (doi: 10.1093/bjs/znad003) (PMID:36810797)
Khan, K. S. , Gall, L. S., Dreyer, S., McCollum, C., Chuntamongkol, R., Craig, C., MacKay, C., Macdonald, A. and Forshaw, M. (2022) Stage migration in newly diagnosed oesophagogastric cancer during the first wave of the COVID-19 pandemic. British Journal of Surgery, 109(8), pp. 773-774. (doi: 10.1093/bjs/znac112) (PMID:35616120)
Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10(1), e002192. (doi: 10.1136/openhrt-2022-002192) (PMID:36822817) (PMCID:PMC9950584)
Stenvinkel, P., Painer, J., Shiels, P.G. , Bansal, A., Fereidouni, S., Natterson-Horowitz, B., Johnson, R.J. and Miranda, J.J. (2021) SARS-COV-2 and biomimetics: what saves the planet will save our health. Journal of Internal Medicine, 289(2), pp. 244-246. (doi: 10.1111/joim.13128) (PMID:32583447) (PMCID:PMC7361468)
Pauley, E., Drake, T. M., Sigfrid, L., Lone, N., Harrison, E. M., Baillie, J. K., Scott, J. T. , Walsh, T. S., Semple, M. G. and Docherty, A. B. (2023) Recovery from Covid-19 critical illness: a secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial. Journal of the Intensive Care Society, 24(2), pp. 162-169. (doi: 10.1177/17511437211052226) (PMID:37255989) (PMCID:PMC10225805)
Morrow, A. J. et al. (2022) A multisystem, cardio-renal investigation of post-COVID-19 illness. Nature Medicine, 28(6), pp. 1303-1313. (doi: 10.1038/s41591-022-01837-9) (PMID:35606551) (PMCID:PMC9205780)
Rosas, I. O. et al. (2022) Tocilizumab in patients hospitalised with COVID-19 pneumonia: efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA). EClinicalMedicine, 47, 101409. (doi: 10.1016/j.eclinm.2022.101409) (PMID:35475258) (PMCID:PMC9022847)
Calvert, C. et al. (2022) A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection. Nature Communications, 13, 6124. (doi: 10.1038/s41467-022-33937-y) (PMID:36253471) (PMCID:PMC9574832)
Emary, K. R. W. et al. (2021) Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet, 397(10282), pp. 1351-1362. (doi: 10.1016/S0140-6736(21)00628-0) (PMID:33798499) (PMCID:PMC8009612)
Grocutt, L., Rutherford, A., Caldwell, D., Wilkinson, C., Chalmers, A.J. , Dempsey, L., Kelly, C. and O'Cathail, S.M. (2023) The impact of COVID-19 on radiotherapy services in Scotland, UK: a population-based study. Clinical Oncology, 35(2), e227-e234. (doi: 10.1016/j.clon.2022.11.018) (PMID:36528474) (PMCID:PMC9708615)
Khan, K. S. , Reed-Embleton, H., Lewis, J., Bain, P. and Mahmud, S. (2020) Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study. Scottish Medical Journal, 65(4), pp. 149-153. (doi: 10.1177/0036933020951926) (PMID:32873147) (PMCID:PMC7468667)
Reed-Embleton, H., Khan, K. S. , Mathias, N. and Mahmud, S. (2020) Case report: incidental findings of COVID-19 infection on positron emission tomography/computed tomography for staging of a giant gastric gastrointestinal stromal tumor. Pan African Medical Journal, 35(Sup 2), 28. (doi: 10.11604/pamj.supp.2020.35.2.23167) (PMID:33623553) (PMCID:PMC7875735)
Hanna, C. R. , Robb, K. A. , Blyth, K. G. , Jones, R. J. and Chalmers, A. J. (2021) Clinician attitudes to using low dose radiotherapy to treat COVID-19 lung disease. International Journal of Radiation Oncology, Biology, Physics, 109(4), pp. 886-890. (doi: 10.1016/j.ijrobp.2020.12.003) (PMID:33309910) (PMCID:PMC7726525)
Walker, A. S. et al. (2021) Tracking the emergence of SARS-CoV-2 alpha variant in the United Kingdom. New England Journal of Medicine, 385(27), pp. 2582-2585. (doi: 10.1056/NEJMc2103227) (PMID:34879193) (PMCID:PMC8693687)
Clements, K., Thapa, A., Cowell, A., Conway, D. , Douglas, C. M. and Paterson, C. (2024) Impact of the COVID-19 pandemic on stage and incidence of head and neck cancer: a rapid review and meta-analysis. Clinical Otolaryngology, 49(4), pp. 363-375. (doi: 10.1111/coa.14152) (PMID:38514776)
Morrow, A. J. et al. (2024) Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization. Communications Medicine, 4, 32. (doi: 10.1038/s43856-024-00455-5) (PMID:38418616) (PMCID:PMC10901805)
Khan, K. S. , Keay, R., McLellan, M. and Mahmud, S. (2020) Impact of the COVID-19 pandemic on core surgical training. Scottish Medical Journal, 65(4), pp. 133-137. (doi: 10.1177/0036933020949217) (PMID:32772846) (PMCID:PMC7424606)
Jackson, M. R. et al. (2022) Low-dose lung radiotherapy for COVID-19 lung disease: a preclinical efficacy study in a bleomycin model of pneumonitis. International Journal of Radiation Oncology, Biology, Physics, 112(1), pp. 197-211. (doi: 10.1016/j.ijrobp.2021.08.029) (PMID:34478832) (PMCID:PMC8406661)
Bennett, S. S., Leung, H. Y. and Ahmad, I. (2023) A cohort analysis of patients receiving neoadjuvant androgen deprivation therapy prior to robot-assisted laparoscopic prostatectomy during the Covid-19 pandemic. Journal of Clinical Urology, 16(2), pp. 13-139. (doi: 10.1177/20514158211022216)
Goulding, A. et al. (2023) Confirmed SARS-CoV-2 infection in Scottish neonates 2020–2022: a national, population-based cohort study. Archives of Disease in Childhood, 108(4), pp. 367-372. (doi: 10.1136/archdischild-2022-324713) (PMID:36609412) (PMCID:PMC10313998)
Curtin, N., Bányai, K., Thaventhiran, J., Le Quesne, J., Helyes, Z. and Bai, P. (2020) Repositioning PARP inhibitors for SARS‐CoV‐2 infection(COVID‐19); a new multi‐pronged therapy for acute respiratory distress syndrome? British Journal of Pharmacology, 177(16), pp. 3635-3645. (doi: 10.1111/bph.15137) (PMID:32441764) (PMCID:PMC7280733)
Wei, J. et al. (2021) Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom. Nature Microbiology, 6(9), pp. 1140-1149. (doi: 10.1038/s41564-021-00947-3) (PMID:34290390) (PMCID:PMC8294260)
Jones, C. M. et al. (2021) Reply to comment on “The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic”. British Journal of Cancer, 124(3), pp. 679-680. (doi: 10.1038/s41416-020-01133-8) (PMID:33139799) (PMCID:PMC7851158)
Khan, K. S. , McLellan, M., Torpiano, G., Ng, S. and Mahmud, S. (2020) Sensitivity of nasal and oropharyngeal swabs in diagnosing COVID-19 in hospitalised patients. Annals of Public Health Reports, 4(1), pp. 136-140. (doi: 10.36959/856/509)
Walker, A. S. et al. (2021) Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time. eLife, 10, e64683. (doi: 10.7554/elife.64683) (PMID:34250907) (PMCID:PMC8282332)
Stock, S. J. et al. (2022) SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland. Nature Medicine, 28(3), pp. 504-512. (doi: 10.1038/s41591-021-01666-2) (PMID:35027756)
Jones, C. M. et al. (2020) Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. British Journal of Cancer, 123(5), pp. 709-713. (doi: 10.1038/s41416-020-0980-x) (PMID:32641867) (PMCID:PMC7341025)
School of Cardiovascular & Metabolic Health
Covid19 Cardiovascular Research
Please see our SCMH Covid19 Cardiovascular Research pages for all current projects, publications and outputs.
School of Health & Wellbeing
Covid19 Publications
Vasileiou, E. et al. (2022) Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data. BMJ Open, 12(2), e050062. (doi: 10.1136/bmjopen-2021-050062) (PMID:35165107) (PMCID:PMC8844955)
Bedston, S. et al. (2022) COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: a national prospective cohort study in Wales. Vaccine, 40(8), pp. 1180-1189. (doi: 10.1016/j.vaccine.2021.11.061) (PMID:35042645) (PMCID:PMC8760602)
Banda, J., Dube, A., Brumfield, S., Amoah, A., Crampin, A. , Reniers, G. and Helleringer, S. (2021) Knowledge, risk perceptions and behaviors related to the COVID-19 pandemic in Malawi. Demographic Research, 44, pp. 459-480. (doi: 10.4054/DemRes.2021.44.20)
Anker, S. D. et al. (2020) Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an expert consensus position paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Heart Journal, 41(22), pp. 2109-2117. (doi: 10.1093/eurheartj/ehaa461) (PMID:32498081)
Nickbakhsh, S. et al. (2022) Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning. Scientific Reports, 12, 11735. (doi: 10.1038/s41598-022-15661-1) (PMID:35853960) (PMCID:PMC9296497)
Shi, T. et al. (2022) Risk of COVID-19 hospitalizations among school-aged children in Scotland: a national incident cohort study. Journal of Global Health, 12, 05044. (doi: 10.7189/jogh.12.05044) (PMID:36134546) (PMCID:PMC9494196)
Niedzwiedz, C. L. et al. (2021) Mental health and health behaviours before and during the initial phase of the COVID-19 lockdown: longitudinal analyses of the UK Household Longitudinal Study. Journal of Epidemiology and Community Health, 75(3), pp. 224-231. (doi: 10.1136/jech-2020-215060) (PMID:32978210) (PMCID:PMC7892383)
Cowie, M. and Cleland, J. G.F. (2022) The COVID-19 pandemic and heart failure: lessons from GUIDE-HF. European Heart Journal, 43(27), pp. 2619-2621. (doi: 10.1093/eurheartj/ehac226) (PMID:35511076) (PMCID:PMC9279113)
Leyland, A. (2020) The UK Society for Social Medicine and Population Health: reflections on COVID-19 in Europe. European Journal of Public Health, 30(4), p. 843. (doi: 10.1093/eurpub/ckaa151) (PMID:32838420)
Agrawal, U. et al. (2022) Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales. Lancet, 400(10360), pp. 1305-1320. (doi: 10.1016/S0140-6736(22)01656-7) (PMID:36244382) (PMCID:PMC9560746)
Stock, S. J. et al. (2022) Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study. Lancet Respiratory Medicine, 10(12), pp. 1129-1136. (doi: 10.1016/S2213-2600(22)00360-5) (PMID:36216011) (PMCID:PMC9708088)
Pan, D. et al. (2023) Are clinical outcomes from COVID-19 improving in ethnic minority groups? EClinicalMedicine, 61, 102091. (doi: 10.1016/j.eclinm.2023.102091) (PMID:37483547) (PMCID:PMC10362284)
Katikireddi, S. V. et al. (2022) Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil. Lancet, 399(10319), pp. 25-35. (doi: 10.1016/S0140-6736(21)02754-9) (PMID:34942103) (PMCID:PMC8687670)
Mercer, C. et al. (2021) Early Impacts of the COVID-19 Pandemic on Sexual Behaviour in Britain: Findings From a Large, Quasi-Representative Survey (Natsal-COVID). Sexually Transmitted Infections. 97(Suppl 1). STI & HIV World Congress, 14-17 Jul 2021. A27. (doi: 10.1136/sextrans-2021-sti.78)
Fenton, L. et al. (2021) Risk of hospital admission with covid-19 among teachers compared with healthcare workers and other adults of working age in Scotland, March 2020 to July 2021: population based case-control study. British Medical Journal, 374, n2060. (doi: 10.1136/bmj.n2060) (PMID:34470747) (PMCID:PMC8408959)
Burton, J. K. et al. (2021) Impact of COVID-19 on care-home mortality and life expectancy in Scotland. Age and Ageing, 50(4), pp. 1029-1037. (doi: 10.1093/ageing/afab080) (PMID:33914870) (PMCID:PMC8135527)
Shenderovich, Y., Sacolo-Gwebu, H., Fang, Z., Lachman, J. , Cluver, L. and Ward, C. (2023) Adaptations and staff experiences in delivering parenting programmes and other family support services in three community-based organisations in Cape Town, South Africa during the COVID pandemic. Global Public Health, 18(1), 2129725. (doi: 10.1080/17441692.2022.2129725) (PMID:36342401)
McCartney, G. , Leyland, A. , Walsh, D. and Dundas, R. (2021) Scaling COVID-19 against inequalities: should the policy response consistently match the mortality challenge? Journal of Epidemiology and Community Health, 75(4), pp. 315-320. (doi: 10.1136/jech-2020-214373) (PMID:33144334) (PMCID:PMC7958082)
Wetherall, K. et al. (2022) Mental health and well-being during the second wave of COVID-19: longitudinal analyses of the UK COVID-19 Mental Health and Wellbeing study (UK COVID-MH). BJPsych Open, 8(4), e103. (doi: 10.1192/bjo.2022.58) (PMID:35642377) (PMCID:PMC9171032)
Irizar, P. et al. (2023) Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission, and death: a global systematic review and meta-analysis of over 200 million study participants. EClinicalMedicine, 57, 101877. (doi: 10.1016/j.eclinm.2023.101877) (PMID:36969795) (PMCID:PMC9986034)
Sonnenberg, P. et al. (2021) Investigating Intimate Physical Contact Between Partners From Different Households During the COVID-19 Pandemic: Findings From a Large, Quasi-Representative Survey (Natsal-COVID). Sexually Transmitted Infections. 97(Suppl 1). STI & HIV World Congress, 14-17 Jul 2021. A25. (doi: 10.1136/sextrans-2021-sti.74)
Menezes, D., Sonnenberg, P., Willis, M. , Mercer, C. H., Mitchell, K. and Field, N. (2024) Compliance with COVID-19 rules on intimate physical contact between households. Sexually Transmitted Infections, 100, p. 54. (doi: 10.1136/sextrans-2023-055948) (PMID:38071580)
Scott, J. et al. (2021) ISARIC4C: Multicentre cohort study on symptoms and quality of life following hospitalisation for COVID-19 - preliminary results, 25 February 2021. Documentation. Scientific Advisory Group for Emergencies.
Rooksby, M. , Furuhashi, T. and McLeod, H. J. (2020) Hikikomori: a hidden mental health need following the COVID-19 pandemic. World Psychiatry, 19(3), pp. 399-400. (doi: 10.1002/wps.20804) (PMID:32931118)
Lewis, R. , Blake, C. , Shimonovich, M. , Coia, N., Duffy, J., Kerr, Y., Wilson, J., Graham, C. and Mitchell, K. (2021) Disrupted prevention: condom and contraception access and use among young people during the initial months of the COVID-19 pandemic. Other. MRC/CSO Social and Public Health Sciences Unit, University of Glasgow.
Douglas, M., Katikireddi, V. , Taulbut, M., McKee, M. and McCartney, G. (2020) Mitigating the wider health effects of covid-19 pandemic response. British Medical Journal, 369, m1557. (doi: 10.1136/bmj.m1557) (PMID:32341002) (PMCID:PMC7184317)
Eyles, E. et al. (2021) Systematic review of the impact of the COVID-19 pandemic on suicidal behaviour amongst health and social care workers across the world. Journal of Affective Disorders Reports, 6, 100271. (doi: 10.1016/j.jadr.2021.100271) (PMID:34841385) (PMCID:PMC8607051)
Huggins, C. F. et al. (2022) TeenCovidLife: a resource to understand the impact of the COVID-19 pandemic on adolescents in Scotland. Wellcome Open Research, 6, 277. (doi: 10.12688/wellcomeopenres.17252.2) (PMID:35999909) (PMCID:PMC9360910)
Shah, A. S.V. et al. (2020) Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study. British Medical Journal, 371, m3582. (doi: 10.1136/bmj.m3582) (PMID:33115726) (PMCID:PMC7591828)
Gallego Marquez, N., Howarth, A. R., Dema, E., Burns, F., Copas, A. J., Mercer, C. H., Sonnenberg, P., Mitchell, K. , Field, N. and Gibbs, J. (2024) Who accessed STI testing in Britain during the COVID-19 pandemic and how: Findings from Natsal-COVID, a cross-sectional quasi-representative survey. International Journal of STD and AIDS, (doi: 10.1177/0956462424127758) (Early Online Publication)
Agrawal, U. et al. (2021) COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study. Lancet Respiratory Medicine, 9(12), pp. 1439-1449. (doi: 10.1016/S2213-2600(21)00380-5) (PMID:34599903) (PMCID:PMC8480963)
Rudan, I., Adeloye, D., Katikireddi, V. , Murray, J., Simpson, C., Shah, S. A., Robertson, C. and Sheikh, A. (2021) The COVID-19 pandemic in children and young people during 2020-2021: A complex discussion on vaccination. Journal of Global Health, 11, 01011. (doi: 10.7189/jogh.11.01011) (PMID:35047183) (PMCID:PMC8763337)
Stead, M. et al. (2022) A “step too far” or “perfect sense”? A qualitative study of British adults’ views on mandating COVID-19 vaccination and vaccine passports. Vaccine, 40(51), pp. 7389-7396. (doi: 10.1016/j.vaccine.2022.05.072) (PMID:35773124) (PMCID:PMC9162982)
Wielgoszewksa, B., Booth, C., Green, M. J. , Hamilton, O. K.L. and Wels, J. (2022) Association between home working and mental health by key worker status during the Covid-19 pandemic. Evidence from four British longitudinal studies. Industrial Health, 60(4), pp. 345-359. (doi: 10.2486/indhealth.2022-0081) (PMID:35584949)
Di Gessa, G. et al. (2022) Pre-pandemic mental health and disruptions to healthcare, economic and housing outcomes during the COVID-19 pandemic: evidence from 12 UK longitudinal studies. British Journal of Psychiatry, 220(1), pp. 21-30. (doi: 10.1192/bjp.2021.132) (PMID:35045893)
O'Donnell, C. A. , Macdonald, S. , Browne, S. , Albanese, A., Blane, D. , Ibbotson, T. , Laidlaw, L., Heaney, D. and Lowe, D. J. (2022) Widening or narrowing inequalities? The equity implications of digital tools to support COVID-19 contact tracing: a qualitative study. Health Expectations, 25(6), pp. 2851-2861. (doi: 10.1111/hex.13593) (PMID:36063060) (PMCID:PMC9538145)
Das, R. R., Jaiswal, N. , Dev, N., Jaiswal, N., Naik, S. S. and Sankar, J. (2020) Efficacy and safety of anti-malarial drugs (chloroquine and hydroxy-chloroquine) in treatment of COVID-19 infection: a systematic review and meta-analysis. Frontiers in Medicine, 7, 482. (doi: 10.3389/fmed.2020.00482) (PMID:32850924) (PMCID:PMC7403461)
Haag, L. et al. (2023) The remote diet intervention to reduce Long COVID symptoms trial (ReDIRECT): protocol for a randomised controlled trial to determine the effectiveness and cost-effectiveness of a remotely delivered supported weight management programme for people with Long COVID and excess weight, with personalised improvement goals. NIHR Open Research, 2, 57. (doi: 10.3310/nihropenres.13315.2) (PMID:37881302) (PMCID:PMC10593354)
Kerr, S. et al. (2023) Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales. International Journal of Epidemiology, 52(1), pp. 22-31. (doi: 10.1093/ije/dyac199) (PMID:36272418) (PMCID:PMC9620314)
Lee, D. , Robertson, C., McRae, C. and Baker, J. (2022) Quantifying the impact of air pollution on Covid-19 hospitalisation and death rates in Scotland. Spatial and Spatio-Temporal Epidemiology, 42, 100523. (doi: 10.1016/j.sste.2022.100523) (PMID:PMC917620)
Maclachlan, A. , McMellon, C. and Inchley, J. (2023) Public mental health during the COVID-19 pandemic: impacts on children’s rights. International Journal of Human Rights, 27(9-10), pp. 1406-1425. (doi: 10.1080/13642987.2022.2057958)
Kromydas, T., Green, M. , Craig, P. , Katikireddi, S. V. , Leyland, A. H. , Niedzwiedz, C. L. , Pearce, A. , Thomson, R. M. and Demou, E. (2022) Comparing population-level mental health of UK workers before and during the COVID-19 pandemic: a longitudinal study using Understanding Society. Journal of Epidemiology and Community Health, 76(6), pp. 527-536. (doi: 10.1136/jech-2021-218561) (PMID:35296523) (PMCID:PMC8931794)
Nzawa Soko, R. et al. (2021) Effects of coronavirus disease pandemic on tuberculosis notifications, Malawi. Emerging Infectious Diseases, 27(7), pp. 1831-1839. (doi: 10.3201/eid2707.210557) (PMID:34152962) (PMCID:PMC8237899)
Caton, S., Hatton, C., Bradshaw, J., Jahoda, A. , Kelly, R., Maguire, R., Oloidi, E., Taggart, L., Todd, S. and Hastings, R. P. (2024) (Not) going out and barriers to leaving the house for people with intellectual disabilities through the COVID-19 pandemic in the UK. Journal of Applied Research in Intellectual Disabilities, 37(6), e13302. (doi: 10.1111/jar.13302) (PMID:39370614)
Mccaughey, E. J., Ho, F. K., Mackay, D. F. , Pell, J. P. , Humburg, P. and Purcell, M. (2024) The impact of COVID-19 and associated lockdowns on traumatic spinal cord injury incidence: a population based study. Spinal Cord, 62(1), pp. 1-5. (doi: 10.1038/s41393-023-00939-6) (PMID:37919383) (PMCID:PMC10783541)
Morrow, A. J. et al. (2022) A multisystem, cardio-renal investigation of post-COVID-19 illness. Nature Medicine, 28(6), pp. 1303-1313. (doi: 10.1038/s41591-022-01837-9) (PMID:35606551) (PMCID:PMC9205780)
Sanya, R. E. et al. (2024) Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and Tanzania. Global Health Action, 17(1), 2345970. (doi: 10.1080/16549716.2024.2345970) (PMID:38774927)
Lachman, J. M. et al. (2024) Innovate! Accelerate! Evaluate! Harnessing the RE-AIM Framework to examine the global dissemination of parenting resources during COVID-19 to more than 210 million people. BMC Public Health, 24, 2391. (doi: 10.1186/s12889-024-19751-9) (PMID:39227875) (PMCID:PMC11373112)
Pirkis, J. et al. (2022) Suicide numbers during the first 9-15 months of the COVID-19 pandemic compared with pre-existing trends: An interrupted time series analysis in 33 countries. EClinicalMedicine, 51, 101573. (doi: 10.1016/j.eclinm.2022.101573) (PMID:35935344) (PMCID:PMC9344880)
Morrow, A. J. et al. (2024) Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization. Communications Medicine, 4, 32. (doi: 10.1038/s43856-024-00455-5) (PMID:38418616) (PMCID:PMC10901805)
McQueenie, R. et al. (2020) Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS ONE, 15(8), e0238091. (doi: 10.1371/journal.pone.0238091) (PMID:32817712) (PMCID:PMC7440632)
Devleesschauwer, B., McDonald, S. A., Speybroeck, N. and Wyper, G. M.A. (2020) Valuing the years of life lost due to COVID-19: the differences and pitfalls. International Journal of Public Health, 65, pp. 719-720. (doi: 10.1007/s00038-020-01430-2) (PMID:32691080) (PMCID:PMC7370635)
Caton, S. et al. (2024) Online social connections and Internet use among people with intellectual disabilities in the United Kingdom during the COVID-19 pandemic. New Media and Society, 26(5), pp. 2804-2828. (doi: 10.1177/14614448221093762)
Mitchell, K. R. et al. (2023) Sexual and reproductive health in Britain during the first year of the COVID-19 pandemic: cross-sectional population survey (Natsal-COVID-Wave 2) and national surveillance data. Sexually Transmitted Infections, 99(6), pp. 386-397. (doi: 10.1136/sextrans-2022-055680) (PMID:36973042) (PMCID:PMC10447381)
Zhang, J., Pellicori, P. , Schutte, R. and Cleland, J.G. (2021) The association between blood groups and COVID-19 infection: a study from the UK Biobank. Journal of Internal Medicine, 289(5), pp. 747-748. (doi: 10.1111/joim.13226) (PMID:33306225)
Ashwell, G., Blane, D. , Lunan, C. and Matheson, J. (2020) General practice post-COVID-19: time to put equity at the heart of health systems? British Journal of General Practice, 70(697), p. 400. (doi: 10.3399/bjgp20X712001) (PMID:32732207)
de Lusignan, S. et al. (2020) In-pandemic development of an application ontology for COVID-19 surveillance in a primary care sentinel network. JMIR Public Health and Surveillance, (doi: 10.2196/preprints.21434) (Submitted)
Ul Haq, Z. et al. (2020) Clinical characteristics, mortality and associated risk factors in COVID-19 patients reported in ten major hospitals of Khyber Pakhtunkhwa, Pakistan. Journal of Ayub Medical College, Abbottabad, 32(4-Sup1), S633-S639. (PMID:33754522)
McGurnaghan, S. J. et al. (2021) Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes and Endocrinology, 9(2), pp. 82-93. (doi: 10.1016/S2213-8587(20)30405-8) (PMID:33357491) (PMCID:PMC7832778)
Leggat, F. J., Heaton-Shrestha, C., Fish, J. , Siriwardena, A. N., Domeney, A., Rowe, C., Patel, I., Parsons, J., Blair, J. and Jones, F. (2024) An exploration of the experiences and self-generated strategies used when navigating everyday life with Long Covid. BMC Public Health, 24, 789. (doi: 10.1186/s12889-024-18267-6) (PMID:38481230)
Thompson, E. J. et al. (2022) Psychological distress, depression, anxiety and life satisfaction following COVID-19 infection: evidence from 11 UK longitudinal population studies. Lancet Psychiatry, 9(11), pp. 894-906. (doi: 10.1016/S2215-0366(22)00307-8) (PMID:36244359) (PMCID:PMC9560745)
O'Connor, R. C. et al. (2021) Mental health and wellbeing during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing study. British Journal of Psychiatry, 218(6), pp. 326-333. (doi: 10.1192/bjp.2020.212) (PMID:33081860) (PMCID:PMC7684009)
Byrne, P., Harding-Edgar, L. and Pollock, A. M. (2022) SARS-CoV-2: public health measures for managing the transition to endemicity. Journal of the Royal Society of Medicine, 115(5), pp. 165-168. (doi: 10.1177/01410768221089023) (PMID:35357251)
Polašek, O. et al. (2022) Research priorities to reduce the impact of COVID-19 in low- and middle-income countries. Journal of Global Health, 12, 09003. (doi: 10.7189/jogh.12.09003) (PMID:35475006) (PMCID:PMC9010705)
Kopasker, D. et al. (2024) Evaluating the influence of taxation and social security policies on psychological distress: a microsimulation study of the UK during the COVID-19 economic crisis. Social Science and Medicine, 351, 116953. (doi: 10.1016/j.socscimed.2024.116953) (PMID:38759385)
Chauhan, A., Agarwal, A., Jaiswal, N. and Singh, M. (2020) ChAdOx1 nCoV-19 vaccine for SARS-CoV-2. Lancet, 396(10261), pp. 1485-1486. (doi: 10.1016/S0140-6736(20)32271-6) (PMID:33160563) (PMCID:PMC7832915)
Parsons, V., Wainwright, E., Karanika-Murray, M., Muiry, G. and Demou, E. (2022) The impact of Covid-19 on research into work and health. Occupational Medicine, (doi: 10.1093/occmed/kqac080) (PMID:36039847) (PMCID:PMC9452128) (Early Online Publication)
Jones, F., Domeny, A., Fish, J. , Leggat, F., Patel, I., McRae, J., Rowe, C. and Busse, M. E. (2024) Using co‐design methods to develop new personalised support for people living with Long Covid: the ‘LISTEN’ intervention. Health Expectations, 27(3), e14093. (doi: 10.1111/hex.14093) (PMID:38783782) (PMCID:PMC11116943)
Wang, R., Clemens, T., Douglas, M., Keller, M. and van der Horst, D. (2023) Spatiotemporal modelling of the association between neighborhood factors and COVID-19 incidence rates in Scotland. Professional Geographer, 75(5), pp. 803-815. (doi: 10.1080/00330124.2023.2194363)
Oberndorfer, M. , Stolz, E. and Dorner, T. E. (2022) Evidence for changes in population-level subjective well-being during the COVID-19 pandemic from 30 waves of representative panel data collected in Austria between March 2020 and March 2022. Public Health, 212, pp. 84-88. (doi: 10.1016/j.puhe.2022.09.004) (PMCID:PMC9472574)
Stokes, J. , Turner, A. J., Anselmi, L., Morciano, M. and Hone, T. (2022) The relative effects of non-pharmaceutical interventions on wave one Covid-19 mortality: natural experiment in 130 countries. BMC Public Health, 22, 1113. (doi: 10.1186/s12889-022-13546-6) (PMID:35659646) (PMCID:PMC9165709)
Teece, L. et al. (2021) United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol. BMJ Open, 11(6), e046392. (doi: 10.1136/bmjopen-2020-046392) (PMID:34183342) (PMCID:PMC8245289)
Holmes, E. A. et al. (2020) Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health services. Lancet Psychiatry, 7(6), pp. 547-560. (doi: 10.1016/S2215-0366(20)30168-1) (PMID:32304649) (PMCID:PMC7159850)
Zhao, L., Wirth, M. D., Petermann-Rocha, F., Parra-Soto, S., Mathers, J. C., Pell, J. P. , Ho, F. K., Celis-Morales, C. A. and Hebert, J. R. (2023) Diet-related inflammation is associated with worse COVID-19 outcomes in the UK biobank cohort. Nutrients, 15(4), 884. (doi: 10.3390/nu15040884) (PMID:36839240) (PMCID:PMC9959636)
Anderson, J. J. et al. (2021) Remote history of VTE is associated with severe COVID-19 in middle and older age: UK Biobank cohort study. Journal of Thrombosis and Haemostasis, 19(10), pp. 2533-2538. (doi: 10.1111/jth.15452) (PMID:34242477) (PMCID:PMC8420476)
Hanlon, P. et al. (2021) COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study. Wellcome Open Research, 5, 75. (doi: 10.12688/wellcomeopenres.15849.3) (PMID:33709037) (PMCID:PMC7927210)
Da Silva Filipe, A. et al. (2021) Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland. Nature Microbiology, 6(1), pp. 112-122. (doi: 10.1038/s41564-020-00838-z) (PMID:33349681)
Costello, R. E. et al. (2024) Impacts of the COVID-19 pandemic on deprivation-level differences in cardiovascular hospitalisations: a comparison of England and Denmark using the OpenSAFELY platform and National Registry Data. BMJ Open, 14(10), e088710. (doi: 10.1136/bmjopen-2024-088710) (PMID:39414266) (PMCID:PMC11481132)
Hastie, C. E. et al. (2020) Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(4), pp. 561-565. (doi: 10.1016/j.dsx.2020.04.050) (PMID:32413819) (PMCID:PMC7204679)
Fitzgerald, N., Manca, F., Uny, I., Martin, J. G., O'Donnell, R., Ford, A., Begley, A., Stead, M. and Lewsey, J. (2022) Lockdown and licensed premises: COVID-19 lessons for alcohol policy. Drug and Alcohol Review, 41(3), pp. 533-545. (doi: 10.1111/dar.13413) (PMID:34904313)
Dema, E. et al. (2024) Methodology of Natsal-COVID Wave 2: a large, quasi-representative, longitudinal survey measuring the impact of COVID-19 on sexual and reproductive health in Britain. Wellcome Open Research, 7, 166. (doi: 10.12688/wellcomeopenres.17850.2) (PMID:37794900) (PMCID:PMC10545983)
Haag, L. et al. (2024) Baseline characteristics in the Remote Diet Intervention to REduce long-COVID Symptoms Trial (ReDIRECT). NIHR Open Research, 4, 7. (doi: 10.3310/nihropenres.13522.1) (PMID:39145102) (PMCID:PMC11320183)
Patone, M. et al. (2021) Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature Medicine, 27(12), pp. 2144-2153. (doi: 10.1038/s41591-021-01556-7) (PMID:34697502) (PMCID:PMC8629105)
Torabi, F. et al. (2022) Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: a self-controlled case series analysis in Wales. Scientific Reports, 12, 16406. (doi: 10.1038/s41598-022-20118-6) (PMID:36180455) (PMCID:PMC9524320)
Divala, T., Burke, R. M., Ndeketa, L., Corbett, E. L. and MacPherson, P. (2020) Africa faces difficult choices in responding to COVID-19. Lancet, 395(10237), p. 1611. (doi: 10.1016/S0140-6736(20)31056-4) (PMID:32405104) (PMCID:PMC7217642)
Thompson, E. J. et al. (2022) Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nature Communications, 13, 3528. (doi: 10.1038/s41467-022-30836-0) (PMID:35764621) (PMCID:PMC9240035)
Niedzwiedz, C. , Benzeval, M., Hainey, K., Leyland, A. and Katikireddi, V. (2021) Psychological distress among people with probable COVID-19 infection: analysis of the UK Household Longitudinal Study. BJPsych Open, 7(3), e104. (doi: 10.1192/bjo.2021.63) (PMID:34001295) (PMCID:PMC8134894)
Quinn, T. J. et al. (2021) Following the Science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic. BMC Medicine, 19, 46. (doi: 10.1186/s12916-021-01920-x) (PMID:33618741) (PMCID:PMC7899793)
Hardie, I. , Stevely, A. K., Sasso, A., Meier, P. S. and Holmes, J. (2022) The impact of changes in COVID-19 lockdown restrictions on alcohol consumption and drinking occasion characteristics in Scotland and England in 2020: an interrupted time-series analysis. Addiction, 117(6), pp. 1622-1639. (doi: 10.1111/add.15794) (PMID:35108758)
Moran, D. P., Monteiro Pires, S., Wyper, G. M.A. , Devleesschauwer, B., Cuschieri, S. and Kabir, Z. (2022) Estimating the direct disability-adjusted life years associated with SARS-CoV-2 (COVID-19) in the Republic of Ireland: the first full year. International Journal of Public Health, 67, 1604699. (doi: 10.3389/ijph.2022.1604699) (PMID:35719731) (PMCID:PMC9200950)
Wasilewski, M. B., Szigeti, Z., Sheppard, C. L., Minezes, J., Hitzig, S. L., Mayo, A. L., Robinson, L. R., Lung, M. and Simpson, R. (2023) Patients, caregivers, and healthcare providers’ experiences with COVID care and recovery across the care continuum: a qualitative study. International Journal of Integrated Care, 23(2), 27. (doi: 10.5334/ijic.6952) (PMID:37333775) (PMCID:PMC10275165)
Sosenko, F. et al. (2023) Understanding covid-19 outcomes among people with intellectual disabilities in England. BMC Public Health, 23, 2099. (doi: 10.1186/s12889-023-16993-x) (PMID:37880687) (PMCID:PMC10601171)
Simpson, R. and Robinson, L. (2020) Rehabilitation following critical illness in people with COVID-19 infection. American Journal of Physical Medicine and Rehabilitation, 99(6), pp. 470-474. (doi: 10.1097/PHM.0000000000001443) (PMID:32282359) (PMCID:PMC7253039)
MacLennan, K., Byrne, P., Allan, S., Gambier-Ross, K., Jain, P. and Chan, S. W.Y. (2024) Soothing dementia carers: a pilot evaluation of an imagery-based wellbeing app feature to support family carers of people with dementia during the COVID-19 pandemic. Wellcome Open Research, 9, 225. (doi: 10.12688/wellcomeopenres.20933.1)
Calvert, C. et al. (2023) A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection. Nature Communications, 14, 107. (doi: 10.1038/s41467-022-35771-8) (PMID:36609574) (PMCID:PMC9821346)
Whitley, E. , Reeve, K. and Benzeval, M. (2023) Tracking the mental health of home-carers during the first COVID-19 national lockdown: evidence from a nationally representative UK survey. Psychological Medicine, 53(3), pp. 1096-1105. (doi: 10.1017/S0033291721002555) (PMID:34108060) (PMCID:PMC8245331)
Amele, S. et al. (2023) Ethnic inequalities in positive SARS-CoV-2 tests, infection prognosis, COVID-19 hospitalisations, and deaths: Analysis of two years of a record linked national cohort study in Scotland. Journal of Epidemiology and Community Health, 77, pp. 641-648. (doi: 10.1136/jech-2023-220501) (PMID:37524538) (PMCID:PMC10511958)
McKeigue, P. M., Porter, D., Hollick, R. J., Ralston, S. H., McAllister, D. A. and Colhoun, H. M. (2023) Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland. Scandinavian Journal of Rheumatology, 52(4), pp. 412-417. (doi: 10.1080/03009742.2022.2063376) (PMID:35549809)
Wingdield, T., Karmadwala, F., MacPherson, P. , Millington, K. A., Walker, N. F., Cuevas, L. E. and Squire, S. B. (2021) Challenges and opportunities to end tuberculosis in the COVID-19 era. Lancet Respiratory Medicine, 9(6), pp. 556-558. (doi: 10.1016/s2213-2600(21)00161-2) (PMID:33773121) (PMCID:PMC7988354)
Seidler, Z. E., Wilson, M. J., Oliffe, J. L., Fisher, K., O'Connor, R. , Pirkis, J. and Rice, S. M. (2023) Suicidal ideation in men during COVID-19: an examination of protective factors. BMC Psychiatry, 23, 46. (doi: 10.1186/s12888-023-04539-9) (PMID:36650456) (PMCID:PMC9845104)
Sabir, S. R., Thomson, E. C. , Guzik, T. J., D’Acquisto, F. and Maffia, P. (2020) COVID-19: the new immune challenge. Frontiers for Young Minds, 8, 582971. (doi: 10.3389/frym.2020.582971)
Bynner, C. and Terje, A. (2021) What types of knowledge do policy makers need to respond to the COVID-19 pandemic? [Website]
Demkowicz, O. et al. (2021) Looking back to move forward: reflections on the strengths and challenges of the COVID-19 UK mental health research response. Frontiers in Psychiatry, 12, 622562. (doi: 10.3389/fpsyt.2021.622562) (PMID:33897488) (PMCID:PMC8060503)
Goulding, A. et al. (2023) Confirmed SARS-CoV-2 infection in Scottish neonates 2020–2022: a national, population-based cohort study. Archives of Disease in Childhood, 108(4), pp. 367-372. (doi: 10.1136/archdischild-2022-324713) (PMID:36609412) (PMCID:PMC10313998)
Wilson, B.A., Betteridge, S. and Fish, J. (2020) Neuropsychological consequences of Covid-19. Neuropsychological Rehabilitation, 30(9), pp. 1625-1628. (doi: 10.1080/09602011.2020.1808483) (PMID:32869697)
Boso Perez, R., Reid, D., Maxwell, K. J., Gibbs, J., Dema, E., Bonell, C., Mercer, C. H., Sonnenberg, P., Field, N. and Mitchell, K. R. (2023) Access to and quality of sexual and reproductive health services in Britain during the early stages of the COVID-19 pandemic: a qualitative interview study of patient experiences. BMJ Sexual and Reproductive Health, 49, pp. 12-20. (doi: 10.1136/bmjsrh-2021-201413) (PMID:35444001) (PMCID:PMC9062459)
Katikireddi, V. , Hainey, K. and Beale, S. (2021) The impact of COVID-19 on different population subgroups: ethnic, gender and age-related disadvantage. Journal of the Royal College of Physicians of Edinburgh, 51(S1), S40-S46. (doi: 10.4997/JRCPE.2021.240) (PMID:34185037)
Macdonald, E. (2022) Impact of Long Covid on workers and workplaces and the role of OSH. Discussion Paper. European Agency for Health and Safety at Work (EUOSHA).
Katus, H. A., Cleland, J. G.F. and Jaffe, A. S. (2020) Myocardial injury in severe COVID-19 infection. European Heart Journal, 41(22), pp. 2080-2082. (doi: 10.1093/eurheartj/ehaa447) (PMID:32464642)
Almagor, J. and Picascia, S. (2020) Exploring the effectiveness of a COVID-19 contact tracing app using an agent-based model. Scientific Reports, 10, 22235. (doi: 10.1038/s41598-020-79000-y) (PMID:33335125) (PMCID:PMC7746740)
Bowyer, R. C.E. et al. (2023) Characterising patterns of COVID-19 and long COVID symptoms: evidence from nine UK longitudinal studies. European Journal of Epidemiology, 38(2), pp. 199-210. (doi: 10.1007/s10654-022-00962-6) (PMID:36680646) (PMCID:PMC9860244)
Angelopoulos, K. , Lazarakis, S., Mancy, R. and Schroeder, M. (2021) Briefing Note: Medium-run wealth inequality following COVID-19. Other. University of Glasgow and Lancaster University.
Cysique, L. A. et al. (2022) Assessment of neurocognitive functions, olfaction, taste, mental, and psycho-social health in COVID-19 in adults: recommendations for harmonization of research and implications for clinical practice. Journal of the International Neuropsychological Society, 28(6), pp. 642-660. (doi: 10.1017/S1355617721000862) (PMID:34365990) (PMCID:PMC8825876)
Karugu, C. H. et al. (2024) Economic Impact of COVID-19 on patients with Type 2 diabetes in Kenya and Tanzania: a costing analysis. BMJ Public Health, 2(2), e000383. (doi: 10.1136/bmjph-2023-000383)
Bouttell, J. et al. (2020) Evidence Review: Assessment of COVID-19 in Primary Care: The identification of symptoms, clinical signs, characteristics, and comorbidities in adults, children and young people, which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.
Adeloye, D. et al. (2021) Uptake, effectiveness and safety of COVID-19 vaccines in children and young people in Scotland: Protocol for early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II). Journal of Global Health, 11, 05026. (doi: 10.7189/jogh.11.05026) (PMID:35003715) (PMCID:PMC8709900)
Purba, A. K. (2020) How should the role of the nurse change in response to Covid-19? Nursing Times, 116(6), pp. 25-28.
Wasilewski, M. B., Szigeti, Z., Simpson, R., Minezes, J., Mayo, A. L., Robinson, L. R., Lung, M. and Hitzig, S. L. (2023) Characteristics and healthcare utilization of COVID-19 rehabilitation patients during the first and second waves of the pandemic in Toronto, Canada. International Journal of Rehabilitation Research, 46(3), pp. 258-263. (doi: 10.1097/MRR.0000000000000592) (PMID:37345433)
Clark, A. et al. (2020) Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Global Health, 8(8), e1003-e1017. (doi: 10.1016/S2214-109X(20)30264-3) (PMID:32553130) (PMCID:PMC7295519)
Wels, J. et al. (2023) Home working and social and mental wellbeing at different stages of the COVID-19 pandemic in the UK: evidence from 7 longitudinal population surveys. PLoS Medicine, 20(4), e1004214. (doi: 10.1371/journal.pmed.1004214) (PMID:37104282) (PMCID:PMC10138202)
Wood, R. et al. (2021) Sharing a household with children and risk of COVID-19: a study of over 300 000 adults living in healthcare worker households in Scotland. Archives of Disease in Childhood, 106(12), pp. 1212-1217. (doi: 10.1136/archdischild-2021-321604) (PMID:33737319) (PMCID:PMC7985971)
Patel, K. et al. (2022) Psychological distress before and during the COVID-19 pandemic among adults in the United Kingdom based on coordinated analyses of 11 longitudinal studies. JAMA Network Open, 5(4), e227629. (doi: 10.1001/jamanetworkopen.2022.7629) (PMID:35452109) (PMCID:PMC9034408)
Hastie, C. E. , Foster, H. M.E. , Jani, B. D. , O'Donnell, C. A. , Ho, F. K., Pell, J. P. , Sattar, N. , Katikireddi, S. V. , Mair, F. S. and Nicholl, B. I. (2023) Chronic pain and COVID-19 hospitalisation and mortality: a UK Biobank cohort study. Pain, 164(1), pp. 84-90. (doi: 10.1097/j.pain.0000000000002663) (PMID:35452027) (PMCID:PMC9756431)
Mangion, K. et al. (2023) Post-COVID-19 illness and associations with sex and gender. BMC Cardiovascular Disorders, 23, 389. (doi: 10.1186/s12872-023-03412-7) (PMID:37553628) (PMCID:PMC10408208)
Sykes, R. A. et al. (2023) Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy. European Heart Journal: Cardiovascular Pharmacotherapy, 9(4), pp. 371-386. (doi: 10.1093/ehjcvp/pvad025) (PMID:37019821) (PMCID:PMC10236521)
Tawse, J. and Demou, E. (2022) Qualitative study to explore UK medical students’ and junior doctors’ experiences of occupational stress and mental health during the COVID-19 pandemic. BMJ Open, 12(12), e065639. (doi: 10.1136/bmjopen-2022-065639) (PMID:36523252) (PMCID:PMC9748513)
Maxwell, K. J., Boso Perez, R., Reid, D., Freeman, L., Menezes, D., Sonnenberg, P., Field, N. and Mitchell, K. R. (2023) Balancing risk, intimacy and (non)compliance: a qualitative study of sex across household during COVID-19 social restrictions. Culture, Health and Sexuality, 25(5), pp. 582-598. (doi: 10.1080/13691058.2022.2078507) (PMID:35674048) (PMCID:PMC10184729)
Ghebrehewet, S., Stewart, A.G. and MacPherson, P. (2024) A natural experiment during lockdown and on-going care-home COVID-19 outbreaks showed a single dose of vaccine reduced hospitalisation and deaths of care-home residents in North West England. Public Health Action, 233, pp. 60-64. (doi: 10.1016/j.puhe.2024.05.002) (PMID:38850602)
Baxter, A. J. et al. (2023) Contraceptive use and pregnancy planning in Britain during the first year of the COVID-19 pandemic: Findings from a large, quasi-representative survey (Natsal-COVID). BMJ Sexual and Reproductive Health, 49, pp. 260-273. (doi: 10.1136/bmjsrh-2022-201763) (PMID:36958823) (PMCID:PMC10579517)
Manera, M. R., Fiabane, E., Pain, D., Aiello, E. N., Radici, A., Ottonello, M., Padovani, M., Wilson, B. A., Fish, J. and Pistarini, C. (2022) Clinical features and cognitive sequelae in COVID-19: a retrospective study on N=152 patients. Neurological Sciences, 43(1), pp. 45-50. (doi: 10.1007/s10072-021-05744-8) (PMID:34779965) (PMCID:PMC8591589)
Webb, R. T., McManus, S. and O'Connor, R. C. (2021) Evidencing the detrimental impact of the COVID-19 pandemic on mental health across Europe. Lancet Regional Health - Europe, 2, 100052. (doi: 10.1016/j.lanepe.2021.100052)
Butler, C. C. et al. (2023) Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial. Lancet, 401(10373), pp. 281-293. (doi: 10.1016/S0140-6736(22)02597-1) (PMID:36566761) (PMCID:PMC9779781)
Burnett, H., Olsen, J. R. , Nicholls, N. and Mitchell, R. (2021) Change in time spent visiting and experiences of green space following restrictions on movement during the COVID-19 pandemic: a nationally representative cross-sectional study of UK adults. BMJ Open, 11(3), e044067. (doi: 10.1136/bmjopen-2020-044067) (PMID:34006030) (PMCID:PMC7942249)
Whyte, B., Mcarthur, D. , Garnham, L. and Livingston, M. (2022) Cycling trends in Scotland during the early phase of the Covid pandemic. Active Travel Studies, 2(1), pp. 1-19. (doi: 10.16997/ats.1120)
Wasilewski, M. B., Szigeti, Z., Sheppard, C. L., Minezes, J., Hitzig, S. L., Mayo, A. L., Robinson, L. R., Lung, M. and Simpson, R. (2023) “You want them to be partners in therapy, but that's tricky when they’re not there”: A qualitative study exploring caregiver involvement across the continuum of care during the early COVID pandemic. Clinical Rehabilitation, (doi: 10.1177/02692155231191011) (PMID:37518867) (Early Online Publication)
Pellicori, P. et al. (2021) COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database of Systematic Reviews, 2021(3), CD013879. (doi: 10.1002/14651858.CD013879) (PMID:33704775)
Davidson, J. C., Karadzhov, D. and Wilson, G. (2021) Practitioners’ and policymakers’ successes, challenges, innovations, and learning in promoting children’s well-being during COVID-19: protocol for a multinational smartphone app survey. JMIR Research Protocols, 10(7), e31013. (doi: 10.2196/31013) (PMID:34323850)
Willis, M. et al. (2023) Prevalence and correlates of fearing a partner during the COVID-19 pandemic in Britain: findings from Natsal-COVID. Journal of Family Violence, (doi: 10.1007/s10896-023-00665-w) (Early Online Publication)
Yates, T. A., Cooke, G. S. and MacPherson, P. (2020) Rational use of SARS-CoV-2 polymerase chain reaction tests within institutions caring for the vulnerable. F1000Research, 9, 671. (doi: 10.12688/f1000research.24872.1) (PMID:32968484) (PMCID:PMC7489272)
Monteiro Pires, S. et al. (2022) Burden of disease of COVID-19: strengthening the collaboration for national studies. Frontiers in Public Health, 10, 907012. (doi: 10.3389/fpubh.2022.907012) (PMID:35734754) (PMCID:PMC9208200)
Liu, Y., Du, X., Chen, J., Jin, Y., Peng, L., Wang, H. H.X. , Luo, M., Chen, L. and Zhao, Y. (2020) Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. Journal of Infection, 81(1), e6-e12. (doi: 10.1016/j.jinf.2020.04.002) (PMID:32283162) (PMCID:PMC7195072)
Caiazzo, E., Rezig, A. O.M. , Bruzzese, D., Ialenti, A., Cicala, C., Cleland, J. G.F. , Guzik, T. J., Maffia, P. and Pellicori, P. (2022) Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: a systematic review and meta-analysis of randomised trials. Pharmacological Research, 176, 106053. (doi: 10.1016/j.phrs.2021.106053) (PMID:34979235) (PMCID:PMC8719379)
Mansaray, B. et al. (2022) Implications of COVID-19 for safeguarding in international development research: learning, action and reflection from a research hub. BMJ Global Health, 7(5), e008122. (doi: 10.1136/bmjgh-2021-008122) (PMID:35606015) (PMCID:PMC9125381)
Sheppard, C. L., Szigeti, Z., Simpson, R., Minezes, J., Hitzig, S. L., Mayo, A., Robinson, L. R., Lung, M. and Wasilewski, M. B. (2022) Implementation considerations for delivering inpatient COVID rehabilitation: a qualitative study. Journal of Evaluation in Clinical Practice, 28(6), pp. 971-985. (doi: 10.1111/jep.13757) (PMID:36070223) (PMCID:PMC9537784)
Kyle, D., Shaw, M., Maguire, D., McMillan, D. , Quasim, T. , Leyland, A. H. and McPeake, J. (2021) The wider implications of the COVID-19 pandemic: assessing the impact of accident and emergency use for frequent attenders. International Emergency Nursing, 56, 100984. (doi: 10.1016/j.ienj.2021.100984) (PMID:33677141) (PMCID:PMC7896822)
Lewis, R. , Blake, C. , Shimonovich, M. , Coia, N., Duffy, J., Kerr, Y., Wilson, J., Graham, C. A. and Mitchell, K. R. (2021) Disrupted prevention: Condom and contraception access and use among young adults during the initial months of the COVID-19 pandemic. An online survey. BMJ Sexual and Reproductive Health, 47(4), pp. 269-276. (doi: 10.1136/bmjsrh-2020-200975) (PMID:33707178) (PMCID:PMC7956735)
Wismans, A. et al. (2020) Hygiene and social distancing as distinct public health related behaviours among university students during the COVID-19 pandemic. Social Psychological Bulletin, 15(4), (doi: 10.32872/spb.4383)
Swann, O. V. et al. (2022) Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales. BMJ Open, 12(11), e063271. (doi: 10.1136/bmjopen-2022-063271) (PMID:36356998) (PMCID:PMC9659708)
Maddock, J. et al. (2022) Inequalities in healthcare disruptions during the COVID-19 pandemic: evidence from 12 UK population-based longitudinal studies. BMJ Open, 12(10), e064981. (doi: 10.1136/bmjopen-2022-064981) (PMID:36229151) (PMCID:PMC9561494)
Stock, S. J. et al. (2022) Cohort profile: the Covid-19 in pregnancy in Scotland (COPS) dynamic cohort of pregnant women to assess effects of viral and vaccine exposures on pregnancy. International Journal of Epidemiology, 51(5), e245-e255. (doi: 10.1093/ije/dyab243) (PMID:34977922) (PMCID:PMC9557859)
Richardson, L., Long, E. , Goodfellow, C. , Milicev, J. and Gardani, M. (2024) Starting an undergraduate degree amid the COVID-19 pandemic: a mixed-method egocentric network study on student loneliness. PLoS ONE, 19(2), e0297953. (doi: 10.1371/journal.pone.0297953) (PMID:38306333) (PMCID:PMC10836688)
Wyper, G. M. A. , McDonald, S. A., Haagsma, J. A., Devleesschauwer, B., Charalampous, P., Maini, R., Smith, P. and Pires, S. M. (2023) A proposal for further developing fatigue-related post COVID-19 health states for burden of disease studies. Archives of Public Health, 81(1), 193. (doi: 10.1186/s13690-023-01212-1) (PMID:37919765) (PMCID:PMC10621107)
Lo, S. et al. (2023) Participatory development of a 3D telemedicine system during Covid: the future of remote consultations. Journal of Plastic, Reconstructive and Aesthetic Surgery, 87, pp. 479-490. (doi: 10.1016/j.bjps.2022.10.012) (PMID:36890078)
Loh, M. et al. (2023) Measurement of SARS-CoV-2 in air and on surfaces in Scottish hospitals. Journal of Hospital Infection, 133, pp. 1-7. (doi: 10.1016/j.jhin.2022.11.019) (PMID:36473553) (PMCID:PMC9721166)
Juárez, S. P., Honkaniemi, H., Aradhya, S., Debiasi, E., Katikireddi, S. V. , Cederström, A. F., Mussino, E. and Rostila, M. (2023) Explaining COVID-19 mortality among immigrants in Sweden from a social determinants of health perspective (COVIS): protocol for a national register-based observational study. BMJ Open, 13(4), e070670. (doi: 10.1136/bmjopen-2022-070670) (PMID:37094903) (PMCID:PMC10151235)
Cheetham, N. J. et al. (2023) Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies. eLife, 12, e80428. (doi: 10.7554/eLife.80428) (PMID:36692910) (PMCID:PMC9940912)
Aldridge, R. W., Lewer, D., Katikireddi, S. V. , Mathur, R., Pathak, N., Burns, R. and Fragaszy, E. B. (2020) Black, Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data. Wellcome Open Research, 5, 88. (doi: 10.12688/wellcomeopenres.15922.2) (PMID:32613083) (PMCID:PMC7317462)
Stock, S. J. et al. (2020) COVID-19 in Pregnancy in Scotland (COPS): protocol for an observational study using linked Scottish national data. BMJ Open, 10(11), e042813. (doi: 10.1136/bmjopen-2020-042813) (PMID:33243817) (PMCID:PMC7691999)
Green, M. J. et al. (2022) The UK Coronavirus Job Retention Scheme and smoking, alcohol consumption and vaping during the COVID-19 pandemic: evidence from eight longitudinal population surveys. BMC Medicine, 20, 345. (doi: 10.1186/s12916-022-02511-0) (PMID:36127702) (PMCID:PMC9489267)
Amele, S. et al. (2024) Quality of ethnicity data within Scottish health records and implications of misclassification for ethnic inequalities in severe COVID-19: a national linked data study. Journal of Public Health, 46(1), pp. 116-122. (doi: 10.1093/pubmed/fdad196) (PMID:37861114) (PMCID:PMC10901260)
Wels, J. et al. (2022) Mental and social wellbeing and the UK coronavirus job retention scheme: evidence from nine longitudinal studies. Social Science and Medicine, 308, 115226. (doi: 10.1016/j.socscimed.2022.115226) (PMID:35932537) (PMCID:PMC9296227)
Olsen, J. and Mitchell, R. (2020) S&SR Environments and Spaces Group: Change in use of green and open space following COVID-19 lockdown ‘stay at home’ phase and initial easing of lockdown. Project Report. University of Glasgow. (doi: 10.36399/gla.pubs.223180). (Unpublished)
Almorox, E. G., Stokes, J. and Morciano, M. (2022) Has COVID-19 changed carer's views of health and care integration in care homes? A sentiment difference-in-difference analysis of on-line service reviews. Health Policy, 126(11), pp. 1117-1123. (doi: 10.1016/j.healthpol.2022.08.010) (PMID:36064471) (PMCID:PMC9396455)
McKeigue, P. M., McGurnaghan, S., Blackbourn, L., Bath, L. E., McAllister, D. A. , Caparrotta, T. M., Wild, S. H., Wood, S. N., Stockton, D. and Colhoun, H. M. (2023) Relation of incident type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland. Diabetes Care, 46(5), pp. 921-928. (doi: 10.2337/dc22-0385) (PMID:35880797)
Simpson, C. R. et al. (2022) Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nature Communications, 13, 4800. (doi: 10.1038/s41467-022-32264-6) (PMID:35970827) (PMCID:PMC9377297)
Kopasker, D. (2021) Good work and mental health in the post-Covid era. In: McCann, P. and Vorley, T. (eds.) Productivity and the Pandemic: Challenges and Insights from Covid-19. Edward Elgar Publishing Limited: Cheltenham, UK, pp. 119-131. ISBN 9781800374591 (doi: 10.4337/9781800374607.00015)
Greenhalgh, T., Schmid, M. B., Czypionka, T., Bassler, D. and Gruer, L. (2020) Face masks for the public during the covid-19 crisis. British Medical Journal, 369, m1435. (doi: 10.1136/bmj.m1435) (PMID:32273267)
McKeigue, P. M. et al. (2020) Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): a population-based case-control study. PLoS Medicine, 17(10), e1003374. (doi: 10.1371/journal.pmed.1003374) (PMID:33079969) (PMCID:PMC7575101)
Cleland, J. G.F. , Clark, R. A., Pellicori, P. and Inglis, S. C. (2020) Caring for people with heart failure and many other medical problems through and beyond the COVID‐19 pandemic; the advantages of universal‐access to home telemonitoring. European Journal of Heart Failure, 22(6), pp. 995-998. (doi: 10.1002/ejhf.1864) (PMID:32385954) (PMCID:PMC7273055)
Burton, J. K. , Drummond, M., Gallacher, K. I. and Quinn, T. J. (2023) Listening and learning: a qualitative study of Scottish care home staff experiences of managing COVID-19 between March 2020-August 2022. BMC Geriatrics, 23(1), 544. (doi: 10.1186/s12877-023-04251-z) (PMID:37679720) (PMCID:PMC10485989)
Bouttell, J. and Hawkins, N. (2021) Evaluation of triage tests when existing test capacity is constrained: application to rapid diagnostic testing in COVID-19. Medical Decision Making, 41(8), pp. 978-987. (doi: 10.1177/0272989X211014114) (PMID:34009068) (PMCID:PMC8488642)
Sherr, L., Mebrahtu, H., Mwaba, K., Nurova, N., Chetty, A. N., Swartz, A., Cluver, L., Steventon Roberts, K. J. and Lachman, J. M. (2022) ‘Tipping the balance' – an evaluation of COVID-19 parenting resources developed and adapted for child protection during global emergency responses. Health Psychology and Behavioral Medicine, 10(1), pp. 676-694. (doi: 10.1080/21642850.2022.2104285) (PMID:35957956) (PMCID:PMC9359164)
Jani, B. D. et al. (2021) Family history of diabetes and risk of SARS-COV-2 in UK Biobank: a prospective cohort study. Endocrinology, Diabetes and Metabolism, 4(4), e00283. (doi: 10.1002/edm2.283) (PMID:34505416) (PMCID:PMC8420405)
Hatton, C. et al. (2021) The willingness of UK adults with intellectual disabilities to take COVID‐19 vaccines. Journal of Intellectual Disability Research, 65(11), pp. 949-961. (doi: 10.1111/jir.12884) (PMID:34529314)
Gbinigie, O. et al. (2023) Platform adaptive trial of novel antivirals for early treatment of COVID-19 in the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease. BMJ Open, 13(8), e069176. (doi: 10.1136/bmjopen-2022-069176) (PMID:37550022) (PMCID:PMC10407406)
Gostoli, U. and Silverman, E. (2022) An agent-based model of social care provision during the early stages of Covid-19. Scientific Reports, 12, 16534. (doi: 10.1038/s41598-022-20846-9) (PMID:36192471) (PMCID:PMC9528879)
Wismans, A. et al. (2021) The role of impulsivity and delay discounting in student compliance with COVID-19 protective measures. Personality and Individual Differences, 179, 110925. (doi: 10.1016/j.paid.2021.110925)
Gostoli, U. and Silverman, E. (2023) Self-isolation and testing behaviour during the COVID-19 pandemic: an agent-based model. Artificial Life, 29(1), pp. 94-117. (doi: 10.1162/artl_a_00392) (PMID:36269874)
Mareev, V. Y. et al. (2020) Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study). Kardiologiia, 60(6), pp. 15-29. (doi: 10.18087/cardio.2020.6.n1226) (PMID:32720612)
Chambers, S. , Clarke, J., Kipping, R., Langford, R., Brophy, R., Hannam, K., Taylor, H., Willis, K. and Simpson, S. A. (2022) Parents’ perceptions of children's emotional wellbeing during spring 2020 COVID-19 restrictions: a qualitative study with parents of young children in England. Child: Care, Health and Development, 48(6), pp. 1071-1080. (doi: 10.1111/cch.13034) (PMID:35839296) (PMCID:PMC9349486)
Fitzgerald, N., Uny, I., Brown, A., Eadie, D., Ford, A., Lewsey, J. and Stead, M. (2021) Managing COVID-19 transmission risks in bars: an interview and observation study. Journal of Studies on Alcohol and Drugs, 82(1), pp. 42-54. (doi: 10.15288/jsad.2021.82.42) (PMID:33573721)
Shi, T. et al. (2022) Risk of COVID-19 hospital admission among children aged 5–17 years with asthma in Scotland: a national incident cohort study. Lancet Respiratory Medicine, 10(2), pp. 191-198. (doi: 10.1016/S2213-2600(21)00491-4) (PMID:34861180) (PMCID:PMC8631918)
Clarke, J., Kipping, R., Chambers, S. , Willis, K., Taylor, H., Brophy, R., Hannam, K., Simpson, S. A. and Langford, R. (2021) Impact of COVID-19 restrictions on preschool children’s eating, activity and sleep behaviours: a qualitative study. BMJ Open, 11(10), e051497. (doi: 10.1136/bmjopen-2021-051497) (PMID:34663663) (PMCID:PMC8523958)
McCall, P.J. , Willder, J.M., Stanley, B.L. , Messow, C.-M. , Allan, J., Gemmell, L., Puxty, A., Strachan, D., Berry, C. and Shelley, B.G. (2022) Right ventricular dysfunction in patients with COVID-19 pneumonitis whose lungs are mechanically ventilated: a multicentre prospective cohort study. Anaesthesia, 77(7), pp. 772-784. (doi: 10.1111/anae.15745) (PMID:35607911) (PMCID:PMC9322018)
Dema, E., Gibbs, J., Clifton, S., Riddell, J. , Boso Perez, R., Copas, A., Mercer, C., Mitchell, K. , Sonnenberg, P. and Field, N. (2021) Measuring Impacts of COVID-19 on Sexual and Reproductive Health Service Use in Britain: Findings From a Large, Quasi-Representative Survey (Natsal-COVID). Sexually Transmitted Infections. 97(Suppl 1). STI & HIV World Congress, 14-17 Jul 2021. A24. (doi: 10.1136/sextrans-2021-sti.71)
Devleesschauwer, B. et al. (2023) The direct disease burden of COVID-19 in Belgium in 2020 and 2021. BMC Public Health, 23(1), 1707. (doi: 10.1186/s12889-023-16572-0) (PMID:37667264) (PMCID:PMC10476343)
Standing, J. F. et al. (2024) Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients. Nature Communications, 15, 1652. (doi: 10.1038/s41467-024-45641-0) (PMID:38396069) (PMCID:PMC10891158)
Miall, N. , Pearce, A. , Moore, J. C., Benzeval, M. and Green, M. J. (2023) Inequalities in children’s mental health before and during the COVID-19 pandemic: findings from the UK Household Longitudinal Study. Journal of Epidemiology and Community Health, 77(12), pp. 762-769. (doi: 10.1136/jech-2022-220188) (PMID:37748928) (PMCID:PMC10646900)
Shoaib, A. et al. (2021) Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic. European Heart Journal: Quality of Care and Clinical Outcomes, 7(4), pp. 378-387. (doi: 10.1093/ehjqcco/qcab040) (PMID:34043762) (PMCID:PMC8244536)
Hastie, C. E. et al. (2022) Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland Study. Nature Communications, 13, 5663. (doi: 10.1038/s41467-022-33415-5) (PMID:36224173) (PMCID:PMC9556711)
Green, M. et al. (2024) Trends in inequalities in avoidable hospitalisations across the COVID-19 pandemic: A cohort study of 23.5 million people in England. BMJ Open, 14(1), e077948. (doi: 10.1136/bmjopen-2023-077948) (PMID:38191251)
Morrow, A. et al. (2022) Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise—CISCO-21. Trials, 23, 660. (doi: 10.1186/s13063-022-06632-y) (PMID:35971155) (PMCID:PMC9376905)
Maguire, R., Pert, C., Baines, S., Gillooly, A., Hastings, R. P., Hatton, C., Dagnan, D. and Jahoda, A. (2022) Adapted guided self-help booklets for supporting the well-being of people with intellectual disabilities during the COVID-19 pandemic: an evaluation of impact. Tizard Learning Disability Review, 27(1), pp. 17-25. (doi: 10.1108/TLDR-08-2021-0024)
Aronowitz, S. V. et al. (2022) Substance use policy and practice in the COVID-19 pandemic: learning from early pandemic responses through internationally comparative field data. Global Public Health, 17(12), pp. 3654-3669. (doi: 10.1080/17441692.2022.2129720) (PMID:36692903)
Stead, M., Jessop, C., Angus, K., Bedford, H., Ussher, M., Ford, A., Eadie, D., MacGregor, A., Hunt, K. and MacKintosh, A. M. (2021) National survey of attitudes towards and intentions to vaccinate against COVID-19: implications for communications. BMJ Open, 11(10), e055085. (doi: 10.1136/bmjopen-2021-055085) (PMID:34711602) (PMCID:PMC8557244)
Lalloo, D., Williams, A., Roy, M., MacDonald, E. and Rayner, C. (2021) COVID-19 Return to Work in the Roadmap Out of Lockdown: Guidelines for Workers, Employers and Health Practitioners. Documentation. Society of Occupational Medicine, London.
Wasilewski, M. B., Szigeti, Z., Sheppard, C. L., Minezes, J., Hitzig, S. L., Mayo, A. L., Robinson, L. R., Lung, M. and Simpson, R. (2022) Infection prevention and control across the continuum of COVID‐19 care: a qualitative study of patients', caregivers' and providers' experiences. Health Expectations, 25(5), pp. 2431-2439. (doi: 10.1111/hex.13558) (PMID:35818850) (PMCID:PMC9350031)
Nafilyan, V. et al. (2021) Ethnicity, household composition and COVID-19 mortality: a national linked data study. Journal of the Royal Society of Medicine, 114(4), pp. 182-211. (doi: 10.1177/0141076821999973) (PMID:33759630) (PMCID:PMC7994923)
Kotzur, M. , O'Connor, R. C. and Robb, K. A. (2022) How has physical distancing impacted on health and well-being during the COVID-19 pandemic? A Scottish longitudinal qualitative study. BMJ Open, 12(5), e054506. (doi: 10.1136/bmjopen-2021-054506) (PMID:35534078) (PMCID:PMC9086282)
Wilson, J., Demou, E. and Kromydas, T. (2024) COVID-19 lockdowns and working women’s mental health: does motherhood and size of workplace matter? A comparative analysis using understanding society. Social Science and Medicine, 340, 116418. (doi: 10.1016/j.socscimed.2023.116418) (PMID:37992613) (PMCID:PMC7615337)
Olsen, J. and Mitchell, R. (2021) S&SR Environment and Spaces Group Report: COVID-19 Green and Open Space Use in Autumn 2020. Project Report. MRC/CSO Social and Public Health Sciences Unit, Glasgow. (doi: 10.36399/gla.pubs.234770).
Dema, E. et al. (2022) Initial impacts of the COVID-19 pandemic on sexual and reproductive health service use and unmet need in Britain: findings from a quasi-representative survey (Natsal-COVID). Lancet Public Health, 7(1), e36-e47. (doi: 10.1016/S2468-2667(21)00253-X) (PMID:34995541) (PMCID:PMC8730819)
Hastie, C. , Pell, J. and Sattar, N. (2021) Vitamin D and COVID-19 infection and mortality in UK Biobank. European Journal of Nutrition, 60, pp. 545-548. (doi: 10.1007/s00394-020-02372-4) (PMID:32851419) (PMCID:PMC7449523)
McKeigue, P. M., Burgul, R., Bishop, J., Robertson, C., McMenamin, J., O’Leary, M., McAllister, D. A. and Colhoun, H. M. (2021) Association of cerebral venous thrombosis with recent COVID-19 vaccination: case-crossover study using ascertainment through neuroimaging in Scotland. BMC Infectious Diseases, 21, 1275. (doi: 10.1186/s12879-021-06960-5)
Barton, C. M. et al. (2020) Call for transparency of COVID-19 models. Science, 368(6490), pp. 482-483. (doi: 10.1126/science.abb8637) (PMID:32355024)
Shah, S. A. et al. (2022) Impact of first UK COVID-19 lockdown on hospital admissions: Interrupted time series study of 32 million people. EClinicalMedicine, 49, 101462. (doi: 10.1016/j.eclinm.2022.101462) (PMID:35611160) (PMCID:PMC9121886)
Katikireddi, S. V. , Lal, S., Carrol, E. D., Niedzwiedz, C. L. , Khunti, K., Dundas, R. , Diderichsen, F. and Barr, B. (2021) Unequal impact of the COVID-19 crisis on minority ethnic groups: a framework for understanding and addressing inequalities. Journal of Epidemiology and Community Health, 75(10), pp. 970-974. (doi: 10.1136/jech-2020-216061) (PMID:33883198)
Rhead, R. et al. (2024) Long COVID and financial outcomes: evidence from four longitudinal population surveys. Journal of Epidemiology and Community Health, (doi: 10.1136/jech-2023-221059) (PMID:38508701) (Early Online Publication)
Young, B., Kotzur, M. , Gatting, L., Bonner, C., Ayre, J., McConnachie, A. , Batcup, C., McCaffery, K., O'Carroll, R. and Robb, K. A. (2021) The impact of theory-based messages on COVID-19 vaccination intentions: a structured summary of a study protocol for a randomised controlled trial. Trials, 22, 311. (doi: 10.1186/s13063-021-05277-7) (PMID:33926540) (PMCID:PMC8082050)
Banda, L. et al. (2023) Characterising the evolving SARS-CoV-2 seroprevalence in urban and rural Malawi between February 2021 and April 2022: A population-based cohort study. International Journal of Infectious Diseases, 137, pp. 118-125. (doi: 10.1016/j.ijid.2023.10.020) (PMCID:PMC10695832)
Cannegieter, S. C. et al. (2022) First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales. PLoS Medicine, 19(2), e1003927. (doi: 10.1371/journal.pmed.1003927) (PMID:35192598) (PMCID:PMC8863261)
Zhang, H., Thygesen, J. and Wu, H. (2021) Increased COVID-19 related mortality rate for patients with rare diseases: a retrospective cohort study with data from Genomics England. Lancet, 398(Sup 2), S95. (PMCID:PMC8617313)
Davidson, J., Karadzhov, D. , Collins, H. and Brown, A. (2023) Complexities of protecting children from violence during the COVID-19 pandemic: providers' and policymakers' best practices, innovations and challenges in 12 countries. Child Abuse and Neglect, 146, 106480. (doi: 10.1016/j.chiabu.2023.106480) (PMID:37801758)
Dema, E. et al. (2023) How did the COVID-19 pandemic affect access to condoms, chlamydia and HIV testing, and cervical cancer screening at a population level in Britain? (Natsal-COVID). Sexually Transmitted Infections, 99(4), pp. 261-267. (doi: 10.1136/sextrans-2022-055516) (PMID:35981863) (PMCID:PMC10313967)
Wilding, S., O’Connor, D. B., Ferguson, E., Wetherall, K., Cleare, S. , O’Carroll, R. E. O., Robb, K. A. and O’Connor, R. C. O. (2022) Information seeking, mental health and loneliness: Longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing study. Psychiatry Research, 317, 114876. (doi: 10.1016/j.psychres.2022.114876) (PMID:36215778) (PMCID:PMC9526871)
Al-Ozairi, E. et al. (2021) Risk of mortality among inpatients with COVID-19 and type 2 diabetes: national data from Kuwait. Endocrinology, Diabetes and Metabolism, 4(4), e00287. (doi: 10.1002/edm2.287) (PMID:34505420) (PMCID:PMC8420596)
Voors, A. A. et al. (2020) Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors. European Heart Journal, 41(19), pp. 1810-1817. (doi: 10.1093/eurheartj/ehaa373) (PMID:32388565) (PMCID:PMC7239195)
Menear, M. et al. (2023) Understanding the impacts of the COVID-19 pandemic on the care experiences of people with mental-physical multimorbidity: protocol for a mixed methods study. BMC Primary Care, 24(1), 154. (doi: 10.1186/s12875-023-02106-5) (PMID:37488515) (PMCID:PMC10364355)
Caton, S. et al. (2023) Digital participation of people with profound and multiple learning disabilities during the Covid‐19 pandemic in the UK. British Journal of Learning Disabilities, 51(2), pp. 163-174. (doi: 10.1111/bld.12501)
Wielgoszewska, B. et al. (2022) The UK Coronavirus Job Retention Scheme and diet, physical activity, and sleep during the COVID-19 pandemic: evidence from eight longitudinal population surveys. BMC Medicine, 20, 147. (doi: 10.1186/s12916-022-02343-y) (PMID:35387639) (PMCID:PMC8984671)
Shah, S. A. et al. (2021) Predicted COVID-19 positive cases, hospitalisations, and deaths associated with the Delta variant of concern, June-July, 2021. Lancet Digital Health, 3(9), E539-E541. (doi: 10.1016/S2589-7500(21)00175-8) (PMID:34384736) (PMCID:PMC8352493)
Simpson, C.R. et al. (2021) First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nature Medicine, 27(7), pp. 1290-1297. (doi: 10.1038/s41591-021-01408-4) (PMID:34108714) (PMCID:PMC8282499)
Korczak, D. J. et al. (2024) The trajectory of depression and anxiety among children and adolescents over two years of the COVID-19 pandemic. Psychiatry Research, 339, 116101. (doi: 10.1016/j.psychres.2024.116101) (PMID:39068897)
Pauley, E., Drake, T. M., Sigfrid, L., Lone, N., Harrison, E. M., Baillie, J. K., Scott, J. T. , Walsh, T. S., Semple, M. G. and Docherty, A. B. (2023) Recovery from Covid-19 critical illness: a secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial. Journal of the Intensive Care Society, 24(2), pp. 162-169. (doi: 10.1177/17511437211052226) (PMID:37255989) (PMCID:PMC10225805)
Hainey, K. J. and Katikireddi, S. V. (2021) The inverse care law in critical care during the COVID-19 pandemic. Lancet Regional Health - Europe, 1, 100008. (doi: 10.1016/j.lanepe.2020.100008) (PMCID:PMC7834397)
Pirkis, J. et al. (2021) Suicide trends in the early months of the COVID-19 pandemic: interrupted time series analysis of preliminary data from 21 countries. Lancet Psychiatry, 8(7), pp. 579-588. (doi: 10.1016/S2215-0366(21)00091-2) (PMID:33862016)
Costello, R. et al. (2023) Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform. eClinicalMedicine, 61, p. 102077. (doi: 10.1016/j.eclinm.2023.102077) (PMID:37434746) (PMCID:PMC10331810)
Savage, H. R., Finch, L., Body, R., Watkins, R. L., Hayward, G., Cook, E., Cubas-Atienzar, A. I., Cuevas, L. E., MacPherson, P. and Adams, E. R. (2022) A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing. PLoS ONE, 17(6), e0270715. (doi: 10.1371/journal.pone.0270715) (PMID:35771760) (PMCID:PMC9246218)
Sonnenberg, P. et al. (2022) Intimate physical contact between people from different households during the COVID-19 pandemic: a mixed-methods study from a large, quasi representative survey (Natsal-COVID). BMJ Open, 12(2), e055284. (doi: 10.1136/bmjopen-2021-055284) (PMID:35140158) (PMCID:PMC8829844)
Rudan, I. et al. (2022) BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12-17 years in Scotland. Lancet Regional Health - Europe, 23, 100513. (doi: 10.1016/j.lanepe.2022.100513) (PMID:36189425) (PMCID:PMC9514975)
Cherrie, J. W., Cherrie, M. P.C., Smith, A., Holmes, D., Semple, S., Steinle, S., MacDonald, E. , Moore, G. and Loh, M. (2021) Contamination of air and surfaces in workplaces with SARS-CoV-2 Virus: a systematic review. Annals of Work Exposures and Health, 65(8), pp. 879-892. (doi: 10.1093/annweh/wxab026) (PMID:34329379) (PMCID:PMC8385829)
van der Klaauw, A. A. et al. (2023) Accelerated waning of the humoral response to COVID-19 vaccines in obesity. Nature Medicine, 29(5), pp. 1146-1154. (doi: 10.1038/s41591-023-02343-2) (PMID:37169862) (PMCID:PMC10202802)
Taylor, A. K., Kingstone, T., Briggs, T. A., O'Donnell, C. A. , Atherton, H., Blane, D. N. and Chew‐Graham, C. A. (2021) 'Reluctant pioneer’: a qualitative study of doctors’ experiences as patients with long-COVID. Health Expectations, 24(3), pp. 833-842. (doi: 10.1111/hex.13223) (PMID:33749957) (PMCID:PMC8235894)
O'Connor, D. B. et al. (2023) Effects of COVID-19-related worry and rumination on mental health and loneliness during the pandemic: longitudinal analyses of adults in the UK COVID-19 mental health & wellbeing study. Journal of Mental Health, 32(6), pp. 1122-1133. (doi: 10.1080/09638237.2022.2069716) (PMID:35579054)
Young, B. and Robb, K. (2020) How to get people to comply with COVID-19 public health measures – lessons from cancer screening. Conversation, 24 Nov.
Bergman, B. P., Mackay, D. F. and Pell, J. P. (2024) The impact of COVID-19 on the veteran population: evidence from the Trends in Scottish Veterans Health study. BMJ Military Health, (doi: 10.1136/military-2024-002677) (PMID:38697753) (Early Online Publication)
Robertson, E., Reeve, K. S., Niedzwiedz, C. L. , Moore, J., Blake, M., Green, M. , Katikireddi, S. V. and Benzeval, M. J. (2021) Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain, Behavior, and Immunity, 94, pp. 41-50. (doi: 10.1016/j.bbi.2021.03.008) (PMID:33713824) (PMCID:PMC7946541)
Gibson Smith, K. et al. (2022) Supporting doctors' well‐being and resilience during COVID‐19: a framework for rapid and rigorous intervention development. Applied Psychology: Health and Well‐Being, 14(1), pp. 236-251. (doi: 10.1111/aphw.12300) (PMID:34414681) (PMCID:PMC8444870)
Wyper, G. M.A. et al. (2020) Population vulnerability to COVID-19 in Europe: a burden of disease analysis. Archives of Public Health, 78, 47. (doi: 10.1186/s13690-020-00433-y) (PMID:32501409) (PMCID:PMC7256342)
Perry, R. J. et al. (2021) Characteristics and outcomes of COVID-19-associated stroke: a UK multicentre case-control study. Journal of Neurology, Neurosurgery and Psychiatry, 92(3), pp. 242-248. (doi: 10.1136/jnnp-2020-324927) (PMID:33154179)
Teuton, J., Sloan, P., Whyte, B., Cope, A., Macdonald, A., Cozzolino, N., Davis, A. and Douglas, M. (2020) Transport use, health and health inequalities: The impact of measures to reduce the spread of COVID-19. Project Report. Public Health Scotland, Edinburgh.
Linden, M. A., Forbes, T., Brown, M., Marsh, L., Truesdale, M. , McCann, E., Todd, S. and Hughes, N. (2022) Impact of the COVID-19 pandemic on family carers of those with profound and multiple intellectual disabilities: perspectives from UK and Irish Non-Governmental Organisations. BMC Public Health, 22, 2095. (doi: 10.1186/s12889-022-14560-4) (PMID:36384516) (PMCID:PMC9668390)
Hastie, C. E. et al. (2023) Natural history of long-COVID in a nationwide, population cohort study. Nature Communications, 14, 3504. (doi: 10.1038/s41467-023-39193-y) (PMID:37311808) (PMCID:PMC10263377)
Sigfrid, L. et al. (2021) Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Regional Health - Europe, 8, 100186. (doi: 10.1016/j.lanepe.2021.100186) (PMID:34386785) (PMCID:PMC8343377)
Wyper, G. M.A. , Mackay, D. F. , Fraser, C., Lewsey, J. , Robinson, M., Beeston, C. and Giles, L. (2023) COVID-19 and commerce complicate assessing the impact of minimum unit pricing for alcohol on health outcomes in Scotland – Authors’ reply. Lancet, 402(10399), pp. 368-369. (doi: 10.1016/S0140-6736(23)01251-5) (PMID:37516536)
Mitchell, K. et al. (2023) Initial impacts of COVID-19 on sex life and relationship quality in steady relationships in Britain: findings from a large, quasi-representative survey (Natsal-COVID). Journal of Sex Research, 60(1), pp. 1-12. (doi: 10.1080/00224499.2022.2035663) (PMID:35286182)
Daines, L. et al. (2022) Deriving and validating a risk prediction model for long COVID-19: protocol for an observational cohort study using linked Scottish data. BMJ Open, 12(7), e059385. (doi: 10.1136/bmjopen-2021-059385) (PMID:35793922) (PMCID:PMC9260199)
Macdonald, E. , Lalloo, D., Raynor, C., Yarker, J. and SOM Long Covid Group (Society of Occupational Medicine), . (2021) COVID-19 infection and long COVID – guide for workers. Documentation. European Agency for Health and Safety at Work (EUOSHA).
Grant, A. et al. (2024) Four years in, what are the research priorities for Long COVID? a research priority setting partnership between people with lived experience, carers, clinicians, and researchers. Health Expectations, 27(5), e70072. (doi: 10.1111/hex.70072) (PMID:39445814) (PMCID:PMC11500202)
Fenny, A. P., Otieku, E., Owusu Achiaw, S. , Okoe Boye, B., Asenso-Boadi, F., Addo-Cobbiah, V. and Musah, M. (2024) Impact of COVID-19 on the management of hypertension: a perspective on disease severity, service use patterns and expenditures from Ghana’s health insurance claims data. Journal of Human Hypertension, (doi: 10.1038/s41371-024-00924-3) (PMID:38902509) (Early Online Publication)
De Kock, J. H., Latham, H. A., Cowden, R. G., Cullen, B. , Narzisi, K., Jerdan, S., Munoz, S.-A., Leslie, S. J., Stamatis, A. and Eze, J. (2022) Brief digital interventions to support the psychological well-being of NHS staff during the COVID-19 pandemic: 3-arm pilot randomized controlled trial. JMIR Mental Health, 9(4), e34002. (doi: 10.2196/34002) (PMID:35044927) (PMCID:PMC8982650)
Critchlow, N., Hunt, K. , Wardle, H. and Stead, M. (2023) Expenditure on paid-for gambling advertising during the national COVID-19 ‘lockdowns’: an observational study of media monitoring data from the United Kingdom. Journal of Gambling Studies, 39(3), pp. 1451-1465. (doi: 10.1007/s10899-022-10153-3) (PMID:36031649) (PMCID:PMC9420675)
Murphy, D. et al. (2020) Meeting the Psychological Needs of People Recovering from Severe Coronavirus. Other. British Psychological Society.
Thomson, M. , Martin, A. , Long, E. , Logue, J. and Simpson, S. A. (2022) A qualitative exploration of weight management during COVID-19. Clinical Obesity, 12(3), e12512. (doi: 10.1111/cob.12512) (PMID:35194943) (PMCID:PMC9286397)
Cuschieri, S., Calleja, N., Devleesschauwer, B. and Wyper, G. M. A. (2021) Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year. BMC Public Health, 21, 1827. (doi: 10.1186/s12889-021-11893-4) (PMID:34627228) (PMCID:PMC8501913)
Bécares, L., Shaw, R. J. , Katikireddi, S. V. , Irizar, P., Amele, S. , Kapadia, D., Nazroo, J. and Taylor, H. (2022) Racism as the fundamental cause of ethnic inequities in COVID-19 vaccine hesitancy: a theoretical framework and empirical exploration using the UK Household Longitudinal Study. SSM - Population Health, 19, 101150. (doi: 10.1016/j.ssmph.2022.101150) (PMID:35765366) (PMCID:PMC9225926)
Blane, D. , McMahon, A., Lunan, C., Montgomery, J. and Richardson, H. (2021) GPs at the Deep End Report 37: COVID-19 vaccine deployment for marginalised groups in Scotland. Documentation. University of Glasgow, Glasgow.
Bell, S. et al. (2020) COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry. BMC Nephrology, 21, 419. (doi: 10.1186/s12882-020-02061-8) (PMID:33004002) (PMCID:PMC7528715)
Jackman, P. C., Sanderson, R., Haughey, T. J., Brett, C. E., White, N. , Zile, A., Tyrrell, K. and Byrom, N. C. (2022) The impact of the first COVID-19 lockdown in the UK for doctoral and early career researchers. Higher Education, 84(4), pp. 705-722. (doi: 10.1007/s10734-021-00795-4) (PMID:34924592) (PMCID:PMC8669662)
Potter, C. et al. (2023) Effectiveness and cost-effectiveness of a personalised self-management intervention for living with long COVID: protocol for the LISTEN randomised controlled trial. Trials, 24, 75. (doi: 10.1186/s13063-023-07090-w) (PMID:36726167) (PMCID:PMC9890432)
Rudan, I., Adeloye, D., Katikireddi, S. V. , Murray, J., Simpson, C., Shah, S. A., Robertson, C. and Sheikh, A. (2021) The COVID-19 pandemic in children and young people during 2020-2021: Learning about clinical presentation, patterns of spread, viral load, diagnosis and treatment. Journal of Global Health, 11, 01010. (doi: 10.7189/jogh.11.01010) (PMID:35047182) (PMCID:PMC8763336)
Irizar, P. et al. (2023) Pathways to ethnic inequalities in COVID-19 health outcomes in the United Kingdom: a systematic map. Social Science and Medicine, 329, 116044. (doi: 10.1016/j.socscimed.2023.116044) (PMID:37364448) (PMCID:PMC10284430)
Willder, J. M., McCall, P. , Messow, C.-M. , Gillies, M., Berry, C. and Shelley, B. (2021) Study protocol for COVID-RV: a multicentre prospective observational cohort study of right ventricular dysfunction in ventilated patients with COVID-19. BMJ Open, 11(1), e042098. (doi: 10.1136/bmjopen-2020-042098) (PMID:33441361) (PMCID:PMC7811959)
Shah, A. S.V. et al. (2021) Effect of vaccination on transmission of SARS-CoV-2. New England Journal of Medicine, 385(18), pp. 1718-1720. (doi: 10.1056/NEJMc2106757) (PMID:34496200) (PMCID:PMC8451182)
Pollock, A. M., Clements, L. and Harding-Edgar, L. (2020) Covid-19: why we need a national health and social care service. British Medical Journal, 369, m1465. (doi: 10.1136/bmj.m1465) (PMID:32291259)
De Kock, J. H. et al. (2022) The mental health of NHS staff during the COVID-19 pandemic: a two-wave Scottish cohort study. BJPsych Open, 8(1), e23. (doi: 10.1192/bjo.2021.1079) (PMID:35043077) (PMCID:PMC8755549)
Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, 116(14), pp. 2185-2196. (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (PMCID:PMC7454350)
Burnett, H., Olsen, J. R. and Mitchell, R. (2022) Green space visits and barriers to visiting during the Covid-19 pandemic: a three-wave nationally representative cross-sectional study of UK adults. Land, 11(4), 503. (doi: 10.3390/land11040503)
Mair, F. S. , Foster, H. M.E. and Nicholl, B. I. (2020) Multimorbidity and the COVID-19 pandemic – an urgent call to action. Journal of Comorbidity, 10, pp. 1-2. (doi: 10.1177/2235042X20961676) (PMID:33117721) (PMCID:PMC7573706)
Ho, F. K. and Pell, J. P. (2022) Thromboembolism and bleeding after covid-19. British Medical Journal, 377, o817. (doi: 10.1136/bmj.o817) (PMID:35387800)
Henderson, A. , Fleming, M. , Cooper, S.-A. , Pell, J. P. , Melville, C. , Mackay, D. F. , Hatton, C. and Kinnear, D. (2022) COVID-19 infection and outcomes in a population-based cohort of 17 203 adults with intellectual disabilities compared with the general population. Journal of Epidemiology and Community Health, 76, pp. 550-555. (doi: 10.1136/jech-2021-218192) (PMID:35232778) (PMCID:PMC8914402)
Linden, M., Leonard, R., Forbes, T., Brown, M., Marsh, L., Todd, S., Hughes, N. and Truesdale, M. (2023) Experiences of UK and Irish family carers of people with profound and multiple intellectual disabilities during the COVID-19 pandemic. BMC Public Health, 23(1), 2475. (doi: 10.1186/s12889-023-17432-7) (PMID:38082349) (PMCID:PMC10714525)
Harrison, E. M. et al. (2020) Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients. SSRN Electronic Journal, (doi: 10.2139/ssrn.3618215) (Submitted)
Mitchell, K. et al. (2021) Early Impacts of COVID-19 on Sex Life and Relationship Quality: Findings From a Large British Quasi-Representative Online Survey (Natsal-COVID). Sexually Transmitted Infections. 97(Suppl 1). STI & HIV World Congress, 14-17 Jul 2021. A26. (doi: 10.1136/sextrans-2021-sti.76)
Mutambudzi, M. et al. (2021) Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occupational and Environmental Medicine, 78(5), pp. 307-314. (doi: 10.1136/oemed-2020-106731) (PMID:33298533)
Gostoli, U. and Silverman, E. (2021) Towards a Behavioural Model of Covid-19 Spread. 3rd International Workshop on Agent-Based Modelling of Human Behaviour (ABMHuB'21), 19 Jul 2021.
Dema, E. et al. (2022) Methodology of Natsal-COVID Wave 1: a large, quasi-representative survey with qualitative follow-up measuring the impact of COVID-19 on sexual and reproductive health in Britain. Wellcome Open Research, 6, 209. (doi: 10.12688/wellcomeopenres.16963.2) (PMCID:PMC9020538)
Green, M. A., McKee, M., Hamilton, O. K.L. , Shaw, R. J. , Macleod, J., Boyd, A., The LH&W NCS Collaborative, and Katikireddi, S. V. (2023) Associations between self-reported healthcare disruption due to covid-19 and avoidable hospital admission: evidence from seven linked longitudinal studies for England. British Medical Journal, 382, e075133. (doi: 10.1136/bmj-2023-075133) (PMID:37468148) (PMCID:PMC10354595)
Kumleben, N., Bhopal, R., Czypionka, T., Gruer, L., Kock, R., Stebbing, J. and Stigler, F.L. (2020) Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers. Public Health, 185, pp. 88-90. (doi: 10.1016/j.puhe.2020.06.006) (PMID:32590234) (PMCID:PMC7287442)
Rhodes, S., Wilkinson, J., Pearce, N., Mueller, W., Cherrie, M., Stocking, K., Gittins, M., Katikireddi, S. V. and Tongeren, M. V. (2022) Occupational differences in SARS-CoV-2 infection: analysis of the UK ONS COVID-19 infection survey. Journal of Epidemiology and Community Health, 76(10), pp. 841-846. (doi: 10.1136/jech-2022-219101) (PMID:35817467) (PMCID:PMC9484374)
Niederkrotenthaler, T. et al. (2020) Suicide research, prevention, and COVID-19: towards a global response and the establishment of an international research collaboration. Crisis: The Journal of Crisis Intervention and Suicide Prevention, 41(5), pp. 321-330. (doi: 10.1027/0227-5910/a000731) (PMID:32716205)
Pellicori, P. (2020) At the heart of COVID-19. European Heart Journal, 41(19), pp. 1830-1832. (doi: 10.1093/eurheartj/ehaa415) (PMID:32405639)
Psotka, M. A. et al. (2020) Conduct of clinical trials in the era of COVID-19: JACC scientific expert panel. Journal of the American College of Cardiology, 76(20), pp. 2368-2378. (doi: 10.1016/j.jacc.2020.09.544) (PMID:33183511)
Hatton, C. et al. (2024) Health and healthcare of people with learning disabilities in the United Kingdom through the COVID‐19 pandemic. British Journal of Learning Disabilities, (doi: 10.1111/bld.12578) (Early Online Publication)
Wardle, H. et al. (2021) The impact of the initial Covid-19 lockdown upon regular sports bettors in Britain: findings from a cross-sectional online study. Addictive Behaviors, 118, 106876. (doi: 10.1016/j.addbeh.2021.106876) (PMID:33647707)
Long, E. et al. (2022) COVID-19 pandemic and its impact on social relationships and health. Journal of Epidemiology and Community Health, 76(2), pp. 128-132. (doi: 10.1136/jech-2021-216690) (PMID:34413184) (PMCID:PMC8380476)
Hastie, C. E. et al. (2023) True prevalence of long-COVID in a nationwide, population cohort study. Nature Communications, 14, 7892. (doi: 10.1038/s41467-023-43661-w) (PMID:38036541) (PMCID:PMC10689486)
Binyaruka, P., Mtenga, S. M., Mashasi, I., Karugu, C. H., Mohamed, S. F., Asiki, G., Mair, F. S. and Gray, C. M. (2023) Factors associated with COVID-19 vaccine uptake among people with type 2 diabetes in Kenya and Tanzania: A mixed-methods study. BMJ Open, 13(12), e073668. (doi: 10.1136/bmjopen-2023-073668)
Karadzhov, D. , Davidson, J. C. and Wilson, G. (2022) “You cannot pour from an empty cup!”: child well-being service providers’ and policymakers’ professional supervision, coping and well-being during COVID-19. Journal of Public Mental Health, 21(2), pp. 95-107. (doi: 10.1108/JPMH-08-2021-0095)
Artico, J. et al. (2023) Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study. Circulation, 147(5), pp. 364-374. (doi: 10.1161/CIRCULATIONAHA.122.060632) (PMID:36705028) (PMCID:PMC9889203)
Watt, G., Mullin, A. and Blane, D. (2020) GPs at the Deep End Report 36: General Practice in the time of COVID-19. Documentation. University of Glasgow, Glasgow.
Chadwick, F. J. et al. (2022) Combining rapid antigen testing and syndromic surveillance improves community-based COVID-19 detection in a low-income country. Nature Communications, 13, 2877. (doi: 10.1038/s41467-022-30640-w) (PMID:35618714) (PMCID:PMC9135686)
Xin, Y. , Nevill, C. R., Nevill, J., Gray, E., Cooper, N. J., Bradbury, N. and Sutton, A. J. (2022) Feasibility study for interactive reporting of network meta-analysis: experiences from the development of the MetaInsight COVID-19 app for stakeholder exploration, re-analysis and sensitivity analysis from living systematic reviews. BMC Medical Research Methodology, 22, 26. (doi: 10.1186/s12874-022-01507-x) (PMID:35065603) (PMCID:PMC8783587)
Bhandari, R. and Nesterova, Y. (2020) Support thy neighbour : why a strong local response will help beat COVID-19. [Website]
Aggarwal, K. et al. (2020) Ocular surface manifestations of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. PLoS ONE, 15(11), e0241661. (doi: 10.1371/journal.pone.0241661) (PMID:33151999) (PMCID:PMC7643964)
Cluver, L. et al. (2020) Parenting in a time of COVID-19. Lancet, 395(10231), e64. (doi: 10.1016/S0140-6736(20)30736-4) (PMID:32220657) (PMCID:PMC7146667)
Mohamed, S. F. et al. (2024) Policies for type 2 diabetes and non- communicable disease management during the COVID-19 pandemic in Kenya and Tanzania: A desk review and views of decision-makers. BMJ Open, 14(3), e073261. (doi: 10.1136/bmjopen-2023-073261) (PMID:38531573) (PMCID:PMC10966805)
Siddaway, A. P. (2020) Multidisciplinary research priorities for the COVID-19 pandemic. Lancet Psychiatry, 7(7), e43. (doi: 10.1016/S2215-0366(20)30220-0) (PMID:32563318) (PMCID:PMC7302784)
Stock, S. J. et al. (2022) SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland. Nature Medicine, 28(3), pp. 504-512. (doi: 10.1038/s41591-021-01666-2) (PMID:35027756)
Gordon, L. et al. (2022) Heard, valued, supported? Doctors' wellbeing during transitions triggered by COVID‐19. Medical Education, 56(5), pp. 516-526. (doi: 10.1111/medu.14698) (PMID:34796541) (PMCID:PMC8662221)
Lalloo, D., Roy, M. and MacDonald, E. (2020) COVID-19 Return to Work Guide for Health Professionals Advising Patients and Employers. Documentation. Society of Occupational Medicine, London.
Macdonald, E. , Lalloo, D., Raynor, C., Yarker, J. and SOM Long Covid Group (Society of Occupational Medicine), . (2021) COVID -19 infection and long COVID – guide for managers. Documentation. European Agency for Health and Safety at Work (EUOSHA).
Bouttell, J. , Corcoran, N. , Doyle, E., Harding-Edgar, L., Jani, B. , O'Donnell, K. , Oliver, J., Stein, A., Thompson, L. and White, B. (2022) SIGN 162 Assessment of COVID-19 in Primary Care: The identification of symptoms, clinical signs, characteristics, and comorbidities in adults, children and young people, which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.
Jeffrey, K. et al. (2024) Prevalence and risk factors for long COVID among adults in Scotland using electronic health records: a national, retrospective, observational cohort study. EClinicalMedicine, 71, 102590. (doi: 10.1016/j.eclinm.2024.102590) (PMID:38623399) (PMCID:PMC11016856)
Charura, D., Hill, A. P. and Etherson, M. E. (2023) COVID-19 vaccine hesitancy, medical mistrust, and mattering in ethnically diverse communities. Journal of Racial and Ethnic Health Disparities, 10(3), pp. 1518-1525. (doi: 10.1007/s40615-022-01337-z) (PMID:35641735) (PMCID:PMC9154033)
Fallesen, P., Oberndorfer, M. and Cozzani, M. (2023) Changes in conception rates, not in pregnancy-related behaviour, likely caused decline in preterm births during the first year of the COVID-19 pandemic. BJOG: An International Journal of Obstetrics and Gynaecology, 130(10), pp. 1153-1155. (doi: 10.1111/1471-0528.17568) (PMID:37271739)
Morciano, M., Stokes, J. , Kontopantelis, E., hall, i. and Turner, A. J. (2021) Excess mortality for care home residents during the first 23 weeks of the COVID-19 pandemic in England: a national cohort study. BMC Medicine, 19, 71. (doi: 10.1186/s12916-021-01945-2) (PMID:33663498) (PMCID:PMC7932761)
Rhodes, S. et al. (2023) The potential contribution of vaccination uptake to occupational differences in risk of SARS-CoV-2: Analysis of the ONS COVID-19 Infection Survey. Occupational and Environmental Medicine, (doi: 10.1136/oemed-2023-108931) (Early Online Publication)
Kennedy, J., Parker, M., Seaborne, M., Mhereeg, M., Walker, A., Walker, V., Denaxas, S., Kennedy, N., Katikireddi, S.V. and Brophy, S. (2023) Healthcare use attributable to COVID-19: a propensity-matched national electronic health records cohort study of 249,390 people in Wales, UK. BMC Medicine, 21(1), 259. (doi: 10.1186/s12916-023-02897-5) (PMID:37468884) (PMCID:PMC10354936)
Olsen, J. and Mitchell, R. (2021) S&SR Environment and Spaces Group - COVID-19 Green and Open Space Use in Spring 2021 (Wave 3): Priorities for post-pandemic recovery. Project Report. University of Glasgow, Glasgow. (doi: 10.36399/gla.pubs.246702).
Zhang, C. X. et al. (2022) Migrants’ primary care utilisation before and during the COVID-19 pandemic in England: an interrupted time series analysis. Lancet Regional Health - Europe, 20, 100455. (doi: 10.1016/j.lanepe.2022.100455) (PMID:35789753) (PMCID:PMC9243519)
Davidson, J. C., Karadzhov, D. and Wilson, G. (2024) Short take: designing a multinational smartphone app survey during COVID-19: rewards, risks, and recommendations. Field Methods, (doi: 10.1177/1525822x231218192)
Karadzhov, D. , Wilson, G., Shields, S., Lux, E. and Davidson, J. C. (2023) Effective child well-being practices, barriers and priority actions: survey findings from service providers and policymakers in 22 countries during COVID-19. Journal of Children's Services, (doi: 10.1108/JCS-10-2022-0028) (Early Online Publication)
Bouttell, J. et al. (2021) Assessment of COVID-19 in primary care: the identification of symptoms, signs, characteristics, comorbidities and clinical signs in adults which may indicate a higher risk of progression to severe disease. Other. Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh.
Raffle, A. E., Pollock, A. M. and Harding-Edgar, L. (2020) Covid-19 mass testing programmes. British Medical Journal, 370, m3262. (doi: 10.1136/bmj.m3262) (PMID:32819920)
Ochieng, L., Salehi, M., Ochieng, R., Nijhof, D. , Wong, R., Gupta, V., Prasad, R. and Ochieng, B. (2022) Augmented video consultations in care homes during the COVID-19 pandemic: a qualitative study. BJGP Open, 6(4), 2022.0073. (doi: 10.3399/bjgpo.2022.0073) (PMID:35764408) (PMCID:PMC9904791)
Sivertsen, B., Knapstad, M., Petrie, K., O'Connor, R. , Lønning, K. J. and Hysing, M. (2022) Changes in mental health problems and suicidal behaviour in students and their associations with COVID-19-related restrictions in Norway: a national repeated cross-sectional analysis. BMJ Open, 12(2), e057492. (doi: 10.1136/bmjopen-2021-057492) (PMID:35140162) (PMCID:PMC8829843)
Marshall, A. , Leach, J.P. , Mackay, D. and Heath, C.A. (2023) The impact of the COVID-19 pandemic on a cohort of adults with epilepsy. Seizure, 111, pp. 191-195. (doi: 10.1016/j.seizure.2023.09.002) (PMID:37678077)
Henery, P. et al. (2021) Ethnic and social inequalities in COVID-19 outcomes in Scotland: protocol for early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II). BMJ Open, 11(8), e048852. (doi: 10.1136/bmjopen-2021-048852) (PMID:34376451) (PMCID:PMC8359861)
Kingstone, T., Taylor, A. K., O'Donnell, C. A. , Atherton, H., Blane, D. N. and Chew-Graham, C. A. (2020) Finding the 'right' GP: a qualitative study of the experiences of people with long-COVID. BJGP Open, 4(5), bjgpopen20X101143. (doi: 10.3399/bjgpopen20X101143) (PMID:33051223) (PMCID:PMC7880173)
Hotopf, M., Bullmore, E., O'Connor, R. C. and Holmes, E. A. (2020) The scope of mental health research in the COVID-19 Pandemic and its aftermath. British Journal of Psychiatry, 217(4), pp. 540-542. (doi: 10.1192/bjp.2020.125) (PMID:32493516) (PMCID:PMC7330278)
Wasilewski, M. B., Cimino, S. R., Kokorelias, K. M., Simpson, R., Hitzig, S. L. and Robinson, L. (2022) Providing rehabilitation to patients recovering from COVID-19: a scoping review. PM&R, 14(2), pp. 239-258. (doi: 10.1002/pmrj.12669) (PMID:34240576) (PMCID:PMC8441670)
Kromydas, T., Demou, E. , Edge, R., Gittins, M., Katikireddi, S. V. , Pearce, N., van Tongeren, M., Wilkinson, J. and Rhodes, S. (2023) Occupational differences in the prevalence and severity of long-COVID: analysis of the Coronavirus (COVID-19) Infection Survey. Occupational and Environmental Medicine, 80(10), pp. 545-552. (doi: 10.1136/oemed-2023-108930) (PMID:37770179) (PMCID:PMC7615205)
Harris, V. et al. (2024) Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial. Lancet Infectious Diseases, (doi: 10.1016/S1473-3099(24)00431-6) (In Press)
Rizeq, J. et al. (2023) Vulnerability pathways to mental health outcomes in children and parents during COVID-19. Current Psychology, 42(20), pp. 17348-17358. (doi: 10.1007/s12144-021-02459-z) (PMID:34815638) (PMCID:PMC8603653)
Vink, E. et al. (2024) Prevalence of endemic respiratory viruses during the COVID-19 pandemic in urban and rural Malawi. Open Forum Infectious Diseases, 11(2), ofad643. (doi: 10.1093/ofid/ofad643) (PMID:38312213) (PMCID:PMC10836885)
Oberndorfer, M. , Henery, P. M., Dundas, R. , Leyland, A. H. , Paranjothy, S., Stock, S. J., Wood, R., Nelson, S. M. , Kearns, R. and Pearce, A. (2023) Study protocol: examining the impacts of COVID-19 mitigation measures on pregnancy and birth outcomes in Scotland—a linked administrative data study. BMJ Open, 13(2), e066293. (doi: 10.1136/bmjopen-2022-066293) (PMID:36792327) (PMCID:PMC9933130)
Gorecka, M. et al. (2021) Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART—a UK, multicentre, observational study. Journal of Cardiovascular Magnetic Resonance, 23, 77. (doi: 10.1186/s12968-021-00752-1) (PMID:34112195) (PMCID:PMC8190746)
Hunt, K. et al. (2020) Protocol for a mixed-method investigation of the impact of the COVID-19 pandemic and gambling practices, experiences and marketing in the UK: the “Betting and Gaming COVID-19 Impact Study”. International Journal of Environmental Research and Public Health, 17(22), 8449. (doi: 10.3390/ijerph17228449) (PMID:33203076) (PMCID:PMC7697159)
Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10(1), e002192. (doi: 10.1136/openhrt-2022-002192) (PMID:36822817) (PMCID:PMC9950584)
Riddell, J. et al. (2022) Sexual and Reproductive Health in Scotland During the First Year of the COVID Pandemic (March 2020-March 2021). Natsal-COVID study Scotland report. Documentation. Natsal Resource.
Tagoe, E.T., Sheikh, N. , Morton, A., Nonvignon, J., Sarker, A.R., Williams, L. and Megiddo, I. (2021) COVID-19 vaccination in lower-middle income countries: national stakeholder views on challenges, barriers, and potential solutions. Frontiers in Public Health, 9, 709127. (doi: 10.3389/fpubh.2021.709127) (PMID:34422750) (PMCID:PMC8377669)
Jani, B. D. , Pell, J. P. , McGagh, D., Liyanage, H., Kelly, D., de Lusignan, S., Weatherburn, C. J., Burns, R., Sullivan, F. M. and Mair, F. S. (2020) Recording COVID-19 consultations: review of symptoms, risk factors, and proposed SNOMED CT terms. BJGP Open, 4(4), bjgpopen20X101125. (doi: 10.3399/bjgpopen20X101125) (PMID:32843331) (PMCID:PMC7606148)
Edoka, I., Fraser, H. , Jamieson, L., Meyer-Rath, G. and Mdewa, W. (2022) Inpatient care costs of COVID-19 in South Africa’s public healthcare system. International Journal of Health Policy and Management, 11(8), pp. 1354-1361. (doi: 10.34172/ijhpm.2021.24) (PMID:33949817) (PMCID:PMC9808349)
Hussain, T., Jawed, N., Mughal, S. and Shafique, K. (2022) Public perception of isolation, quarantine, social distancing and community containment during COVID-19 pandemic. BMC Public Health, 22, 528. (doi: 10.1186/s12889-022-12970-y) (PMID:35303851) (PMCID:PMC8931453)
Greene, G. J. et al. (2023) Whole-population trends in pathology-confirmed cancer incidence in Northern Ireland, Scotland and Wales during the SARS-CoV-2 pandemic: a retrospective observational study. Cancer Epidemiology, 84, 102367. (doi: 10.1016/j.canep.2023.102367) (PMID:37119604) (PMCID:PMC10121133)
Wyper, G. M. A. et al. (2021) Burden of disease methods: a guide to calculate COVID-19 disability-adjusted life years. International Journal of Public Health, 66, 619011. (doi: 10.3389/ijph.2021.619011) (PMID:34744580) (PMCID:PMC8565264)
Martin, A. , Clarke, J., Johnstone, A. , McCrorie, P. , Langford, R., Simpson, S. A. and Kipping, R. (2023) A qualitative study of parental strategies to enable pre-school children’s outdoor and nature experiences during COVID-19 restrictions. Health and Place, 79, 102967. (doi: 10.1016/j.healthplace.2023.102967) (PMID:36621065)
Ho, F. K. et al. (2020) Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study. BMJ Open, 10, e040402. (doi: 10.1136/bmjopen-2020-040402) (PMID:33444201) (PMCID:PMC7678347)
Mseka, U. L. et al. (2023) Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in Malawi. EClinicalMedicine, 56, 101800. (doi: 10.1016/j.eclinm.2022.101800) (PMID:36600885) (PMCID:PMC9800171)
Petermann-Rocha, F. et al. (2020) Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank. BMC Medicine, 18, 355. (doi: 10.1186/s12916-020-01822-4) (PMID:33167965) (PMCID:PMC7652674)
Wilding, S., O'Connor, D. B., Ferguson, E., Cleare, S. , Wetherall, K., O'Carroll, R. E., Robb, K. A. and O'Connor, R. C. (2022) Probable COVID-19 infection is associated with subsequent poorer mental health and greater loneliness in the UK COVID-19 Mental Health and Wellbeing study. Scientific Reports, 12, 20795. (doi: 10.1038/s41598-022-24240-3) (PMID:36460665) (PMCID:PMC9718764)
Cerqueira-Silva, T. et al. (2023) Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: a test-negative design case-control study. PLoS Medicine, 20(1), e1004156. (doi: 10.1371/journal.pmed.1004156) (PMID:36630477) (PMCID:PMC9879484)
Wauye, V. M., Ho, F. K. and Lyall, D. M. (2023) Psychosocial predictors of COVID-19 infection in UK biobank (N = 104 201). Journal of Public Health, (doi: 10.1093/pubmed/fdad009) (PMID:37144429) (Early Online Publication)
O'Connor, R. et al. (2020) Multidisciplinary research priorities for the COVID-19 pandemic: authors’ reply. Lancet Psychiatry, 7(7), e44-e45. (doi: 10.1016/S2215-0366(20)30247-9) (PMID:32563319) (PMCID:PMC7302786)
Morrison, K. et al. (2023) Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland: two retrospective cohort analyses of the primary schedule and third dose. Vaccine, 41(40), pp. 5863-5876. (doi: 10.1016/j.vaccine.2023.07.070) (PMID:37598025)
Haneef, R. et al. (2023) Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020. PLoS ONE, 18(1), e0280990. (doi: 10.1371/journal.pone.0280990) (PMID:36693071) (PMCID:PMC9873186)
Niedzwiedz, C. L. et al. (2020) Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Medicine, 18, 160. (doi: 10.1186/s12916-020-01640-8) (PMID:32466757) (PMCID:PMC7255908)
Khattak, M. I., Khattak, S. I., Khan, M., Khan, Z., Dikomitis, L., Ul-Haq, Z. and Saddki, N. (2022) Experiences of newly diagnosed oral cancer patients during the first wave of the COVID-19 pandemic: a qualitative study from Pakistan. International Journal of Environmental Research and Public Health, 19(14), 8508. (doi: 10.3390/ijerph19148508) (PMID:35886367) (PMCID:PMC9324128)
Vasileiou, E. et al. (2021) Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study. Lancet, 397(10285), pp. 1646-1657. (doi: 10.1016/S0140-6736(21)00677-2) (PMID:33901420) (PMCID:PMC8064669)
Zhang, H., Thygesen, J. H., Shi, T., Gkoutos, G. V., Hemingway, H., Guthrie, B., Wu, H. and Genomics England Research Consortium, (2022) Increased COVID-19 mortality rate in rare disease patients: a retrospective cohort study in participants of the Genomics England 100,000 Genomes project. Orphanet Journal of Rare Diseases, 17, 166. (doi: 10.1186/s13023-022-02312-x) (PMID:35414031) (PMCID:PMC9003178)
Green, M. A., McKee, M. and Katikireddi, S. V. (2022) Remote general practitioner consultations during COVID-19. Lancet Digital Health, 4(1), E7. (doi: 10.1016/S2589-7500(21)00279-X) (PMID:34952678) (PMCID:PMC8691847)
Pollock, A. M. and Harding-Edgar, L. (2020) Policy Note: Coronavirus crisis: underfunding, restructuring, privatisation and fragmentation at the heart of the crisis in Holyrood and Westminster. Documentation. Scottish Centre on European Relations, Edinburgh, UK.
Maxwell, K., Freeman, L., Boso Perez, R., Reid, D., Menezes, D., Sonnenberg, P., Mercer, C., Mitchell, K. and Field, N. (2021) Sexual Contact With Partners Outside of Household During the COVID-19 Pandemic: Investigating Motivations and Decision-Making Using Natsal-COVID Data. Sexually Transmitted Infections. 97(Suppl 1). STI & HIV World Congress, 14-17 Jul 2021. A27. (doi: 10.1136/sextrans-2021-sti.79)
Wyper, G. M. A. , Fletcher, E., Grant, I., Harding, O., de Haro Moro, M. T., Stockton, D. L. and McCartney, G. (2021) Inequalities in population health loss by multiple deprivation: COVID-19 and pre-pandemic all-cause disability-adjusted life years (DALYs) in Scotland. International Journal for Equity in Health, 20, 214. (doi: 10.1186/s12939-021-01547-7) (PMID:34565406) (PMCID:PMC8474788)
Arnold, K. F., Gilthorpe, M. S., Alwan, N. A., Heppenstall, A. J. , Tomova, G. D., McKee, M. and Tennant, P. W.G. (2022) Estimating the effects of lockdown timing on COVID-19 cases and deaths in England: a counterfactual modelling study. PLoS ONE, 17(4), e0263432. (doi: 10.1371/journal.pone.0263432) (PMID:35421094) (PMCID:PMC9009677)
McElroy, E. et al. (2023) Living alone and mental health: parallel analyses in UK longitudinal population surveys and electronic health records prior to and during the COVID-19 pandemic. BMJ Mental Health, 26(1), e300842. (doi: 10.1136/bmjment-2023-300842) (PMID:37562853) (PMCID:PMC10577768)
Armstrong, S. et al. (2020) Left out and locked down: impacts of COVID-19 for marginalised groups in Scotland. Project Report. University of Glasgow, Glasgow, Scotland.
Keyworth, C., Quinlivan, L., Leather, J. Z., O'Connor, R. C. and Armitage, C. J. (2022) The association between COVID-19-related fear and reported self-harm in a national survey of people with a lifetime history of self-harm. BMC Psychiatry, 22, 68. (doi: 10.1186/s12888-021-03625-0) (PMID:35105313) (PMCID:PMC8807142)
Finn McQuaid, C., Henrion, M. Y.R., Burke, R. M., MacPherson, P. , Nzawa-Soko, R. and Horton, K. C. (2022) Inequalities in the impact of COVID-19-associated disruptions on tuberculosis diagnosis by age and sex in 45 high TB burden countries. BMC Medicine, 20(1), 432. (doi: 10.1186/s12916-022-02624-6) (PMID:36372899) (PMCID:PMC9660190)
Elvan-Tuz, A. et al. (2022) Prevalence of Anosmia in 10.157 Pediatric COVID-19 Cases: Multicenter Study from Turkey. Pediatric Infectious Disease Journal, 41(6), pp. 473-477. (doi: 10.1097/INF.0000000000003526) (PMID:35349499) (PMCID:PMC9083317)
Charalampous, P., Haagsma, J. A., Cuschieri, S., Devleesschauwer, B., Pires, S. M., Polinder, S., Wyper, G. M.A. , Hatziyianni, A. and Pallari, E. (2023) Estimating Years of Life Lost due to COVID-19 over the first two years of the pandemic in Cyprus: comparisons across areas, age, and sex. Discover Health Systems, 2(1), 35. (doi: 10.1007/s44250-023-00051-9)
Milicev, J. , Qualter, P., Goodfellow, C. , Inchley, J. , Simpson, S. A. , Leyland, A. H. , Kharicha, K. and Long, E. (2023) The prospective relationship between loneliness, life satisfaction, and psychological distress before and during the Covid-19 pandemic in the UK. Journal of Public Health, 31(9), pp. 1417-1431. (doi: 10.1007/s10389-022-01719-x) (PMID:35668719) (PMCID:PMC9136554)
Hill, G., Archibald, N., Larkin, P., Farquhar, J. and Evans, J. (2023) Foreign accent syndrome and other neuropsychological sequelae of a parieto-occipital lesion following COVID-19 associated posterior reversible encephalopathy syndrome. Clinical Neuropsychologist, 37(6), pp. 1321-1335. (doi: 10.1080/13854046.2022.2108903) (PMID:36000333)
McKeigue, P. M. et al. (2021) Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study. BMC Medicine, 19, 149. (doi: 10.1186/s12916-021-02021-5) (PMID:34158021) (PMCID:PMC8219469)
Simpson, R., Szigeti, Z., Sheppard, C. L., Minezes, J., Hitzig, S. L., Mayo, A. L., Robinson, L., Lung, M. and Wasilewski, M. B. (2023) The experiences of patients, family caregivers, healthcare providers, and health service leaders with compassionate care following hospitalization with COVID-19: a qualitative study. Disability and Rehabilitation, 45(18), pp. 2896-2905. (doi: 10.1080/09638288.2022.2113564) (PMID:36354063)
Miller, J. et al. (2024) “Like fighting a fire with a water pistol”: a qualitative study of the work experiences of critical care nurses during the COVID-19 pandemic. Journal of Advanced Nursing, 80(1), pp. 237-251. (doi: 10.1111/jan.15773) (PMID:37515348)
Berry, C. et al. (2023) Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study. Heart and Mind, 7(4), pp. 235-245. (doi: 10.4103/hm.HM-D-23-00037)
Jani, B. D. , Ho, F. K., Lowe, D. J. , Traynor, J. P., MacBride-Stewart, S. P., Mark, P. B. , Mair, F. S. and Pell, J. P. (2021) Comparison of COVID-19 outcomes among shielded and non-shielded populations. Scientific Reports, 11, 15278. (doi: 10.1038/s41598-021-94630-6) (PMID:34315958) (PMCID:PMC8316565)
Embregts, P., Heerkens, L., Frielink, N., Giesbers, S., Vromans, L. and Jahoda, A. (2021) Experiences of mothers caring for a child with an intellectual disability during the COVID‐19 pandemic in the Netherlands. Journal of Intellectual Disability Research, 65(8), pp. 760-771. (doi: 10.1111/jir.12859) (PMID:34076326) (PMCID:PMC8242374)
Sattar, N. et al. (2020) BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(5), pp. 1149-1151. (doi: 10.1016/j.dsx.2020.06.060) (PMID:32668401) (PMCID:PMC7326434)
Siddaway, A. P. (2020) Multidisciplinary research priorities for the COVID-19 pandemic. Lancet Psychiatry, 7(7), e42. (doi: 10.1016/S2215-0366(20)30249-2) (PMID:32563317) (PMCID:PMC7302763)
Foster, H. M.E. et al. (2022) The association between a lifestyle score, socioeconomic status, and COVID-19 outcomes within the UK Biobank cohort. BMC Infectious Diseases, 22, 273. (doi: 10.1186/s12879-022-07132-9) (PMID:35351028) (PMCID:PMC8964028)
Ho, F. K. et al. (2020) Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS ONE, 15(11), e0241824. (doi: 10.1371/journal.pone.0241824) (PMID:33152008) (PMCID:PMC7644030)
Florentino, P. T.V. et al. (2022) Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study. Lancet Infectious Diseases, 22(11), pp. 1577-1586. (doi: 10.1016/S1473-3099(22)00451-0) (PMID:35952702) (PMCID:PMC9359673)
Chen, Q. et al. (2022) Multi-label classification for biomedical literature: an overview of the BioCreative VII LitCovid Track for COVID-19 literature topic annotations. Database, 2022, baac069. (doi: 10.1093/database/baac069) (PMID:36043400) (PMCID:PMC9428574)
Robles-Zurita, J. A. (2023) Reducing the basic reproduction number of COVID-19: a model simulation focused on QALYs, hospitalisation, productivity costs and optimal (soft) lockdown. European Journal of Health Economics, 24(4), pp. 647-659. (doi: 10.1007/s10198-022-01500-7) (PMID:35916992) (PMCID:PMC9344232)
Calvert, C. et al. (2022) A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection. Nature Communications, 13, 6124. (doi: 10.1038/s41467-022-33937-y) (PMID:36253471) (PMCID:PMC9574832)
Boso Perez, R. et al. (2021) Qualitative Findings From Natsal-COVID: Exploring Difficulties and Distress Within Established Relationships During COVID-19 Pandemic. Sexually Transmitted Infections. 97(Suppl 1). STI & HIV World Congress, 14-17 Jul 2021. A133-A134. (doi: 10.1136/sextrans-2021-sti.350)
Mercer, C. H. et al. (2022) Impacts of COVID-19 on sexual behaviour in Britain: findings from a large, quasi-representative survey (Natsal-COVID). Sexually Transmitted Infections, 98(7), pp. 469-477. (doi: 10.1136/sextrans-2021-055210) (PMID:34916335) (PMCID:PMC8687784)
Wyper, G. M.A. (2023) COVID-19 and commerce complicate minimum unit pricing effects on health - Authors' reply. Lancet, 402(10399), pp. 368-369. (doi: 10.1016/s0140-6736(23)01251-5) (PMID:37516536)
Hanna, C. R. , Robb, K. A. , Blyth, K. G. , Jones, R. J. and Chalmers, A. J. (2021) Clinician attitudes to using low dose radiotherapy to treat COVID-19 lung disease. International Journal of Radiation Oncology, Biology, Physics, 109(4), pp. 886-890. (doi: 10.1016/j.ijrobp.2020.12.003) (PMID:33309910) (PMCID:PMC7726525)
Murphy, S. et al. (2022) Variations in COVID-19 vaccination uptake among people in receipt of psychotropic drugs: cross-sectional analysis of a national population-based prospective cohort. British Journal of Psychiatry, 221(1), pp. 417-424. (doi: 10.1192/bjp.2022.36) (PMID:35249568)
Rayner, C. et al. (2022) Long COVID and Return to Work- What Works? A position paper from the Society of Occupational Medicine. Discussion Paper. Society of Occupational Medicine, London.
Embregts, P. J. C. M., van den Bogaard, K. J. H. M., Frielink, N., Voermans, M. A. C., Thalen, M. and Jahoda, A. (2022) A thematic analysis into the experiences of people with a mild intellectual disability during the COVID-19 lockdown period. International Journal of Developmental Disabilities, 68(4), pp. 578-582. (doi: 10.1080/20473869.2020.1827214) (PMID:35937180) (PMCID:PMC9351556)
Green, M. J. , Craig, P. , Demou, E. , Katikireddi, S. V. , Leyland, A. H. and Pearce, A. (2023) Understanding inequalities in mental health by family structure during COVID-19 lockdowns: evidence from the UK household longitudinal study. Annals of General Psychiatry, 22(1), 24. (doi: 10.1186/s12991-023-00454-1) (PMID:37280641) (PMCID:PMC10242239)
Ho, F. K., Man, K. K.S., Toshner, M., Church, C., Celis-Morales, C. , Wong, I. C.K., Berry, C. , Sattar, N. and Pell, J. P. (2021) Thromboembolic risk in hospitalised and non-hospitalised Covid-19 patients: a self-controlled case series analysis of a nation-wide cohort. Mayo Clinic Proceedings, 96(10), pp. 2587-2597. (doi: 10.1016/j.mayocp.2021.07.002) (PMID:34607634) (PMCID:PMC8282478)
Wismans, A. et al. (2022) Face mask use during the COVID-19 pandemic: how risk perception, experience with COVID-19, and attitude towards government interact with country-wide policy stringency. BMC Public Health, 22, 1622. (doi: 10.1186/s12889-022-13632-9) (PMID:36028876) (PMCID:PMC9412789)
Park, S. H. et al. (2023) Nonpharmaceutical interventions reduce the incidence and mortality of COVID‐19: a study based on the survey from the International COVID‐19 Research Network (ICRN). Journal of Medical Virology, 95(2), e28354. (doi: 10.1002/jmv.28354) (PMID:36447130) (PMCID:PMC9878143)
Grants awarded for COVID-19 research
- Chief Scientist Office. Understanding longer-term health impacts of social distancing and
behavioural interventions introduced to prevent the spread of infection in the population. Dr Katie Robb (PI) & Professor Rory O’Connor. £37,000. - Hunt K, Stead M, Purves R, Bunn C, Gray C, Reith G, Wardle H, Dobbie F, Critchlow N, Donnachie A. Transitions to more harmful forms of gambling during Covid-19 pandemic: behaviours and targeted marketing in young people and bettors on sport. ESRC £464,387. Jun 2020-Dec 2021.
- Gray CM, O’Donnell K, Wyke S part of a Scotland-wide consortium of 33 behavioural scientists Protecting population physical & mental health during the coronavirus pandemic: A representative national weekly survey to understand changes. CSO £324,472. May 2020-Nov 2020.
- Shakespeare T, Watson N, Burns N, Pearson C, Wiseman P, Banks M and Kupar H. Disability and Covid 19. The aim of this study is to understand disabled people's experiences during the COVID-19 epidemic, barriers experienced and lessons learned for policy and practice. £390,000 ESRC COVID-19 Rapid Response research call
- Crampin A, Mwansambo C, Chauma Mwale A, Madise N, Ho A, Mwapasa V, Nyirenda T, Read J, Jewell C, MacPherson P, Price A, Amoah A. SARS-CoV-2 immunoepidemiology in Wellcome-funded urban andrural cohorts in Malawi : generating evidence to inform regional medium and long term decision making. Wellcome £249,544.00
- Hatton, C., Hastings, R, Abbott, D., Beyer, S., Bradshaw, J., Gore, N., Heslop, P., Jahoda, A., Marriot, A., Scior, K., Taggart, L., and Todd, S. Title: The impact of the COVID-19 pandemic on people with learning disabilities and factors associated with better outcomes. MRC award, £763,431 (September 2020- 2021)
- Prof Kate O’Donnell as PI; Dr Sara Macdonald and Dr David Blane as Co-Is. Title: Patient and public understanding of, and preferences for, digital tools to support the Scottish Test, Trace, Isolate, Support programme for COVID-19 infection. DHI/PHS; £30,000. (June – August 2020).
- How has Covid-19 social distancing amplified the mental health vulnerabilities of gay, bisexual and other men who have sex with men (GBM)? Dr Jamie Frankis, Reader in Health Psychology, GCU, Prof P Flowers, U. Strathclyde; Prof L McDaid, U. Glasgow; Dr D Strongylou, R Kincaid, GCU, J Heng, NHS Glasgow; T Tougher, NHS Lanarkshire; Y Kerr & Dr D Clutterbuck, NHS Lothian; Dr L Wallace, HPS; N Sparling, HIV Scotland. CSO £49,728
- Social and health impacts of COVID-19 suppression in vulnerable groups. Prof Sarah Armstrong, Dr Lucy Pickering - CSO £186,869
MRC/CSO Social and Public Health Sciences Unit
Robertson Centre for Biostatistics
The Roberson Centre for Biostatistics are involved as co-applicants/partners in the undernoted Covid19-related grants:
- UKRI NIHR - Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: the COVID-HEART study - Prof Colin J Berry, Robertson Centre (Data Management, Statistics, Project Management, ECGs] – Total Grant award £620,076
- Medical Research Scotland – The influence of COVID-19 pandemic on the Scottish congenital heart disease population – Dr Mark Danton, Professor J G Cleland, Professor Alex McConnachie, Ms Sharon Kean – Total Grant Award £20,000
- Medical Research Scotland - Right Ventricular Dysfunction in Ventilated Patients with COVID-19 (COVID-RV) – Dr Ben Shelley, Professor Colin J Berry, Dr Claudia-Martina Messow – Total Grant Award £18,280
- Chief Scientists Office – Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) – Professor Colin J Berry, Professor Alex McConnachie, Ms Sharon Kean – Total Grant Award £47,940
- Medical Research Scotland - 3D Telemedicine: Transforming Patient Communication during Covid-19 – Dr Steven Lo, Robertson Centre [Statistics] - Total Grant Award £19,829
Additional advisory roles and outputs:
- RCB provides technical support for Professor Pell to analyse data in the Glasgow SafeHaven to inform the Health Board’s strategy on COVID-19 ‘shielding’.
- The RCB team has also created several UK national registries (supported by the British Cardiovascular Society) to capture cardiovascular complications and interventions associated with COVID-19,
- Dr Pierpaolo Pellicori (Clinical Senior Lecturer) is leading a Cochrane Rapid Review on cardiovascular complications of COVID-19.
COVID-19 advisory roles
- Professor Andrew Gumley chairs the Scottish Government Covid-19 Mental Health Advisory Group and Professor Rory O’Connor is a member.
- Professor Rory O’Connor co-led the Academy of Medical Sciences and MQ Transforming Mental Health Position Paper published in Lancet Psychiatry on setting the mental health science research priorities for the COVID-19 pandemic.
- Professor Rory O’Connor was part of the COVID-19 International Suicide Prevention Research Collaboration which highlighted the strategic response for suicide prevention, also published in Lancet Psychiatry.
- Professor Rory O’Connor and Jack Melson worked closely with the Scottish Government on its flagship Distress Brief Intervention Programme and developed all of the intervention and training materials. In May 2020, the First Minister decided to scale up the DBI programme nationally to deal with the impact of Covid-19.
- Professor Jill Pell is a member of the Scottish Government’s Covid-19 Advisory Group and the testing strategy sub-group.
- Professor Andrew Gumley and Professor John Cleland are members of the CSO / NRS Restart Strategic Advisory Group.
- Claire Orange and Professor Julie Brittenden in RESTART group
- Professor Danny Mackay is member of the UKRI-BBSRC COVID-19 Cohort of Experts.
- Professor Kate O'Donnell is member of the Scottish Government Expert Reference Group on Ethnicity COVID-19.
- Professor Vittal Katikireddi is Co-Chair of the Scottish Government Expert Reference Group on Ethnicity COVID-19.
- Dr Janet Bouttell, Professor Olivia Wu, Professor Kate O’Donnell, Dr David Blane and Dr Bhautesh Jani are all part of the working group with SIGN and Health Improvement Scotland to produce evidence-based guidance for Primary Care.
- Dr David Ross provides COVID-19 advice and support to UK Defence, the Army and NATO and is lead researcher looking at the impact of COVID-19 lockdown and social isolation in soldiers.
SPHSU
- Dr Elise Whitley is a member of Public Health Scotland’s Mental Health Cell and currently contributing to priority setting for future work and advising on likely data sources for monitoring.
- Dr Eric Silverman is a member of Covid-19 Healthcare Coalition which is developing a decision-support dashboard intended to help policy-makers in the US to monitor the progress of the pandemic at the state and county level throughout the country.
- Professor Rich Mitchell and Dr Jonathan Olsen are on Public Health Scotland's Social and System Recovery: Environments and Spaces Group. Rich is leading their Evidence and Data subgroup.
The group is currently exploring the implications of the COVID-19 pandemic for open spaces, parks, streets, public spaces. - Ms Ruth Dundas is part of The Scottish COVID-19 Response Consortium (SCRC) - a group of epidemiologists, mathematical modellers, data scientists, software developers and other scientists that have come together to develop new models to help inform the control of COVID-19.
- One of the key groups identified by RAMP to develop a wider range of pandemic models is the University of Glasgow led Scottish COVID-19 Response Consortium. SPHSU is involved in curating data to support model specification and calibration, and we will be increasingly involved in model design and programming.
- Dr Vittal Katikireddi is co-chair and Dr Rachel Thomson, Dr Theocharis Kromydas and Dr Peter Craig are members of a group convened by Public Health Scotland to advise the Scottish Government and other stakeholders (e.g. CoSLA, Social Security Scotland) on the impacts of the COVID-19 response on health and health inequalities that arise through economic and related pathways, and on actions that may mitigate negative impacts and enhance positive impacts. The group has published a briefing looking at protecting the health of the working-age population as lockdown reduces.
Other COVID-19 outputs
INS (International Neuropsychological Society) Newsletter
- Narayanan, J., Evans, J.J., & Wilson, B.A., (2020) Balint’s syndrome as a consequence of COVID-19: A case from Southern India. INS News: International Neuropsychological Society Member Newsletter, Issue 3, p27-31
BMJ Editorial
- Safely returning clinically vulnerable people to work. Ewan Macdonald, honorary professor of occupational medicine, John Middleton, honorary professor of public health, Drushca Lalloo, honorary clinical senior lecturer, Trisha Greenhalgh, professor of primary care research
Public Health Scotland Report
- Flynn R, Riches E, Reid G, Rosenberg S, Niedzwiedz C. Rapid review of the impact of COVID-19 on mental health. Edinburgh: Public Health Scotland; 2020
School of Infection & Immunity
MRC-University of Glasgow Centre for Virus Research (CVR)
Please follow this link for the Centre for Virus Research's response to Covid19.
The Centre for Virus Research (CVR) has also contributed to this year's online Glasgow Science Festival 2020: Science on the Sofa.
- Professor David Robertson on the evolutionary origins of SARS-CoV-2
- Professor Emma Thomson on where SARS-CoV-2 in Scotland came from and a potential vaccine
- Dr Janet Scott on long-term health and psychosocial implications of Covid19 (#LongCovid)
- Dr Antonia Ho on understanding how Covid19 affects the body in Scotland and Malawi
- Dr Ana Da Silva Filipe on sequencing the genome of SARS-CoV-2
- Dr Agnieszka Szemiel on growing the virus in a high containment lab
Covid19 Publications
Brock, R. C., Goudie, R. J.B., Peters, C., Thaxter, R., Gouliouris, T., Illingworth, C. J.R. , Morris, A. C., Beggs, C. B., Butler, M. and Keevil, V. L. (2024) Efficacy of Air Cleaning Units for preventing SARS-CoV-2 and other hospital-acquired infections on medicine for older people wards: a quasi-experimental controlled before-and- after study. Journal of Hospital Infection, (doi: 10.1016/j.jhin.2024.09.017) (Early Online Publication)
Nickbakhsh, S. et al. (2022) Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning. Scientific Reports, 12, 11735. (doi: 10.1038/s41598-022-15661-1) (PMID:35853960) (PMCID:PMC9296497)
Kroon, F. P.B., Najm, A. , Alunno, A., Schoones, J. W., Landewé, R. B.M., Machado, P. M. and Navarro-Compán, V. (2022) Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations. Annals of the Rheumatic Diseases, 81(3), pp. 422-432. (doi: 10.1136/annrheumdis-2021-221575) (PMID:34876462)
Sivan, M. et al. (2024) Long COVID clinical severity types based on symptoms and functional disability: A longitudinal evaluation. Journal of Clinical Medicine, 13(7), 1908. (doi: 10.3390/jcm13071908)
Alunno, A., Najm, A. , Mariette, X., De Marco, G., Emmel, J., Mason, L., McGonagle, D. G. and Machado, P. M. (2021) Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider. RMD Open, 7, e001899. (doi: 10.1136/rmdopen-2021-001899) (PMID:34725262) (PMCID:PMC8562527)
Morehouse, Z. P., Samikwa, L., Proctor, C. M., Meleke, H., Kamdolozi, M., Ryan, G. L., Chaima, D., Ho, A. , Nash, R. J. and Nyirenda, T. S. (2021) Validation of a direct-to-PCR COVID-19 detection protocol utilizing mechanical homogenization: a model for reducing resources needed for accurate testing. PLoS ONE, 16(8), e0256316. (doi: 10.1371/journal.pone.0256316) (PMID:34407126) (PMCID:PMC8372900)
Ferris, M. et al. (2021) Efficacy of FFP3 respirators for prevention of SARS-CoV-2 infection in healthcare workers. eLife, 10, e71131. (doi: 10.7554/elife.71131) (PMID:34783656)
McGovern, J., Al-Azzawi, Y., Kemp, O., Moffitt, P., Richards, C., Dolan, R. D. , Laird, B. J., McMillan, D. C. and Maguire, D. (2022) The relationship between frailty, nutritional status, co-morbidity, CT-body composition and systemic inflammation in patients with COVID-19. Journal of Translational Medicine, 20, 98. (doi: 10.1186/s12967-022-03300-2) (PMID:35189900) (PMCID:PMC8860274)
Illingworth, C. J.R. et al. (2021) Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections. eLife, 10, e67308. (doi: 10.7554/eLife.67308)
Wing, P. A.C. et al. (2021) Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells. Cell Reports, 35(3), 109020. (doi: 10.1016/j.celrep.2021.109020) (PMID:33852916) (PMCID:PMC8020087)
Scott, J. et al. (2021) ISARIC4C: Multicentre cohort study on symptoms and quality of life following hospitalisation for COVID-19 - preliminary results, 25 February 2021. Documentation. Scientific Advisory Group for Emergencies.
Illingworth, C. J.R. , Guerra-Assuncao, J. A., Gregg, S., Charles, O., Pang, J., Roy, S., Abdelnabi, R., Neyts, J. and Breuer, J. (2024) Genetic consequences of effective and suboptimal dosing with mutagenic drugs in a hamster model of SARS-CoV-2 infection. Virus Evolution, (doi: 10.1093/ve/veae001) (Early Online Publication)
Ruiz, M. J. et al. (2022) Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis. Frontiers in Immunology, 13, (doi: 10.3389/fimmu.2022.842468) (PMID:36248831) (PMCID:PMC9560774)
McInnes, I. (2021) Response to: 'Hydroxychloroquine shortages during the COVID-19 pandemic' by Mendel et al. Annals of the Rheumatic Diseases, 80, e32. (doi: 10.1136/annrheumdis-2020-217954) (PMID:32434826)
Read, J. M., Bridgen, J. R. E., Cummings, D. A. T., Ho, A. and Jewell, C. P. (2021) Novel coronavirus 2019-nCoV (COVID-19): early estimation of epidemiological parameters and epidemic size estimates. Philosophical Transactions of the Royal Society B: Biological Sciences, 376(1829), 20200265. (doi: 10.1098/rstb.2020.0265) (PMID:34053269) (PMCID:PMC8165596)
Tegally, H. et al. (2022) The evolving SARS-CoV-2 epidemic in Africa: insights from rapidly expanding genomic surveillance. Science, 378(6615), eabq5358. (doi: 10.1126/science.abq5358) (PMID:36108049) (PMCID:PMC9529057)
Alunno, A., Najm, A. , Mariette, X., De Marco, G., Emmel, J., Mason, L., McGonagle, D. G. and Machado, P. M. (2021) Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider. Annals of the Rheumatic Diseases, 80(6), pp. 803-815. (doi: 10.1136/annrheumdis-2020-219725) (PMID:33589438) (PMCID:PMC8142448)
Meehan, G. R. et al. (2023) Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learning. PLoS Pathogens, 19(11), e1011589. (doi: 10.1371/journal.ppat.1011589) (PMID:37934791) (PMCID:PMC10656012)
Relph, K. A. et al. (2022) Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of hospital admission. Open Forum Infectious Diseases, 9(5), ofac179. (doi: 10.1093/ofid/ofac179) (PMID:35531376) (PMCID:PMC9070482)
Wells, D. A. et al. (2022) Human seasonal coronavirus neutralization and COVID‐19 severity. Journal of Medical Virology, 94(10), pp. 4820-4829. (doi: 10.1002/jmv.27937) (PMID:35705514) (PMCID:PMC9349487)
Lythgoe, K. A. et al. (2021) SARS-CoV-2 within-host diversity and transmission. Science, 372(6539), eabg0821. (doi: 10.1126/science.abg0821) (PMID:33688063) (PMCID:PMC8128293)
Pascall, D. J. et al. (2023) The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: a genomics-based retrospective cohort analysis. PLoS ONE, 18(4), e0284187. (doi: 10.1371/journal.pone.0284187) (PMID:37053201) (PMCID:PMC10101505)
Serwanga, J. et al. (2023) Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months. Frontiers in Immunology, 14, 1152522. (doi: 10.3389/fimmu.2023.1152522) (PMID:37006272) (PMCID:PMC10060567)
McCreath, G., Whitfield, P. D. , Roe, A. J. , Watson, M. J. and Sim, M. A.B. (2021) A Metabolomics approach for the diagnosis Of SecondAry InfeCtions in COVID-19 (MOSAIC): a study protocol. BMC Infectious Diseases, 21, 1204. (doi: 10.1186/s12879-021-06832-y)
Morrow, A. J. et al. (2022) A multisystem, cardio-renal investigation of post-COVID-19 illness. Nature Medicine, 28(6), pp. 1303-1313. (doi: 10.1038/s41591-022-01837-9) (PMID:35606551) (PMCID:PMC9205780)
Carabelli, A. M., Peacock, T. P., Thorne, L. G., Harvey, W. T., Hughes, J. , Peacock, S. J., Barclay, W. S., de Silva, T. I., Towers, G. J. and Robertson, D. L. (2023) SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nature Reviews Microbiology, 21(3), pp. 162-177. (doi: 10.1038/s41579-022-00841-7) (PMID:36653446) (PMCID:PMC9847462)
Crozier, T. W.M. et al. (2022) Quantitative proteomic analysis of SARS-CoV-2 infection of primary human airway ciliated cells and lung epithelial cells demonstrates the effectiveness of SARS-CoV-2 innate immune evasion. Wellcome Open Research, 7, 224. (doi: 10.12688/wellcomeopenres.17946.1) (PMID:36483314) (PMCID:PMC9706147)
Parker, M. D. et al. (2021) Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data. Genome Research, 31, pp. 645-658. (doi: 10.1101/gr.268110.120) (PMID:33722935) (PMCID:PMC8015849)
Ribeiro da Silva, S. J., Kohl, A. , Pena, L. and Pardee, K. (2023) Recent insights into SARS‐CoV‐2 omicron variant. Reviews in Medical Virology, 33(1), e2373. (doi: 10.1002/rmv.2373) (PMID:35662313) (PMCID:PMC9347414)
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D. and Zhou, Y. (2021) The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduction and Targeted Therapy, 6(1), 255. (doi: 10.1038/s41392-021-00679-0) (PMID:34234112) (PMCID:PMC8261820)
Gordon, D. E. et al. (2020) Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science, 370(6521), eabe9403. (doi: 10.1126/science.abe9403) (PMID:33060197) (PMCID:PMC7808408)
MacLean, O. A. , Orton, R. J. , Singer, J. B. and Robertson, D. L. (2020) No evidence for distinct types in the evolution of SARS-CoV-2. Virus Evolution, 6(1), veaa034. (doi: 10.1093/ve/veaa034) (PMID:32817804) (PMCID:PMC7197565)
Morrow, A. J. et al. (2024) Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization. Communications Medicine, 4, 32. (doi: 10.1038/s43856-024-00455-5) (PMID:38418616) (PMCID:PMC10901805)
Brackel, C. L.H. et al. (2024) International care programs for Pediatric Post-COVID Condition (Long COVID) and the way forward. Pediatric Research, (doi: 10.1038/s41390-023-03015-0) (PMID:38287106) (Early Online Publication)
Greenwood, D. C. et al. (2024) Physical, cognitive and social triggers of symptom fluctuations in people living with long COVID: an intensive longitudinal cohort study. Lancet Regional Health - Europe, 46, 101082. (doi: 10.1016/j.lanepe.2024.101082)
Lubinski, B., Frazier, L. E., Phan, M. V. T., Bugembe, D. L., Cunningham, J. L., Tang, T., Daniel, S., Cotten, M. , Jaimes, J. A. and Whittaker, G. R. (2022) Spike protein cleavage-activation in the context of the SARS-CoV-2 P681R mutation: an analysis from its first appearance in lineage A.23.1 identified in Uganda. Microbiology Spectrum, 10(4), e0151422. (doi: 10.1128/spectrum.01514-22) (PMID:35766497) (PMCID:PMC9430374)
Lytras, S. et al. (2023) Resurrection of 2′-5′-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication. PLoS Biology, 21(11), e3002398. (doi: 10.1371/journal.pbio.3002398) (PMID:38015855)
Sidhu, J. K. et al. (2024) Delayed mucosal antiviral responses despite robust peripheral inflammation in fatal COVID-19. Journal of Infectious Diseases, 230(1), e17-e29. (doi: 10.1093/infdis/jiad590) (PMID:39052740) (PMCID:PMC11272059)
Rutherford, M. A. and Basu, N. (2022) Reply to Riza and Hamit comment on ‘Factors influencing severe COVID‐19 in systemic vasculitis patients’. Arthritis and Rheumatology, 74(4), pp. 725-726. (doi: 10.1002/art.42024) (PMID:34783446) (PMCID:PMC8652784)
Konno, Y. et al. (2020) SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant. Cell Reports, 32(12), 108185. (doi: 10.1016/j.celrep.2020.108185) (PMID:32941788) (PMCID:PMC7473339)
Iannucci, S., Harvey, W. T., Hughes, J. , Robertson, D. L. , Poyade, M. and Hutchinson, E. (2023) The SARS-CoV-2 Spike Protein Mutation Explorer: using an interactive application to improve the public understanding of SARS-CoV-2 variants of concern. Journal of Visual Communication in Medicine, 46(3), pp. 122-132. (doi: 10.1080/17453054.2023.2237087) (PMID:37526402) (PMCID:PMC10726978)
Da Silva Filipe, A. et al. (2021) Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland. Nature Microbiology, 6(1), pp. 112-122. (doi: 10.1038/s41564-020-00838-z) (PMID:33349681)
Hosie, M. J. et al. (2021) Detection of SARS-CoV-2 in respiratory samples from cats in the UK associated with human-to-cat transmission. Veterinary Record, 188(8), e247. (doi: 10.1002/vetr.247) (PMID:33890314) (PMCID:PMC8251078)
Dee, K., Goldfarb, D. M., Haney, J., Amat, J. A.R., Herder, V. , Stewart, M., Szemiel, A. M., Baguelin, M. and Murcia, P. R. (2021) Human rhinovirus infection blocks SARS-CoV-2 replication within the respiratory epithelium: implications for COVID-19 epidemiology. Journal of Infectious Diseases, 224(1), pp. 31-38. (doi: 10.1093/infdis/jiab147) (PMID:33754149) (PMCID:PMC8083659)
Voysey, M. et al. (2021) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet, 397(10269), pp. 99-111. (doi: 10.1016/S0140-6736(20)32661-1) (PMID:33306989) (PMCID:PMC7723445)
Heath, P. T. et al. (2023) Safety and efficacy of the NVX-CoV2373 coronavirus disease 2019 vaccine at completion of the placebo-controlled phase of a randomized controlled trial. Clinical Infectious Diseases, 76(3), pp. 298-407. (doi: 10.1093/cid/ciac803) (PMID:36210481) (PMCID:PMC9619635)
Volz, E. et al. (2021) Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature, 593(7858), pp. 266-269. (doi: 10.1038/s41586-021-03470-x) (PMID:33767447)
Stewart, A. et al. (2022) Pandemic, epidemic, endemic: B cell repertoire analysis reveals unique anti-viral responses to SARS-CoV-2, Ebola and Respiratory Syncytial Virus. Frontiers in Immunology, 13, 807104. (doi: 10.3389/fimmu.2022.807104) (PMID:35592326) (PMCID:PMC9111746)
Cotten, M. , Robertson, D. L. and Phan, M. V.T. (2021) Unique protein features of SARS-CoV-2 relative to other Sarbecoviruses. Virus Evolution, 7(2), veab067. (doi: 10.1093/ve/veab067) (PMID:34527286) (PMCID:PMC8385934)
Rosadas, C. et al. (2022) Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility. Journal of Virological Methods, 302, 114475. (doi: 10.1016/j.jviromet.2022.114475) (PMID:35077719) (PMCID:PMC8782753)
Cantoni, D. et al. (2023) Analysis of antibody neutralisation activity against SARS-CoV-2 variants and seasonal human coronaviruses NL63, HKU1, and 229E induced by three different COVID-19 vaccine platforms. Vaccines, 11(1), 58. (doi: 10.3390/vaccines11010058) (PMID:36679903) (PMCID:PMC9864028)
Drake, T. M. et al. (2021) Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet, 398(10296), pp. 223-237. (doi: 10.1016/S0140-6736(21)00799-6) (PMID:34274064) (PMCID:PMC8285118)
Lambisia, A. W. et al. (2022) Optimization of the SARS-CoV-2 ARTIC Network V4 Primers and Whole Genome Sequencing Protocol. Frontiers in Medicine, 9, 836728. (doi: 10.3389/fmed.2022.836728) (PMID:35252269) (PMCID:PMC8891481)
Landewé, R. B.M. et al. (2020) EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Annals of the Rheumatic Diseases, 79(7), pp. 851-858. (doi: 10.1136/annrheumdis-2020-217877) (PMID:32503854)
Roberts, T. et al. (2024) Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia. Blood Cancer Journal, 14, 22. (doi: 10.1038/s41408-023-00940-5) (PMID:38272915) (PMCID:PMC10810811)
Lee, C. et al. (2024) Prevalence of orthostatic intolerance in Long Covid clinic patients: a multicentre observational study. Journal of Medical Virology, 96(3), e29486. (doi: 10.1002/jmv.29486) (PMID:38456315)
Stirrup, O. et al. (2021) Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data. eLife, 10, e65828. (doi: 10.7554/elife.65828) (PMID:34184637) (PMCID:PMC8285103)
Szemiel, A. M. et al. (2021) In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2. PLoS Pathogens, 17(9), e1009929. (doi: 10.1371/journal.ppat.1009929) (PMID:34534263) (PMCID:PMC8496873)
Horvath, D. et al. (2023) Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice. Scientific Reports, 13(1), 4648. (doi: 10.1038/s41598-023-31198-3) (PMID:36944687) (PMCID:PMC10029786)
Emary, K. R. W. et al. (2021) Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet, 397(10282), pp. 1351-1362. (doi: 10.1016/S0140-6736(21)00628-0) (PMID:33798499) (PMCID:PMC8009612)
Parry, H. et al. (2022) Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia. Journal of Hematology and Oncology, 15(1), 3. (doi: 10.1186/s13045-021-01219-7) (PMID:35000597) (PMCID:PMC8743056)
Harvey, W. T. et al. (2021) SARS-CoV-2 variants, spike mutations and immune escape. Nature Reviews Microbiology, 19(7), pp. 409-424. (doi: 10.1038/s41579-021-00573-0) (PMID:34075212) (PMCID:PMC8167834)
McKeigue, P. M., Porter, D., Hollick, R. J., Ralston, S. H., McAllister, D. A. and Colhoun, H. M. (2023) Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland. Scandinavian Journal of Rheumatology, 52(4), pp. 412-417. (doi: 10.1080/03009742.2022.2063376) (PMID:35549809)
Lee, J. Y. et al. (2022) Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences. eLife, 11, e74153. (doi: 10.7554/eLife.74153) (PMID:35049501) (PMCID:PMC8776252)
Sabir, S. R., Thomson, E. C. , Guzik, T. J., D’Acquisto, F. and Maffia, P. (2020) COVID-19: the new immune challenge. Frontiers for Young Minds, 8, 582971. (doi: 10.3389/frym.2020.582971)
Cox, M. et al. (2023) SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies. Nature Reviews Microbiology, 21(2), pp. 112-124. (doi: 10.1038/s41579-022-00809-7) (PMID:36307535) (PMCID:PMC9616429)
Rutherford, M. A. et al. (2021) Risk factors for severe outcomes in patients with systemic vasculitis & COVID-19: a bi-national registry-based cohort study. Arthritis and Rheumatology, 73(9), pp. 1713-1719. (doi: 10.1002/art.41728) (PMID:33750043) (PMCID:PMC8251299)
Boshier, F. A.T. et al. (2021) The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study. Journal of Infection, 83(6), pp. 693-700. (doi: 10.1016/j.jinf.2021.09.022) (PMID:34610391) (PMCID:PMC8487101)
Hamilton, W. L. et al. (2021) Applying prospective genomic surveillance to support investigation of hospital-onset COVID-19. Lancet Infectious Diseases, 21(7), pp. 916-917. (doi: 10.1016/S1473-3099(21)00251-6) (PMID:33984262) (PMCID:PMC8110208)
Jackson, M. R. et al. (2022) Low-dose lung radiotherapy for COVID-19 lung disease: a preclinical efficacy study in a bleomycin model of pneumonitis. International Journal of Radiation Oncology, Biology, Physics, 112(1), pp. 197-211. (doi: 10.1016/j.ijrobp.2021.08.029) (PMID:34478832) (PMCID:PMC8406661)
Castillo-Olivares, J. et al. (2021) Analysis of serological biomarkers of SARS-CoV-2 infection in convalescent samples from severe, moderate and mild COVID-19 cases. Frontiers in Immunology, 12, 748291. (doi: 10.3389/fimmu.2021.748291) (PMID:34867975) (PMCID:PMC8640495)
Munro, A. P.S. et al. (2021) Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Lancet, 398(10318), pp. 2258-2276. (doi: 10.1016/S0140-6736(21)02717-3) (PMID:34863358) (PMCID:PMC8639161)
de Klerk, A. et al. (2022) Conserved recombination patterns across coronavirus subgenera. Virus Evolution, 8(2), veac054. (doi: 10.1093/ve/veac054) (PMID:35814334) (PMCID:PMC9261289)
Lista, M. J. et al. (2022) The P681H mutation in the spike glycoprotein of the alpha variant of SARS-CoV-2 escapes IFITM restriction and is necessary for type I interferon resistance. Journal of Virology, 96(23), e0125022. (doi: 10.1128/jvi.01250-22) (PMID:36350154) (PMCID:PMC9749455)
Montezano, A. C. et al. (2023) SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication. Scientific Reports, 13, 14086. (doi: 10.1038/s41598-023-41115-3) (PMID:37640791) (PMCID:PMC10462711)
Zafferani, M. et al. (2021) Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures. Science Advances, 7(48), eabl6096. (doi: 10.1126/sciadv.abl6096) (PMID:34826236)
Abani, O. et al. (2022) Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet, 400(10349), pp. 359-368. (doi: 10.1016/s0140-6736(22)01109-6) (PMID:35908569) (PMCID:PMC9333998)
Munblit, D. et al. (2021) Incidence and risk factors for persistent symptoms in adults previously hospitalised for COVID-19. Clinical and Experimental Allergy, 51(9), pp. 1107-1120. (doi: 10.1111/cea.13997) (PMID:34351016)
Liu, X. et al. (2023) Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial. Journal of Infection, 87(1), pp. 18-26. (doi: 10.1016/j.jinf.2023.04.012) (PMID:37085049) (PMCID:PMC10116128)
Chibwana, M. G. et al. (2023) Different clinical features in Malawian outpatients presenting with COVID-19 prior to and during Omicron variant dominance: a prospective observational study. PLoS Global Public Health, 3(3), e0001575. (doi: 10.1371/journal.pgph.0001575) (PMID:36963090) (PMCID:PMC10022204)
Meng, B. et al. (2021) Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the variant of concern lineage B.1.1.7. Cell Reports, 35(13), 109292. (doi: 10.1016/j.celrep.2021.109292) (PMID:34166617) (PMCID:PMC8185188)
Dowell, A. C. et al. (2022) Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nature Immunology, 23(1), pp. 40-49. (doi: 10.1038/s41590-021-01089-8) (PMID:34937928) (PMCID:PMC8709786)
Uyoga, S. et al. (2020) Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors. Science, 371(6524), pp. 79-82. (doi: 10.1126/science.abe1916) (PMID:33177105) (PMCID:PMC7877494)
Morgan, D. C. et al. (2021) Stapled ACE2 peptidomimetics designed to target the SARS-CoV-2 spike protein do not prevent virus internalisation. Peptide Science, 113(4), e24217. (doi: 10.1002/pep2.24217) (PMID:33615115) (PMCID:PMC7883042)
Needham, E. J. et al. (2022) Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses. Brain, 145(11), pp. 4097-4107. (doi: 10.1093/brain/awac321) (PMID:36065116) (PMCID:PMC9494359)
Abani, O. et al. (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet, 397(10285), pp. 1637-1645. (doi: 10.1016/S0140-6736(21)00676-0) (PMID:33933206) (PMCID:PMC8084355)
Wood, R. et al. (2021) Sharing a household with children and risk of COVID-19: a study of over 300 000 adults living in healthcare worker households in Scotland. Archives of Disease in Childhood, 106(12), pp. 1212-1217. (doi: 10.1136/archdischild-2021-321604) (PMID:33737319) (PMCID:PMC7985971)
Hufsky, F. et al. (2021) Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research. Briefings in Bioinformatics, 22(2), pp. 642-663. (doi: 10.1093/bib/bbaa232) (PMID:33147627) (PMCID:PMC7665365)
Dowell, A. C. et al. (2022) mRNA or ChAd0x1 COVID-19 vaccination of adolescents induces robust antibody and cellular responses with continued recognition of omicron following mRNA-1273. Frontiers in Immunology, 13, 882515. (doi: 10.3389/fimmu.2022.882515) (PMID:35720281) (PMCID:PMC9201026)
Conway, D.I. et al. (2021) SARS-CoV-2 positivity in asymptomatic-screened dental patients. Journal of Dental Research, 100(6), pp. 583-590. (doi: 10.1177/00220345211004849) (PMID:33779355) (PMCID:PMC8138329)
Nyagwange, J. et al. (2022) Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya. Wellcome Open Research, 7, 69. (doi: 10.12688/wellcomeopenres.17661.1) (PMID:35505772) (PMCID:PMC9034174)
da Silva, S. J. R., da Silva, C. T. A., Guarines, K. M., Mendes, R. P. G., Pardee, K., Kohl, A. and Pena, L. (2020) Clinical and laboratory diagnosis of SARS-CoV-2, the virus causing COVID-19. ACS Infectious Diseases, 6(9), pp. 2319-2336. (doi: 10.1021/acsinfecdis.0c00274) (PMID:32786280) (PMCID:PMC7441751)
Wickenhagen, A. et al. (2021) A prenylated dsRNA sensor protects against severe COVID-19. Science, 374(6567), eabj3624. (doi: 10.1126/science.abj3624) (PMID:34581622) (PMCID:PMC7612834)
Evans, R. A. et al. (2021) Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respiratory Medicine, 9(11), pp. 1275-1287. (doi: 10.1016/S2213-2600(21)00383-0) (PMID:34627560) (PMCID:PMC8497028)
Pairo-Castineira, E. et al. (2021) Genetic mechanisms of critical illness in Covid-19. Nature, 591(7848), pp. 92-98. (doi: 10.1038/s41586-020-03065-y) (PMID:33307546)
Maher, M. C. et al. (2022) Predicting the mutational drivers of future SARS-CoV-2 variants of concern. Science Translational Medicine, 14(633), eabk3445. (doi: 10.1126/scitranslmed.abk3445) (PMID:35014856) (PMCID:PMC8939770)
Cotten, M. , Bugembe, D. L., Kaleebu, P. and Phan, M. V.T. (2021) Alternate primers for whole-genome SARS-CoV-2 sequencing. Virus Evolution, 7(1), veab006. (doi: 10.1093/ve/veab006) (PMID:33841912) (PMCID:PMC7928614)
Sampson, A. T. et al. (2021) Coronavirus pseudotypes for all circulating human coronaviruses for quantification of cross-neutralizing antibody responses. Viruses, 13(8), 1579. (doi: 10.3390/v13081579) (PMID:34452443) (PMCID:PMC8402765)
Caiazzo, E., Rezig, A. O.M. , Bruzzese, D., Ialenti, A., Cicala, C., Cleland, J. G.F. , Guzik, T. J., Maffia, P. and Pellicori, P. (2022) Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: a systematic review and meta-analysis of randomised trials. Pharmacological Research, 176, 106053. (doi: 10.1016/j.phrs.2021.106053) (PMID:34979235) (PMCID:PMC8719379)
Parry, H. et al. (2022) COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia. Cancer Cell, 40(6), pp. 584-586. (doi: 10.1016/j.ccell.2022.05.001) (PMID:35588735) (PMCID:PMC9072807)
Brevini, T. et al. (2023) FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. Nature, 615(7950), pp. 134-142. (doi: 10.1038/s41586-022-05594-0) (PMID:36470304) (PMCID:PMC9977684)
Pazukina, E. et al. (2024) Long covid: a global health issue - a prospective, cohort study set in four continents. BMJ Global Health, 9(10), e015245. (doi: 10.1136/bmjgh-2024-015245)
Cotten, M. and Phan, M. V.T. (2023) Evolution of increased positive charge on the SARS-CoV-2 spike protein may be adaptation to human transmission. iScience, 26(3), 106230. (doi: 10.1016/j.isci.2023.106230) (PMID:36845032) (PMCID:PMC9937996)
Telenti, A., Hodcroft, E. B. and Robertson, D. L. (2022) The evolution and biology of SARS-CoV-2 variants. Cold Spring Harbor Perspectives in Medicine, 12(5), a041390. (doi: 10.1101/cshperspect.a041390) (PMID:35444005)
Atti, A. et al. (2022) Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study. Journal of Infection, 85(5), pp. 545-556. (doi: 10.1016/j.jinf.2022.09.004) (PMID:36089104) (PMCID:PMC9458758)
Wei, J. et al. (2021) Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom. Nature Microbiology, 6(9), pp. 1140-1149. (doi: 10.1038/s41564-021-00947-3) (PMID:34290390) (PMCID:PMC8294260)
Siracusano, G. et al. (2021) Profiling antibody response patterns in COVID-19: Spike S1-reactive IgA signature in the evolution of SARS-CoV-2 infection. Frontiers in Immunology, 12, 772239. (doi: 10.3389/fimmu.2021.772239) (PMID:34804064) (PMCID:PMC8595940)
Elneima, O. et al. (2024) Cohort profile: Post-hospitalisation COVID-19 study (PHOSP-COVID). International Journal of Epidemiology, 53(1), dyad165. (doi: 10.1093/ije/dyad165) (PMCID:PMC10859139)
Walker, A. S. et al. (2021) Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time. eLife, 10, e64683. (doi: 10.7554/elife.64683) (PMID:34250907) (PMCID:PMC8282332)
Knight, S. R. et al. (2022) Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. Thorax, 77(6), pp. 606-615. (doi: 10.1136/thoraxjnl-2021-217629) (PMID:34810237) (PMCID:PMC8610617)
Ito, J. et al. (2023) Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant. Nature Communications, 14, 2671. (doi: 10.1038/s41467-023-38188-z) (PMID:37169744) (PMCID:PMC10175283)
Twohig, K. A. et al. (2022) Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infectious Diseases, 22(1), pp. 35-42. (doi: 10.1016/S1473-3099(21)00475-8) (PMID:34461056) (PMCID:PMC8397301)
Hüttl, J. et al. (2024) Serological and molecular investigation of SARS-CoV-2 in horses and cattle in Switzerland from 2020 to 2022. Viruses, 16(2), 224. (doi: 10.3390/v16020224)
Kirwan, P. D. et al. (2023) Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort. Lancet Regional Health - Europe, 36, 100809. (doi: 10.1016/j.lanepe.2023.100809) (PMID:38111727) (PMCID:PMC10727938)
Barnes, E. et al. (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine, 29(7), pp. 1760-1774. (doi: 10.1038/s41591-023-02414-4) (PMID:37414897) (PMCID:PMC10353927)
Mehta, P., Porter, J. C., Manson, J. J., Isaacs, J. D., Openshaw, P. J.M., McInnes, I. B. , Summers, C. and Chambers, R. C. (2020) Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities. Lancet Respiratory Medicine, 8(8), pp. 822-830. (doi: 10.1016/S2213-2600(20)30267-8) (PMID:32559419)
Collier, D. A. et al. (2021) Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature, 593(7857), pp. 136-141. (doi: 10.1038/s41586-021-03412-7) (PMID:33706364)
Cantoni, D. et al. (2022) Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients. Communications Biology, 5(1), 409. (doi: 10.1038/s42003-022-03325-9) (PMID:35505237) (PMCID:PMC9065041)
Rihn, S. J. et al. (2021) A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLoS Biology, 19(2), e3001091. (doi: 10.1371/journal.pbio.3001091) (PMID:33630831) (PMCID:PMC7906417)
Osmanov, I. M. et al. (2022) Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. European Respiratory Journal, 59(2), 2101341. (doi: 10.1183/13993003.01341-2021) (PMID:34210789) (PMCID:PMC8576804)
Jackson, C. et al. (2023) Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study. Lancet Respiratory Medicine, 11(8), pp. 673-684. (doi: 10.1016/S2213-2600(23)00124-8) (PMID:37072018) (PMCID:PMC10156429)
Gaultier, G. N. et al. (2024) Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study. Scientific Reports, 14(1), 8926. (doi: 10.1038/s41598-024-59535-0) (PMID:38637558) (PMCID:PMC11026432)
Fielding, C. A. et al. (2022) SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies. eLife, 11, e74489. (doi: 10.7554/elife.74489) (PMID:35587364) (PMCID:PMC9239683)
Vink, E. and Ho, A. (2022) SARS-CoV-2: can isolation be limited to those who are truly infectious? Lancet Respiratory Medicine, 10(11), pp. 1011-1013. (doi: 10.1016/S2213-2600(22)00272-7) (PMID:36228636) (PMCID:PMC9550193)
Pascall, D. J. et al. (2023) Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent. Journal of Infection, 87(2), pp. 128-135. (doi: 10.1016/j.jinf.2023.05.019) (PMID:37270070) (PMCID:PMC10234362)
Ijaz, S. et al. (2022) Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics and linkage to severity of COVID-19 in hospital inpatients. Journal of Infection, 85(2), pp. 152-160. (doi: 10.1016/j.jinf.2022.05.033) (PMID:35667482) (PMCID:PMC9163047)
Coletto, L. A., Giulio Favalli, E. and Caporali, R. (2020) Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID ‐19 days. Dermatologic Therapy, 33(4), e13415. (doi: 10.1111/dth.13415) (PMID:32291828) (PMCID:PMC7235523)
Liew, F. et al. (2024) Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nature Immunology, 25(4), pp. 607-621. (doi: 10.1038/s41590-024-01778-0) (PMID:38589621)
Wright, D. W. et al. (2022) Tracking SARS-CoV-2 mutations and variants through the COG-UK-Mutation Explorer. Virus Evolution, 8(1), veac023. (doi: 10.1093/ve/veac023) (PMID:35502202) (PMCID:PMC9037374)
Munblit, D. et al. (2021) The risk of overlooking children during the COVID-19 pandemic: Paediatric Long-COVID may be a ticking time bomb. Lancet Child and Adolescent Health, (Accepted for Publication)
Ogger, P. P. et al. (2024) SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice. Frontiers in Immunology, 15, 1383612. (doi: 10.3389/fimmu.2024.1383612) (PMID:38742107) (PMCID:PMC11089223)
Alunno, A. et al. (2021) EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19. Annals of the Rheumatic Diseases, 80(6), pp. 698-706. (doi: 10.1136/annrheumdis-2020-219724) (PMID:33547062) (PMCID:PMC7871226)
Das, J. et al. (2022) Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients. PLoS ONE, 17(2), e0261979. (doi: 10.1371/journal.pone.0261979) (PMID:35192617) (PMCID:PMC8863217)
Vöhringer, H. S. et al. (2021) Genomic reconstruction of the SARS-CoV-2 epidemic in England. Nature, 600(7889), pp. 506-511. (doi: 10.1038/s41586-021-04069-y) (PMID:34649268) (PMCID:PMC8674138)
McInnes, I. B. (2020) COVID-19 and rheumatology: first steps towards a different future? Annals of the Rheumatic Diseases, 79(5), pp. 551-552. (doi: 10.1136/annrheumdis-2020-217494) (PMID:32299844)
Tyson, G. B. et al. (2023) Increase in SARS-CoV-2 seroprevalence in UK domestic felids despite weak immunogenicity of post-Omicron variants. Viruses, 15(8), 1661. (doi: 10.3390/v15081661) (PMID:37632004) (PMCID:PMC10458763)
Hastie, C. E. et al. (2022) Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland Study. Nature Communications, 13, 5663. (doi: 10.1038/s41467-022-33415-5) (PMID:36224173) (PMCID:PMC9556711)
Morrow, A. et al. (2022) Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise—CISCO-21. Trials, 23, 660. (doi: 10.1186/s13063-022-06632-y) (PMID:35971155) (PMCID:PMC9376905)
Chaziya, J. et al. (2021) COVID-19 in Malawi: lessons in pandemic preparedness from a tertiary children’s hospital. Archives of Disease in Childhood, 106, pp. 238-240. (doi: 10.1136/archdischild-2020-319980) (PMID:33361067) (PMCID:PMC7768613)
Aggarwal, D. et al. (2022) Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission. Nature Communications, 13, 1012. (doi: 10.1038/s41467-022-28371-z) (PMID:35197443) (PMCID:PMC8866425)
Liew, F. et al. (2023) SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. EBioMedicine, 87, 104402. (doi: 10.1016/j.ebiom.2022.104402) (PMID:36543718) (PMCID:PMC9762734)
Kuhn, J. et al. (2024) Investigations on the potential role of free-ranging wildlife as a reservoir of SARS-CoV-2 in Switzerland. Viruses, 16(9), 1407. (doi: 10.3390/v16091407)
Cantoni, D. et al. (2022) Neutralisation hierarchy of SARS-CoV-2 variants of concern using standardised, quantitative neutralisation assays reveals a correlation with disease severity; towards deciphering protective antibody thresholds. Frontiers in Immunology, 13, 773982. (doi: 10.3389/fimmu.2022.773982) (PMID:35330908) (PMCID:PMC8940306)
Pollock, D. D. et al. (2020) Viral CpG deficiency provides no evidence that dogs were intermediate hosts for SARS-CoV-2. Molecular Biology and Evolution, 37(9), pp. 2706-2710. (doi: 10.1093/molbev/msaa178) (PMID:32658964) (PMCID:PMC7454803)
Liu, X. et al. (2022) Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial. Journal of Infection, 84(6), pp. 795-813. (doi: 10.1016/j.jinf.2022.04.018) (PMID:35405168) (PMCID:PMC8993491)
Machado, P. M. et al. (2022) Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Annals of the Rheumatic Diseases, 81(5), pp. 695-709. (doi: 10.1136/annrheumdis-2021-221490) (PMID:34972811) (PMCID:PMC8720639)
Kaku, Y. et al. (2024) Virological characteristics of the SARS-CoV-2 KP.2 variant. Lancet Infectious Diseases, 24(7), e416. (doi: 10.1016/S1473-3099(24)00298-6) (PMID:38782005)
Graham, M. S. et al. (2021) Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study. Lancet Public Health, 6(5), e335-e345. (doi: 10.1016/S2468-2667(21)00055-4)
Nadesalingam, A. et al. (2023) Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies. Lancet Microbe, 4(2), e58-e59. (doi: 10.1016/s2666-5247(22)00297-x) (PMID:36332646) (PMCID:PMC9625114)
Parry, H. et al. (2022) Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people. Cell Reports Medicine, 3(9), 100739. (doi: 10.1016/j.xcrm.2022.100739) (PMID:36075216) (PMCID:PMC9404227)
Russell, C. D. et al. (2021) Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. Lancet Microbe, 2(8), e354-e365. (doi: 10.1016/S2666-5247(21)00090-2) (PMID:34100002) (PMCID:PMC8172149)
Gupta, R. K. et al. (2021) Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respiratory Medicine, 9(4), pp. 349-359. (doi: 10.1016/S2213-2600(20)30559-2) (PMID:33444539) (PMCID:PMC7832571)
Landewé, R. B.M. et al. (2022) EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update. Annals of the Rheumatic Diseases, 81(12), pp. 1629-1639. (doi: 10.1136/annrheumdis-2021-222006) (PMID:35197264)
Li, K. K. et al. (2021) Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface. Journal of Infection, 83(1), pp. 96-103. (doi: 10.1016/j.jinf.2021.04.020) (PMID:33895226) (PMCID:PMC8061788)
Munblit, D. et al. (2022) Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development. BMC Medicine, 20, 50. (doi: 10.1186/s12916-021-02222-y) (PMID:35114994) (PMCID:PMC8813480)
Alunno, A. et al. (2022) 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19. Annals of the Rheumatic Diseases, 81(1), pp. 34-40. (doi: 10.1136/annrheumdis-2021-221366) (PMID:34620584) (PMCID:PMC8507408)
Docherty, A. B. et al. (2021) Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. Lancet Respiratory Medicine, 9(7), pp. 773-785. (doi: 10.1016/S2213-2600(21)00175-2) (PMID:34000238) (PMCID:PMC8121531)
Dowell, A. C. et al. (2023) Immunological imprinting of humoral immunity to SARS-CoV-2 in children. Nature Communications, 14, 3845. (doi: 10.1038/s41467-023-39575-2) (PMID:37386081) (PMCID:PMC10310754)
Banda, L. et al. (2023) Characterising the evolving SARS-CoV-2 seroprevalence in urban and rural Malawi between February 2021 and April 2022: A population-based cohort study. International Journal of Infectious Diseases, 137, pp. 118-125. (doi: 10.1016/j.ijid.2023.10.020) (PMCID:PMC10695832)
da Silva, S. J. R., de Lima, S. C., da Silva, R. C., Kohl, A. and Pena, L. (2022) Viral load in COVID-19 patients: implications for prognosis and vaccine efficacy in the context of emerging SARS-CoV-2 variants. Frontiers in Medicine, 8, 836826. (doi: 10.3389/fmed.2021.836826) (PMID:35174189) (PMCID:PMC8841511)
Guzik, T. J. et al. (2020) COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research, 116(10), pp. 1666-1687. (doi: 10.1093/cvr/cvaa106) (PMID:32352535) (PMCID:PMC7197627)
Knight, S. R. et al. (2020) Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. British Medical Journal, 2020, 370. (doi: 10.1136/bmj.m3339) (PMID:32907855)
Pazukhina, E. et al. (2024) Event rates and incidence of Post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID). BMC Medicine(22), 48. (doi: 10.1186/s12916-023-03221-x) (PMID:38302974) (PMCID:PMC10835884)
Pauley, E., Drake, T. M., Sigfrid, L., Lone, N., Harrison, E. M., Baillie, J. K., Scott, J. T. , Walsh, T. S., Semple, M. G. and Docherty, A. B. (2023) Recovery from Covid-19 critical illness: a secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial. Journal of the Intensive Care Society, 24(2), pp. 162-169. (doi: 10.1177/17511437211052226) (PMID:37255989) (PMCID:PMC10225805)
Barry, M. et al. (2020) Nosocomial outbreak of the Middle East Respiratory Syndrome coronavirus: a phylogenetic, epidemiological, clinical and infection control analysis. Travel Medicine and Infectious Disease, 37, 101807. (doi: 10.1016/j.tmaid.2020.101807) (PMID:32599173) (PMCID:PMC7319941)
Docherty, A. B. et al. (2020) Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. British Medical Journal, 369, m1985. (doi: 10.1136/bmj.m1985) (PMID:32444460)
Cevik, M., Tate, M., Lloyd, O., Maraolo, A. E., Schafers, J. and Ho, A. (2021) SARS-CoV-2, SARS-CoV-1 and MERS-CoV viral load dynamics, duration of viral shedding and infectiousness: a systematic review and meta-analysis. Lancet Microbe, 2(1), e13-e22. (doi: 10.1016/S2666-5247(20)30172-5)
Mehmood, M., Usman Khan, H., Khan, M. I., Khan, I., Al-Raddadi, R. M., Harakeh, S. and Yousafzai, Y. M. (2022) Trajectory of anti-SARS-COV-2 IgG antibodies from onset of symptoms to 6 months in a cohort of Pakistani patients. Infectious Diseases, 54(6), pp. 460-463. (doi: 10.1080/23744235.2022.2033312) (PMID:35147051)
Tamura, T. et al. (2023) Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nature Communications, 14, 2800. (doi: 10.1038/s41467-023-38435-3) (PMID:37193706) (PMCID:PMC10187524)
Agoti, C. N. et al. (2022) Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: a retrospective genomic study. eLife, 11, e71703. (doi: 10.7554/elife.71703) (PMID:35699426) (PMCID:PMC9282859)
Darbyshire, J. et al. (2024) Improving quality in adult long Covid services: findings from the LOCOMOTION quality improvement collaborative. Clinical Medicine, (Accepted for Publication)
Martin, C. A. et al. (2023) Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis. EClinicalMedicine, 58, 101926. (doi: 10.1016/j.eclinm.2023.101926) (PMID:37034357) (PMCID:PMC10071048)
Willett, B. J. et al. (2022) SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nature Microbiology, 7(8), pp. 1161-1179. (doi: 10.1038/s41564-022-01143-7) (PMID:35798890) (PMCID:PMC9352574)
Jackson, B. et al. (2021) Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic. Cell, 184(20), 5179-5188.e8. (doi: 10.1016/j.cell.2021.08.014) (PMID:34499854) (PMCID:PMC8367733)
Hastie, C. E. et al. (2023) Natural history of long-COVID in a nationwide, population cohort study. Nature Communications, 14, 3504. (doi: 10.1038/s41467-023-39193-y) (PMID:37311808) (PMCID:PMC10263377)
Abrahão, J. S. et al. (2021) Detection of SARS-CoV-2 RNA on public surfaces in a densely populated urban area of Brazil: a potential tool for monitoring the circulation of infected patients. Science of the Total Environment, 766, 142645. (doi: 10.1016/j.scitotenv.2020.142645) (PMID:33069469) (PMCID:PMC7530625)
Sigfrid, L. et al. (2021) Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Regional Health - Europe, 8, 100186. (doi: 10.1016/j.lanepe.2021.100186) (PMID:34386785) (PMCID:PMC8343377)
Becher, G. and Burden, A.D. (2021) Psoriasis, COVID-19 and shielding. British Journal of Dermatology, 185(1), pp. 7-8. (doi: 10.1111/bjd.20055) (PMID:33951179) (PMCID:PMC8239873)
Quintana-Domeque, C., Lee, I., Zhang, A. , Proto, E. , Battisti, M. and Ho, A. (2021) Anxiety and depression among medical doctors in Catalonia, Italy, and the UK during the COVID-19 pandemic. PLoS ONE, 16(11), e0259213. (doi: 10.1371/journal.pone.0259213) (PMID:34727110) (PMCID:PMC8562811)
Holmes, E. C. et al. (2021) The origins of SARS-CoV-2: a critical review. Cell, 184(19), pp. 4848-4856. (doi: 10.1016/j.cell.2021.08.017) (PMID:34480864) (PMCID:PMC8373617)
Najm, A. , Alunno, A. and Machado, P. (2023) COVID - how will it continue to change our lives? Joint Bone Spine, 90(4), 105572. (doi: 10.1016/j.jbspin.2023.105572) (PMID:37028643) (PMCID:PMC10126740)
Ho, A. , McInnes, N., Blunsum, A., Quinn, J., Lynagh, D., Murphy, M. E., Gunson, R., MacConnachie, A. and Lowe, D. J. (2024) Near real-time severe acute respiratory illness surveillance characterising influenza and Covid-19 epidemiology in hospitalised adults, 2021-22. Journal of Infection, 89(6), 106338. (doi: 10.1016/j.jinf.2024.106338) (PMID:39489182)
Pazukhina, E. et al. (2022) Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID). BMC Medicine, 20, 244. (doi: 10.1186/s12916-022-02448-4) (PMID:35794549) (PMCID:PMC9257572)
Nadesalingam, A. et al. (2021) Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK. Lancet Microbe, 2(9), e416-e418. (doi: 10.1016/s2666-5247(21)00157-9) (PMID:34223399) (PMCID:PMC8238451)
Roper, K. J. et al. (2023) Quantifying neutralising antibody responses against SARS‑CoV‑2 in dried blood spots (DBS) and paired sera. Scientific Reports, 13, 15014. (doi: 10.1038/s41598-023-41928-2) (PMID:37697014) (PMCID:PMC10495436)
Flowers, P. , Leiser, R., Mapp, F., McLeod, J., Stirrup, O., Illingworth, C. J.R. , Blackstone, J. and Breuer, J. (2023) A qualitative process evaluation using the behaviour change wheel approach: did a whole genome sequence report form (SRF) used to reduce nosocomial SARS-CoV-2 within UK hospitals operate as anticipated? British Journal of Health Psychology, 28(4), pp. 1011-1035. (doi: 10.1111/bjhp.12666) (PMID:37128667)
Alm, E. et al. (2020) Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020. Eurosurveillance, 25(32), 2001410. (doi: 10.2807/1560-7917.ES.2020.25.32.2001410) (PMID:32794443) (PMCID:PMC7427299)
Illingworth, C. J.R. et al. (2022) A2B-COVID: a tool for rapidly evaluating potential SARS-CoV-2 transmission events. Molecular Biology and Evolution, 39(3), msac025. (doi: 10.1093/molbev/msac025) (PMID:35106603) (PMCID:PMC8892943)
Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, 116(14), pp. 2185-2196. (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (PMCID:PMC7454350)
Kuhlmeier, E. et al. (2023) Detection and molecular characterization of the SARS-CoV-2 Delta variant and the specific immune response in companion animals in Switzerland. Viruses, 15(1), 245. (doi: 10.3390/v15010245) (PMID:36680285) (PMCID:PMC9864232)
Battaglini, D., White, N. M., Premraj, L., Wanjiru Citarella, B., Merson, L., Robba, C., Thomson, D., Cho, S.-M. and ISARIC Clinical Characterization Group, (2024) Long-term neurological symptoms after acute COVID-19 illness requiring hospitalization in adult patients: insights from the ISARIC-COVID-19 follow-up study. Journal of Neurology, 271(1), pp. 79-86. (doi: 10.1007/s00415-023-12133-y) (PMID:38055020) (PMCID:PMC10769963)
Murcia, P. , Streiker, D. , Da Silva Filipe, A. , Robertson, D. , Jarrett, R. , Willett, B. , Hosie, M. , Biek, R. , Allan, K. and Weir, W. (2020) Send cat and dog samples to test for SARS-CoV-2. Veterinary Record, 186(17), p. 571. (doi: 10.1136/vr.m2019) (PMID:32451348)
Anscombe, C. et al. (2023) A comparison of four epidemic waves of COVID-19 in Malawi; an observational cohort study. BMC Infectious Diseases, 23, 79. (doi: 10.1186/s12879-022-07941-y) (PMID:36750921) (PMCID:PMC9902830)
Reyes, L. F. et al. (2022) Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the ISARIC WHO Clinical Characterisation Protocol: a prospective, multinational, multicentre, observational study. ERJ Open Research, 8(1), 00552-2021. (doi: 10.1183/23120541.00552-2021) (PMID:35169585) (PMCID:PMC8669808)
Harrison, E. M. et al. (2020) Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients. SSRN Electronic Journal, (doi: 10.2139/ssrn.3618215) (Submitted)
Lucinde, R. K. et al. (2022) Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21. PLoS ONE, 17(10), e0265478. (doi: 10.1371/journal.pone.0265478) (PMID:36240176) (PMCID:PMC9565697)
Worobey, M. et al. (2022) The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic. Science, 377(6609), pp. 951-959. (doi: 10.1126/science.abp8715) (PMID:35881010) (PMCID:PMC9348750)
Hosie, M. J. et al. (2021) Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic. Viruses, 13(2), 185. (doi: 10.3390/v13020185) (PMID:33530620) (PMCID:PMC7911697)
Memish, Z. A., Cotten, M. , Watson, S. J., Kellam, P., Zumla, A., Alhakeem, R. F., Assiri, A., Al Rabeeah, A. A. and Al-Tawfiq, J. A. (2014) Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study. International Journal of Infectious Diseases, 23, pp. 63-68. (doi: 10.1016/j.ijid.2014.03.1372) (PMID:24699184) (PMCID:PMC4441753)
Hill, V. et al. (2022) The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK. Virus Evolution, 8(2), veac080. (doi: 10.1093/ve/veac080) (PMID:36533153) (PMCID:PMC9752794)
Mwita Morobe, J. et al. (2022) Genomic epidemiology of SARS-CoV-2 in Seychelles, 2020-2021. Viruses, 14(6), 1318. (doi: 10.3390/v14061318) (PMID:35746789) (PMCID:PMC9231335)
Kemp, S. A. et al. (2021) SARS-CoV-2 evolution during treatment of chronic infection. Nature, 592(7853), pp. 277-282. (doi: 10.1038/s41586-021-03291-y) (PMID:33545711) (PMCID:PMC7610568)
Aguinam, E. T. et al. (2023) Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies. Journal of Allergy and Clinical Immunology: Global, 2(2), 100091. (doi: 10.1016/j.jacig.2023.100091) (PMID:37038555) (PMCID:PMC10015741)
Banerjee, A. K. et al. (2020) SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell, (doi: 10.1016/j.cell.2020.10.004) (PMID:33080218) (PMCID:PMC7543886)
Abani, O. et al. (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. Lancet, 397(10289), pp. 2049-2059. (doi: 10.1016/S0140-6736(21)00897-7) (PMID:34000257) (PMCID:PMC8121538)
Hastie, C. E. et al. (2023) True prevalence of long-COVID in a nationwide, population cohort study. Nature Communications, 14, 7892. (doi: 10.1038/s41467-023-43661-w) (PMID:38036541) (PMCID:PMC10689486)
Oluka, G. K., Namubiru, P., Kato, L., Ankunda, V., Gombe, B., Cotten, M. , Musenero, M., Kaleebu, P., Fox, J. and Serwanga, J. (2023) Optimisation and validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda. Frontiers in Immunology, 14, 1113194. (doi: 10.3389/fimmu.2023.1113194) (PMID:36999017) (PMCID:PMC10045470)
Goodyear, C. S. et al. (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. Lancet Rheumatology, 6(6), e339-e351. (doi: 10.1016/S2665-9913(24)00065-1) (PMID:38734019)
Swann, O. V. et al. (2020) Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. British Medical Journal, 370, m3249. (doi: 10.1136/bmj.m3249) (PMID:32960186) (PMCID:PMC7488201)
Volz, E. et al. (2021) Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity. Cell, 184(1), 64-75.e11. (doi: 10.1016/j.cell.2020.11.020) (PMID:33275900) (PMCID:PMC7674007)
Mahindra, A. et al. (2021) Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction. PLoS ONE, 16(11), e0260283. (doi: 10.1371/journal.pone.0260283) (PMID:34793553) (PMCID:PMC8601423)
Young, M., Crook, H., Scott, J. and Edison, P. (2022) COVID-19: virology, variants, and vaccines. BMJ Medicine, 1(1), e000040. (doi: 10.1136/bmjmed-2021-000040) (PMID:36936563) (PMCID:PMC9951271)
Da Silva Filho, J. et al. (2024) A spatially resolved single-cell lung atlas integrated with clinical and blood signatures distinguishes COVID-19 disease trajectories. Science Translational Medicine, 16(764), eadk9149. (doi: 10.1126/scitranslmed.adk9149) (PMID:39259811)
Kartsonaki, C. et al. (2023) Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. International Journal of Epidemiology, 52(2), pp. 355-376. (doi: 10.1093/ije/dyad012) (PMID:36850054) (PMCID:PMC10114094)
Närhi, F. et al. (2022) Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study. Lancet Digital Health, 4(4), e220-e234. (doi: 10.1016/S2589-7500(22)00018-8) (PMID:35337642) (PMCID:PMC8940185)
The PHOSP-COVID Collaborative Group, (2022) Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respiratory Medicine, 10(8), pp. 761-775. (doi: 10.1016/S2213-2600(22)00127-8) (PMID:35472304) (PMCID:PMC9034855)
Pouwels, K. B. et al. (2021) Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey. Lancet Public Health, 6(1), e30-e38. (doi: 10.1016/s2468-2667(20)30282-6) (PMID:33308423) (PMCID:PMC7786000)
Cantoni, D. et al. (2022) Evolutionary remodelling of N-terminal domain loops fine-tunes SARS-CoV-2 spike. EMBO Reports, 23(10), e54322. (doi: 10.15252/embr.202154322) (PMID:35999696) (PMCID:PMC9535765)
Kamel, W. et al. (2021) Global analysis of protein-RNA interactions in SARS-CoV-2 infected cells reveals key regulators of infection. Molecular Cell, 81(13), 2851-2867.e7. (doi: 10.1016/j.molcel.2021.05.023) (PMID:34118193) (PMCID:PMC8142890)
Bugembe, D. L. et al. (2021) Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda. Nature Microbiology, 6(8), pp. 1094-1101. (doi: 10.1038/s41564-021-00933-9) (PMID:34163035) (PMCID:PMC8318884)
Mirza, M. et al. (2022) Impact of the COVID‐19 pandemic on recruitment to clinical research studies in rheumatology. Musculoskeletal Care, 20(1), pp. 209-213. (doi: 10.1002/msc.1561) (PMID:33938621) (PMCID:PMC8242596)
Taquet, M. et al. (2023) Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization. Nature Medicine, (doi: 10.1038/s41591-023-02525-y) (PMID:37653345) (Early Online Publication)
Nickbakhsh, S. , Ho, A. , Marques, D. F.P., McMenamin, J., Gunson, R. N. and Murcia, P. R. (2020) Epidemiology of seasonal coronaviruses: establishing the context for the emergence of coronavirus disease 2019. Journal of Infectious Diseases, 222(1), pp. 17-25. (doi: 10.1093/infdis/jiaa185) (PMID:32296837) (PMCID:PMC7184404)
Thomson, E. C. et al. (2021) Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell, 184(5), 1171-1187.e20. (doi: 10.1016/j.cell.2021.01.037) (PMID:33621484) (PMCID:PMC7843029)
McPeake, J. et al. (2021) Long-term outcomes following severe COVID-19 infection: a multicentre cohort study of family member outcomes. Annals of the American Thoracic Society, 18(12), pp. 2098-2101. (doi: 10.1513/AnnalsATS.202104-481RL) (PMID:34192506) (PMCID:PMC8641813)
Kuhlmeier, E. et al. (2023) Risk factor analysis of SARS-CoV-2 infection in animals in COVID-19-affected households. Viruses, 15(3), 731. (doi: 10.3390/v15030731) (PMID:36992440) (PMCID:PMC10051903)
Kronfeld-Schor, N., Stevenson, T., Nickbakhsh, S. , Schernhammer, E., Dopico, X., Dayan, T., Martinez, M. and Helm, B. (2021) Drivers of infectious disease seasonality: potential implications for COVID-19. Journal of Biological Rhythms, 36(1), pp. 35-54. (doi: 10.1177/0748730420987322) (PMID:33491541) (PMCID:PMC7924107)
da Silva, S. J. R. et al. (2022) Two years into the COVID-19 pandemic: lessons learned. ACS Infectious Diseases, 8(9), pp. 1758-1814. (doi: 10.1021/acsinfecdis.2c00204) (PMID:35940589) (PMCID:PMC9380879)
Wilkinson, E. et al. (2021) A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa. Science, 374(6566), pp. 423-431. (doi: 10.1126/science.abj4336)
Maguire, D. et al. (2020) Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection. Journal of Translational Medicine, 18, 354. (doi: 10.1186/s12967-020-02524-4) (PMID:32933530) (PMCID:PMC7491021)
Vink, E. et al. (2024) Prevalence of endemic respiratory viruses during the COVID-19 pandemic in urban and rural Malawi. Open Forum Infectious Diseases, 11(2), ofad643. (doi: 10.1093/ofid/ofad643) (PMID:38312213) (PMCID:PMC10836885)
MacDonald, L. et al. (2021) COVID-19 and RA share SPP1 myeloid pathway that drives PD-L1pos neutrophils and CD14pos monocytes. JCI Insight, 6(13), e147413. (doi: 10.1172/jci.insight.147413) (PMID:34143756) (PMCID:PMC8328085)
Michelen, M. et al. (2021) Characterising Long Covid: a living systematic review. BMJ Global Health, 6, e005427. (doi: 10.1136/bmjgh-2021-005427) (PMID:34580069) (PMCID:PMC8478580)
Sykes, R. et al. (2023) Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19. Open Heart, 10(1), e002192. (doi: 10.1136/openhrt-2022-002192) (PMID:36822817) (PMCID:PMC9950584)
Ngwira, L. G. et al. (2022) Cost of wastewater-based environmental surveillance for SARS-CoV-2: evidence from pilot sites in Blantyre, Malawi and Kathmandu, Nepal. PLoS Global Public Health, 2(12), e0001377. (doi: 10.1371/journal.pgph.0001377) (PMID:36962924) (PMCID:PMC10021894)
Smith, A. et al. (2024) Psychometric analysis of the modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) in a prospective multicentre study. BMJ Open Respiratory Research, 11(1), e002271. (doi: 10.1136/bmjresp-2023-002271) (PMID:38724221)
Sullivan, M. K. et al. (2022) Acute kidney injury in patients hospitalised with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study. Nephrology Dialysis Transplantation, 37(2), pp. 271-284. (doi: 10.1093/ndt/gfab303) (PMID:34661677) (PMCID:PMC8788218)
Vink, E. et al. (2022) Viral co-infections in hospitalised COVID-19 patients recruited to the ISARIC WHO CCP-UK study. Open Forum Infectious Diseases, 9(11), ofac531. (doi: 10.1093/ofid/ofac531) (PMID:36381618) (PMCID:PMC9619746)
Murray, S. M. et al. (2024) Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients. Journal of Hepatology, 80(1), pp. 109-123. (doi: 10.1016/j.jhep.2023.10.009) (PMID:37863203)
Jones, S. et al. (2023) SARS-CoV-2 in domestic UK cats from Alpha to Omicron: Swab surveillance and case reports. Viruses, 15(8), 1769. (doi: 10.3390/v15081769) (PMID:37632111) (PMCID:PMC10459977)
Mseka, U. L. et al. (2023) Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in Malawi. EClinicalMedicine, 56, 101800. (doi: 10.1016/j.eclinm.2022.101800) (PMID:36600885) (PMCID:PMC9800171)
Abdukahil, S. A. et al. (2021) COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study. Infection, 49(5), pp. 889-905. (doi: 10.1007/s15010-021-01599-5) (PMID:34170486) (PMCID:PMC8231091)
Khan, H. et al. (2021) TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction. PLoS Pathogens, 17(11), e1009820. (doi: 10.1371/journal.ppat.1009820) (PMID:34807954) (PMCID:PMC8648102)
Nalumansi, A. et al. (2021) Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples. International Journal of Infectious Diseases, 104, pp. 282-286. (doi: 10.1016/j.ijid.2020.10.073) (PMID:33130198) (PMCID:PMC7836828)
Michael, B. D. et al. (2023) Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses. Nature Communications, 14, 8487. (doi: 10.1038/s41467-023-42320-4) (PMID:38135686) (PMCID:PMC10746705)
Baillie, J.K. et al. (2023) Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study. Lancet Respiratory Medicine, 11(11), pp. 1003-1019. (doi: 10.1016/S2213-2600(23)00262-X) (PMID:37748493) (PMCID:PMC7615263)
Lytras, S., Hughes, J. , Martin, D., Swanepoel, P., de Klerk, A., Lourens, R., Kosakovsky Pond, S. L., Xia, W., Jiang, X. and Robertson, D. L. (2022) Exploring the natural origins of SARS-CoV-2 in the light of recombination. Genome Biology and Evolution, 14(2), evac018. (doi: 10.1093/gbe/evac018) (PMID:35137080) (PMCID:PMC8882382)
Said Mohammed, K. et al. (2022) An optimization of four SARS-CoV-2 qRT-PCR assays in a Kenyan laboratory to support the national COVID-19 rapid response teams. Wellcome Open Research, 5, 162. (doi: 10.12688/wellcomeopenres.16063.2) (PMID:35330938) (PMCID:PMC8921690)
Silva, S. J. R. d., Germano Mendes, R. P., Alves da Silva, C. T., Lorusso, A., Kohl, A. and Pena, L. (2020) Insights into SARS-CoV-2, the coronavirus underlying COVID-19: recent genomic data and the development of reverse genetics systems. Journal of General Virology, 101(10), pp. 1021-1024. (doi: 10.1099/jgv.0.001458) (PMID:32579100) (PMCID:PMC7660456)
Furnon, W. , Cowton, V., De Lorenzo, G. , Patel, A. and Palmarini, M. (2024) Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants. Nature Microbiology, 9, pp. 451-463. (doi: 10.1038/s41564-023-01588-4) (PMID:38228858) (PMCID:PMC10847042)
Lamb, K. D., Luka, M. M., Saathoff, M., Orton, R. J. , Phan, M. V.T., Cotten, M. , Yuan, K. and Robertson, D. L. (2024) Mutational signature dynamics indicate SARS-CoV-2's evolutionary capacity is driven by host antiviral molecules. PLoS Computational Biology, 20(1), e1011795. (doi: 10.1371/journal.pcbi.1011795) (PMID:38271457) (PMCID:PMC10868779)
Iannucci, S., Harvey, W., Hughes, J. , Robertson, D. L. , Hutchinson, E. and Poyade, M. (2022) Using molecular visualisation techniques to explain the molecular biology of SARS-CoV-2 spike protein mutations to a general audience. In: Shapiro, L. and Rea, P. M. (eds.) Biomedical Visualisation. Volume 12. Series: Advances in experimental medicine and biology (1388). Springer: Cham, pp. 129-152. ISBN 9783031108884 (doi: 10.1007/978-3-031-10889-1_6)
Genova, C. et al. (2021) Production, titration, neutralisation, storage and lyophilisation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lentiviral pseudotypes. Bio-protocol, 11(21), e4236. (doi: 10.21769/bioprotoc.4236) (PMID:34859134) (PMCID:PMC8595416)
Lutalo, T. et al. (2021) Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute. International Journal of Infectious Diseases, 112, pp. 281-287. (doi: 10.1016/j.ijid.2021.09.020) (PMID:34536612) (PMCID:PMC8442260)
Niemi, M. E. K. et al. (2021) Mapping the human genetic architecture of COVID-19. Nature, 600(7889), pp. 472-477. (doi: 10.1038/s41586-021-03767-x) (PMID:34237774) (PMCID:PMC8674144)
Herder, V. et al. (2021) Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defences. PLoS Biology, 19(12), e3001065. (doi: 10.1371/journal.pbio.3001065) (PMID:34932557) (PMCID:PMC8765667)
Morton, B. et al. (2021) Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa. Nature Communications, 12, 3554. (doi: 10.1038/s41467-021-23267-w) (PMID:34117221) (PMCID:PMC8196064)
Berry, C. et al. (2023) Mental health symptoms and illness trajectory following COVID-19 hospitalization: A cohort study. Heart and Mind, 7(4), pp. 235-245. (doi: 10.4103/hm.HM-D-23-00037)
Mollentze, N. , Keen, D., Munkhbayar, U., Biek, R. and Streicker, D. G. (2022) Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction. eLife, 11, e80329. (doi: 10.7554/eLife.80329) (PMID:36416537) (PMCID:PMC9683784)
Etyang, A. O. et al. (2022) Seroprevalence of antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 among healthcare workers in Kenya. Clinical Infectious Diseases, 74(2), pp. 288-293. (doi: 10.1093/cid/ciab346) (PMID:33893491) (PMCID:PMC8135298)
Collier, D. A. et al. (2021) Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature, 596(7872), pp. 417-422. (doi: 10.1038/s41586-021-03739-1) (PMID:34192737) (PMCID:PMC8373615)
Bamford, C. G.G. et al. (2022) Comparison of SARS-CoV-2 evolution in paediatric primary airway epithelial cell cultures compared with vero-derived cell lines. Viruses, 14(2), e325. (doi: 10.3390/v14020325) (PMID:35215919) (PMCID:PMC8877208)
Takahashi, T. et al. (2020) Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature, 588(7837), pp. 315-320. (doi: 10.1038/s41586-020-2700-3) (PMID:32846427) (PMCID:PMC7725931)
Milling, S. (2021) Sensitive detection of anti‐spike antibodies enables improved understanding of SARS‐CoV‐2 pathogenesis. Immunology, 164(1), pp. 1-2. (doi: 10.1111/imm.13399) (PMID:34382228)
Manali, M. et al. (2023) SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunity. Journal of Infectious Diseases, 227(1), pp. 40-49. (doi: 10.1093/infdis/jiac332) (PMID:35920058) (PMCID:PMC9384671)
Stirrup, O. et al. (2021) SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study. BMJ Open Respiratory Research, 8, e001029. (doi: 10.1136/bmjresp-2021-001029) (PMID:34544733) (PMCID:PMC8453594)
Lytras, S., Xia, W., Hughes, J. , Jiang, X. and Robertson, D. L. (2021) The animal origin of SARS-CoV-2. Science, 373(6558), pp. 968-970. (doi: 10.1126/science.abh0117) (PMID:34404734)
Parker, E. et al. (2023) SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: an ISARIC4C prospective study. Frontiers in Immunology, 14, 1146702. (doi: 10.3389/fimmu.2023.1146702) (PMID:37056776) (PMCID:PMC10087108)
ISARIC Clinical Characterization Group, et al. (2022) ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19. Scientific Data, 9(1), 454. (doi: 10.1038/s41597-022-01534-9) (PMID:35908040) (PMCID:PMC9339000)
Stirrup, O. et al. (2022) Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: multicenter, prospective study. eLife, 11, e78427. (doi: 10.7554/elife.78427) (PMID:36098502) (PMCID:PMC9596156)
Parry, R., Gifford, R. J. , Lytras, S., Ray, S. C. and Coin, L. J.M. (2021) No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues. Proceedings of the National Academy of Sciences of the United States of America, 118(33), e2109066118. (doi: 10.1073/pnas.2109066118) (PMID:34344759)
Boni, M. F., Lemey, P., Jiang, X., Lam, T. T.-Y., Perry, B. W., Castoe, T. A., Rambaut, A. and Robertson, D. L. (2020) Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic. Nature Microbiology, 5(11), pp. 1408-1417. (doi: 10.1038/s41564-020-0771-4) (PMID:32724171)
Bouhaddou, M. et al. (2023) SARS-CoV-2 variants evolve convergent strategies to remodel the host response. Cell, 186(21), pp. 4597-4614. (doi: 10.1016/j.cell.2023.08.026) (PMID:37738970) (PMCID:PMC10604369)
Munblit, D. et al. (2022) A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respiratory Medicine, 10(7), pp. 715-724. (doi: 10.1016/S2213-2600(22)00169-2) (PMID:35714658) (PMCID:PMC9197249)
Davis, C. et al. (2021) Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination. PLoS Pathogens, 17(12), e1010022. (doi: 10.1371/journal.ppat.1010022) (PMID:34855916) (PMCID:PMC8639073)
Sattar, N. , McInnes, I. B. and McMurray, J. J.V. (2020) Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation, 142(1), pp. 4-6. (doi: 10.1161/CIRCULATIONAHA.120.047659) (PMID:32320270)
Cantoni, D. and Grove, J. (2023) Low hanging fruit for combatting SARS‐CoV‐2? EMBO Reports, 24(4), e56979. (doi: 10.15252/embr.202356979) (PMID:36876512) (PMCID:PMC10074046)
School of MolecularBiosciences
Covid19 Publications
Mahindra, A. et al. (2021) Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction. PLoS ONE, 16(11), e0260283. (doi: 10.1371/journal.pone.0260283) (PMID:34793553) (PMCID:PMC8601423)
Morgan, D. C. et al. (2021) Stapled ACE2 peptidomimetics designed to target the SARS-CoV-2 spike protein do not prevent virus internalisation. Peptide Science, 113(4), e24217. (doi: 10.1002/pep2.24217) (PMID:33615115) (PMCID:PMC7883042)
Hart, A. (2020) Cover illustration: "Lockdown" mural, Bath Street, Glasgow, by the.rebel.bear Unshackling Plastic Surgery from COVID-19. Journal of Plastic, Reconstructive and Aesthetic Surgery, 73(6), pp. 1009-1011. (doi: 10.1016/j.bjps.2020.05.082) (PMID:32553186) (PMCID:PMC7293883)
School of Psychology & Neuroscience
Covid19 Publications
Vallatos, A. et al. (2021) Adaptive manufacturing for healthcare during the COVID-19 emergency and beyond. Frontiers in Medical Technology, 3, 702526. (doi: 10.3389/fmedt.2021.702526) (PMID:35047941) (PMCID:PMC8757720)
Rooksby, M. , Furuhashi, T. and McLeod, H. J. (2020) Hikikomori: a hidden mental health need following the COVID-19 pandemic. World Psychiatry, 19(3), pp. 399-400. (doi: 10.1002/wps.20804) (PMID:32931118)
Mccaughey, E. J., Ho, F. K., Mackay, D. F. , Pell, J. P. , Humburg, P. and Purcell, M. (2024) The impact of COVID-19 and associated lockdowns on traumatic spinal cord injury incidence: a population based study. Spinal Cord, 62(1), pp. 1-5. (doi: 10.1038/s41393-023-00939-6) (PMID:37919383) (PMCID:PMC10783541)
Claassen, M. A., Lomann, M. and Papies, E. K. (2023) Increased consumption despite fewer occasions: a longitudinal analysis of COVID-19 lockdown effects on soft drink consumption in England. Appetite, 187, 106579. (doi: 10.1016/j.appet.2023.106579) (PMID:37148974)
Buchanan, E. M. et al. (2023) The Psychological Science Accelerator’s COVID-19 rapid-response dataset. Scientific Data, 10, 87. (doi: 10.1038/s41597-022-01811-7) (PMID:36774440) (PMCID:PMC9918828)
Patone, M. et al. (2021) Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nature Medicine, 27(12), pp. 2144-2153. (doi: 10.1038/s41591-021-01556-7) (PMID:34697502) (PMCID:PMC8629105)
Danton, M. H.D. and Bushnell, I. (2023) Zoom and its discontents: group decision making in pediatric cardiology in the time of COVID (and beyond). Journal of Medical Systems, 47(1), 59. (doi: 10.1007/s10916-023-01944-1)